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RIASSUNTO 
 
 
Il progetto di dottorato è stato condotto presso il Dipartimento di Scienza degli Alimenti della 
Facoltà di Agraria della Federico II. Per la realizzazione di tale progetto sono state instaurate 
delle collaborazioni con alcuni laboratori: in particolare si è collaborato con l‟Istituto di 
Scienza dell‟Alimentazione ISA-CNR di Avellino per la parte riguardante la caratterizzazione 
peptidomica dei sieri di lavorazione della mozzarella di bufala e con il Dipartimento di 
Biochimica e Biofisica della Seconda Università di Napoli per lo studio bio-funzionale delle 
componenti peptidiche estratte dai sieri di lavorazione su cellule umane di adenocarcinoma 
del colon CaCo2. 
L‟obiettivo di questo lavoro di Dottorato è stato quello di sviluppare una strategia analitica 
che, mediante l‟applicazione di procedure di tipo proteomico/peptidomico, consentisse di 
valutare la presenza, l‟evoluzione e la bioattività dei peptidi generati sia per effetto 
proteolitico indotto dal processo tecnologico che per quello dovuto alle proteasi endogene al 
latte. 
Per questo motivo, il lavoro di tesi si articola in due capitoli, ciascuno per le rispettive 
tematiche sopra menzionate:  
I. studio dell‟evoluzione dei pattern peptidici prodotti durante il processo tecnologico 
di produzione della Mozzarella di Bufala Campana DOP nei sieri di caseificazione a 
partire dal latte di bufala.  
II. studio dei profili peptidici in campioni individuali di latte di asina. 
 
Per quanto riguarda il primo capitolo di questa tesi di Dottorato, è stato sviluppato un 
approccio integrato di tipo proteomico e bio-funzionale al fine di: 
1) delineare mediante approccio proteomico il pathway di formazione dei peptidi a potenziale 
attività biologica lungo l‟intera filiera di lavorazione della Mozzarella, seguendone la 
produzione a partire dal latte di bufala e passando per il siero dolce, per il siero acido fino ad 
arrivare alla scotta.  
2) studiare l‟effetto di modulazione delle componenti peptidiche estratte sulle cellule CaCo2 
in termini di attività antiproliferativa preliminarmente e, successivamente, di ulteriore 
approfondimento del biochimismo coinvolto nella risposta cellulare per le frazioni risultate 
più attive. 
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Per quanto riguarda il primo punto in cui è articolato il I capitolo, è stato messo a punto un 
metodo di estrazione delle componenti peptidiche a basso peso molecolare, basato su un 
processo di ultrafiltrazione su membrane seguito da estrazione in fase solida, pertanto senza 
l‟utilizzo di precipitanti chimici. Il latte di bufala (BM) della mungitura mattutina, il siero 
dolce (BSW) ottenuto appena dopo la coagulazione del latte, il siero acido (BWW) residuo 
alla maturazione della cagliata e la scotta (BS), nella fase di campionamento in caseificio, 
sono stati immediatamente aggiunti di inibitori di proteasi per ovviare al progredire di 
fenomeni proteolitici indesiderati durante la successiva fase di estrazione. La caratterizzazione 
proteomica dei profili peptidici così estratti ci ha consentito di constatare che sebbene  BM 
disponga di un profilo peptidico intrinseco prodotto dall‟azione delle proteasi endogene al 
latte, la proteolisi durante la produzione della Mozzarella di Bufala Campana DOP, 
contribuisce ad aumentare ulteriormente la complessità e l'eterogeneità di ciascun estratto 
peptidico. La caratterizzazione strutturale ci ha permesso di concludere che la proteolisi del 
latte è il risultato di una complessa serie di eventi dovuti all'azione combinata di proteasi 
native o endogene al latte, di enzimi della coagulazione del latte e microflora contaminante. 
Dalla comparazione dei profili peptidici di BM, BSW, BWW e BS emerge che quello di 
BWW è alquanto eterogeneo, con un gran numero di oligopeptidi diversi tra cui alcuni di essi 
con sequenze bioattive criptate. 
Il secondo punto del I capitolo, è stato delineato partendo dalla considerazione che lo studio in 
vitro dell‟interazione tra modelli cellulari e bio-molecole rappresenta attualmente una 
metodologia analitica innovativa per le scienze dell‟alimentazione. Le cellule epiteliali del 
tratto gastrointestinale, a differenza delle cellule di altri tessuti, sono direttamente esposte al 
contatto con micro- e macronutienti assunti con l‟alimentazione; l'intestino si trova 
all'interfaccia tra l'organismo e il suo ambiente lumenale, rappresentando una barriera 
difensiva fondamentale contro gli agenti tossici. Le cellule epiteliali di adenocarcinoma 
umano del colon (CaCO2) sono state utilizzate come modello per studiare in vitro la 
potenziale attività citomodulante dei peptidi estratti da BM, BSW, BWW e BS. 
Preliminarmente all‟incubazione con gli estratti peptidici, le CaCo2 sono state indotte allo 
stress ossidativo mediante trattamento con H2O2 (H-CaCo2)  al fine di simulare la risposta 
delle cellule intestinali, costantemente esposte ad agenti ossidanti durante la digestione degli 
alimenti.  
Solo l'esposizione delle H-CaCo2 a BM (1 mg/ml) e BWW (1 mg/ml) comporta una riduzione 
della proliferazione cellulare quantitativamente più significativa in quest‟ultimo caso: BWW, 
infatti, riduce del 43% la proliferazione cellulare. Tuttavia, la constatazione che BWW è un 
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“rifiuto organico speciale” ed un inquinante ambientale con valore commerciale trascurabile 
rispetto al latte di bufala, ci ha spinto ad approfondire esclusivamente l‟attività di BWW sia in 
termini di riduzione degli anioni superossido mitocondriali (6,2% per il controllo e 3,7% con 
BWW), che di modulazione del ciclo cellulare. Questi risultati suggeriscono che BWW è in 
grado di inibire la proliferazione cellulare interferendo con il ciclo cellulare ed esercitando 
una possibile attività pro-apoptotica in vitro. La reiterazione dei test biologici con sub-frazioni 
semplificate ottenute da RP-HPLC di BWW, ci ha permesso di dimostrare che solo una sub-
frazione peptidica (f3) esplica un effetto antiproliferativo superiore a BWW riducendo gli 
anioni superossido mitocondriali con conseguente diminuzione dell‟espressione delle proteine 
Hsp (Heat Shock)70 e Hsp90 nelle cellule sopravvissute. E' comunemente noto che le cellule 
CaCo2 sono difficili da trattare e proliferano abbastanza velocemente anche in condizioni 
avverse per le cellule normali. Inoltre esse esprimono costitutivamente alti livelli di Hsp70 e 
Hsp90 anche in condizioni di non-stress: questo è alla base della loro elevata resistenza ai 
trattamenti immunologici e chemio terapeutici. Dunque la riduzione di Hsps indotta dal 
trattamento con f3 rende le CaCo2 significativamente più sensibile agli effetti dannosi degli 
agenti ossidanti. Inoltre, la diminuzione dell‟espressione di ciclina A e l‟arresto del ciclo 
cellulare nella fase G1/G0 indotte da f3, sono state associate con un aumento dell'attività della 
fosfatasi alcalina e di beta-galattosidasi A, marcatori di differenziazione e di senescenza, 
rispettivamente. In questa fase, l‟analisi di spettrometria di massa della frazione solubile in 
cloroformio dei mezzi di coltura cellulari, ci ha consentito di individuare sfingolipidi tra cui 
ceramidi e cerebrosidi che esplicano normalmente la funzione di secondo messaggero 
cellulari: l'aumento della loro concentrazione intracellulare in risposta a segnali extracellulari 
induce l'arresto delle cellule e l'inibizione della crescita delle cellule tumorali. f3 aumentando 
la secrezione di ceramidi, provoca l'arresto del ciclo cellulare, la differenziazione, e una 
successiva morte cellulare per "senescenza accelerata”. 
In conclusione, l‟effetto biologico di f3 ne lascia ipotizzare un suo possibile utilizzo come 
nutraceutico una volta che un opportuno processo industriale di purificazione è stato messo a 
punto a partire da una materia prima a costo zero o nullo, quale BWW. Quest‟ultimo,infatti è 
attualmente considerato un rifiuto organico speciale che pone non pochi problemi per il suo 
smaltimento.   
 
Nel secondo capitolo di questa tesi di Dottorato, invece, la strategia di tipo proteomico è stata 
applicata a 18 campioni di latte di asina individuali forniti nell‟ambito del progetto SELMOL. 
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L‟approccio peptidomico mediante spettrometria di massa MALDI-TOF-MS, ha permesso di 
caratterizzare la componente peptidica in ciascun latte di asina individuale e di individuare, in 
funzione dei cluster peptidici generati, gruppi omogenei di campioni tra loro simili; negli 
stessi campioni è stata valutata l‟attività antiossidante in modo da determinare il ruolo dei 
peptidi del latte d‟asina nel prevenire le reazioni di perossidazione lipidica. 
Dalla valutazione complessiva dei pattern peptidici delineati, è emerso che l‟attività delle 
proteasi endogene al latte di asina si esplica con una specificità di azione intrinseca se 
comparata a quella studiata per il latte di bufala. In particolare è risultato che: 
- in nessun campione sono stati identificati peptidi derivanti dall‟αs1-CN  ad eccezione del 
campione P32. Questo dato lascia emergere da un lato una maggiore resistenza alla proteolisi 
di questa proteina e dall‟altro dimostra la presenza di una zona di suscettibilità proteolitica 
interna alla sequenza proteica diversa rispetto a quella nota per l‟omologa proteina bovina, 
normalmente localizzata nella zona N-terminale della proteina.  
- alcuni peptidi vengono prodotti dalla porzione N-terminale dell‟αs2-CN, notoriamente non 
soggetta all‟azione proteolitica primaria nel latte dei ruminanti. In particolare, tali peptidi, tra 
cui anche caseinfosfopeptidi, sono stati identificati solo in alcuni dei 18 campioni oggetto di 
studio, ossia P28, P29, P30, P31, P32 e P33.  
- diversi peptidi identificati provengono dalla β-CN ed in particolare non solo dalla porzione 
prossima al C-terminale, notoriamente sensibile all‟azione di proteasi di parete di tipo I e III di 
Lactococcus sp, ma anche da una zona interna alla stessa proteina compresa tra i residui 40-55. 
Ad eccezione dei campioni P28, P29, P30, P31, P33 e P39 accomunati da un elevato numero 
di frammenti generati dal peptide 40-55, tutti gli altri presentano pochi frammenti derivati da 
questa zona di sequenza. Relativamente alla porzione C-terminale della β-CN, invece, il 
campione di latte risultato più ricco di peptidi è il P42.  
L‟attività antiossidante, è stata valutata con il metodo della perossidazione lipidica mediante 
TBARS-test incubando le componente peptidiche estratte da ciascun campione di latte in 
presenza di acido linolenico. Essa è stata studiata in presenza di perossido di idrogeno al fine 
di ricreare condizioni di forte stress ossidativo quali sono quelle cui normalmente è esposto 
l‟organismo anche con la normale respirazione cellulare. E‟ noto, infatti, che la 
perossidazione dei lipidi induce un processo radicalico a catena che comporta la formazione 
di un ampio range di effetti dannosi per l‟organismo come mutagenesi, citotossicità ed 
alterazione dell‟espressione genica. I risultati ottenuti permettono di constatare che ad 
eccezione di P38 e P45 che non esprimono nessuna variazione quantitativa rispetto al 
controllo, tutti gli altri campioni determinano un effetto di diminuzione del contenuto di 
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TBARS, particolarmente accentuato in due campioni -P28 e P43- che riducono di circa l‟80% 
la perossidazione dell‟acido linolenico. Comparando i profili peptidici di questi ultimi due, è 
ipotizzabile che l‟effetto antiossidante riscontrato, sia ascrivibile ad una azione sinergica di 
due classi di peptidi a potenziale bioattività antiossidante: i caseinfosfopeptidi provenienti 
dall‟αs2-CN e quelli generati dalla porzione C-terminale della β-CN. Questi ultimi, infatti, 
contengono criptata una sequenza a nota attività antiossidante quale quella 177-183 della 
vacca corrispondente a 183-189 dell‟asina. Tuttavia, il peptide β-CN f183-189 di asina 
presenta, rispetto all‟omologa sequenza vaccina una sostituzione all‟N-terminale 
Val
183→Ala177: poiché gli amminoacidi coinvolti nella sostituzione sono entrambi idrofobici, 
ed è noto che la presenza in sequenza di questi ultimi rappresenta un requisito strutturale 
fondamentale per l‟attività antiossidante, è possibile ipotizzare che la sostituzione 
amminoacidica non né alteri la bioattività.  
 
Tuttavia, l‟identificazione dei componenti peptidici può essere effettuata solo se è nota la 
sequenza della proteina madre da cui essi sono generati. Per questo motivo, preliminarmente 
alla caratterizzazione dei profili peptidici di ciascun campione di latte di asina, è stata 
condotta una caratterizzazione della componente caseinica, mediante uno studio combinato 
dei profili ottenuti da separazione elettroforetica 1-DE (PAGE, UTLIEF) e 2-DE (PAGE  
UTLIEF) ottenuti grazie a colorazione con Comassie Brilliant Blue ed anticorpi policlonali, 
con l‟analisi strutturale mediante spettrometria di massa.   
L‟applicazione combinata di queste metodologie, ci hanno consentito di identificare 
contemporaneamente l‟αs1-CN, αs2-CN, β-CN e k-CN con le relative eterogeneità dovute a 
fosforilazione (αs1-CN, αs2-CN, β-CN), glicosilazione (k-CN) e ad un incorretto splicing 
dell‟RNA in m-RNA (forme delete di αs1-CN e β-CN).  
Inoltre sono state individuate 11 diverse componenti diversamente glicosilate per la k-CN, 6 
forme fosforilate per la β-CN e l‟αs1-CN, 3 isoforme diversamente fosforilate per l‟αs2-CN 
ciascuna con 11, 12 e 13 gruppi fosfato. Relativamente all‟αs2-CN, per la prima volta è stata 
definita la sequenza primaria di questa proteina a partire dalla sequenza dedotta dal cDNA 
noto in letteratura.  
Inoltre, la β-CN è stata identificata sia nello stato omozigote che eterozigote per la presenza di 
una variante genetica con MW di 28 unità di massa in più rispetto al più comune fenotipo di 
β-CN. 
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PREFACE 
 
Proteins are a very diverse family of large organic compounds involved in many important 
biological processes. The process involving protein degradation both in a partial way, giving 
peptides, oligopeptides and/or in a complete one, giving free amino acids, is commonly 
known as “proteolysis” and is due to proteolytic enzymes. 
Although the proteolysis is a conceptually simple phenomenon, it is quite complex in its 
development and evolution dynamics: the proteolytic activity of enzymes is responsible for 
structural, functional and nutritional changes in food proteins. Thus, proteolysis is an event of 
overriding importance in the technology of dairy products processing: in vegetables, bread, 
and other food products, the protein metabolism by proteolytic enzymes is somewhat less 
important compared to proteolysis in dairy products. 
Milk proteolysis is due to enzymatic hydrolysis on casein induced by a series of enzymes.  
The degradation of caseins involves a series of very important effects: it contributes to the 
softening of cheese texture, and because of a subsequent formation of peptides by lower 
molecular weight, it leads to a significant increase in the number of carboxylic and amine-free 
functions, with a resulting decrease of water (aw). The proteolytic process plays an important 
role in the development of cheese sensorial characteristics, in fact many low molecular weight 
peptides (di-and tripeptides) and many amino acids, representing the ultimate product of 
proteolysis, have a particular taste (often bitter, especially in the case of compounds with 
strong hydrophobicity) and therefore their concentration in the final product will be critical 
for the taste. 
Finally, the same amino acids released during proteolysis are themselves substrates of 
catabolic reactions leading to the formation 
of volatile aromatic compounds responsible for the development of cheese flavour. 
During the cheese making process, the action of exogenous proteases simultaneously with 
native ones is responsible for a kind of metamorphosis of the first in processed milk gelled of 
curd until then to get the cheese passing from a rubbery mass of protein and fat into a final 
flavourful, textured fusion of complex substances found in the cheese. 
The capabilities of the metamorphosis/proteolysis is similarly explicit during milk 
gastrointestinal digestion: a complex of digestive reaction steps produces simpler peptide 
fragments easily absorbed and assimilated. 
So, following enzymatic hydrolysis during food processing or digestion, proteins may release 
fragments from their primary amino acid sequence. These fragments are called peptides, and 
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many of them are known to be physiologically active. The possible beneficial effects of 
bioactive peptides have attracted increasing interest in recent years. 
Dietary proteins are traditionally known to provide a source of energy and amino acids 
essential for growth and maintenance of various body functions. In addition, they contribute 
to the physicochemical and sensory properties of protein-rich foods. 
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GENERAL INTRODUCTION 
 
 
1. Milk casein proteolysis by endogenous, exogenous  and gastrointestinal proteases 
 
Among constituents of secreted milk there are several endogenous enzymes including 
proteases. The principal constituents of milk (lactose, lipids and proteins) can be modified by 
exogenous enzymes, added to induce specific changes. In addition, milk and most dairy 
products contain viable micro-organisms which secrete extracellular enzymes or release 
intracellular enzymes after the cells have died and lysed. Some of these enzymes may cause 
undesirable changes, e.g. hydrolytic rancidity of milk and dairy products, bitterness and/or 
age gelation of UHT milks, bitterness in cream, malty flavours or bitterness in fluid milk, or 
they may cause desirable flavours, e.g. in ripened cheese. 
The following paragraphs are devoted mainly to the significance of endogenous milk 
proteases and exogenous enzymes with a proteolytic activity on caseins during 
gastrointestinal digestion and cheese-making.  
 
 
1.1 Endogenous milk proteolytic enzymes 
 
Milk contains essentially two proteinase systems, both derived from blood: one is involved in 
dissolving blood clots (plasmin) and the other in defence against invasive micro-organisms 
(lysosomal proteinases of somatic cells). Both systems which are involved in milk caseins 
hydrolysis, are complex in their regulation and sensitivity to external factors, and vary in 
activity due to factors such as stage of lactation and mastitis. While plasmin is the principal 
proteinase in good-quality milk, other proteinases, including cathepsins and elastase, are 
probably also active, particularly as the somatic cell count of milk increases. In terms of 
activity and technological significance, plasmin is the most important of the endogenous 
proteinases and has been the most controversial subject. 
Plasmin (EC 3.4.21.7) is a serine proteinase, similar to trypsin in its activity and 
characteristics. Plasmin is a heat-stable alkaline serine proteinase with a relatively broad 
specificity on the caseins; it exists in milk as a component of a complex system, including its 
zymogen, plasminogen, plasminogen activators (PAs) and inhibitors of both plasmin and PAs 
[1]. Plasmin cleaves proteins on the carboxyl side of L-Arg and L-Lys residues, with a 
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preference for the latter. Plasmin certainly hydrolyzes αs1-, αs2- and β-CN, while although κ-
CN contains several Lys and Arg residues, it appears to be quite resistant to plasmin, 
presumably due to a relatively high level of secondary and tertiary structure. Plasmin has little 
or no activity on the whey proteins β-lactoglobulin and α-lactalbumin. Degradation of αs2-and 
β-CN occurs at the same rate while αs1-CN is hydrolyzed at a slower rate [2]. β-CN is the 
most susceptible milk protein to plasmin action: it is hydrolysed rapidly at Lys
28
-Lys
29
, 
Lys
105
-His
106
 and Lys
107
-Glu
108
, to yield γ1 (β-CN f29-209), γ2 (β-CN f106-209) and γ3 (β-CN 
f108-209) caseins and proteose-peptone (PP)5 (β-CN fl-105/7), PP8 slow (β-CN f29-105/7) 
and PP8 fast (β-CN fl-29). From a quantitative point of view, γ-caseins normally represent 
about 3% of total N in milk  while the concentration of proteose peptones is about half that of 
the γ -caseins. Although αs2-CN in solution is hydrolysed very rapidly by plasmin at bonds on 
Lys
21
, Lys
24
, Lys
149
, Lys
150
, Lys
181
, Lys
187
, Lys
188
 and on Arg
114
, it is not known if it is 
hydrolysed in milk. Similarly, αs1-CN in solution is also readily hydrolysed by plasmin but it 
does not appear to be hydrolysed to a significant extent [3].  
The second proteinase identified in milk is the more heat-labile lysosomal (i.e., somatic cell-
derived) aspartyl proteinase, cathepsin D even if other lysosomal proteinases (e.g., elastase, 
cathepsin B as well cathepsins G, S, K, H and L) are almost certainly present in milk [4]. 
Undoubtedly the casein breakdown product is a function of the milk endogenous enzyme 
activity, but it also depends on the time for which the enzyme(s) acts on the caseins, as for 
example during dairy products storage. A number of peptides have been identified in freshly 
drawn bovine milk as a consequence of a simultaneously action of plasmin and cathepsins D 
and B on specific cleavage sites of αs1- and β-CN [4].  
 
 
1.2 Microbial fermentation 
 
The function of lactic acid bacteria (LAB) in the manufacture of cultured dairy products is to 
ferment lactose to lactic acid so that milk pH decreases and the isoelectric point 4.6 of casein 
is reached giving the formation of a coagulum. Anyway, like many bacteria, LAB have a 
limited capacity to synthesize amino acids and are therefore dependent on the use of 
exogenous nitrogen sources for optimal growth [5]. 
Since most foods contain only a small pool of free amino acids, this means that LAB must 
first be able to degrade proteins and large peptides and then also be able to transport the free 
amino acids and small peptides released during proteolysis. The proteolytic system in LAB, 
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especially those species involved in dairy fermentations, has been well studied. Certain LAB, 
mainly the strains belonging to the genera Lactobacillus, are increasingly marketed as health- 
promoting, that is, probiotic bacteria [6], while certain Lactobacillus strains can release 
bioactive health-beneficial peptides from milk proteins [7].  The caseins utilization system in 
LAB, involves three main steps: a) caseins are hydrolyzed by proteinases to form peptides; b) 
the peptides are transported into cells via peptide transport systems; c) the peptides are 
hydrolyzed by intracellular peptidases to form free amino acids.  
Each of this step is described below. 
 
a. The proteinase system 
Caseins hydrolysis by LAB occurs via a cell envelope-associated serine proteinase called PrtP 
which is actually synthesized as a large inactive pre-pro-proteinase (>200 kDa). The “pre” 
portion contains a leader sequence with the function to direct the protein across the 
cytoplasmic membrane while the “pro” sequence presumably stabilizes the protein during its 
synthesis. After both “pre-pro” regions are removed, the mature proteinase remains linked to 
the cell envelope. More than 100 products are formed by PrtP on the casein substrate. The 
majority are large oligopeptides (up to thirty amino acid residues), but most are between four 
and ten residues. 
 
b. Peptide transport systems 
Lactococci and other LABs transport peptides directly into the cell without further 
extracellular hydrolysis. In addition, although there is a myriad of peptides formed by PrtP, 
relatively few transporters can deliver these peptides into the cell, and even fewer are actually 
essential for growth in milk. An oligopeptide transport system (Opp) is used by Lactococci 
and LABs to satisfy their amino acid requirements. The Opp system transports about ten to 
fourteen different peptides of varying size (between four and eleven amino acid residues).  
 
c. Peptidases 
In the final step of protein metabolism, the peptides accumulated in the cytoplasm by the Opp 
system are hydrolyzed by intracellular peptidases. There are more than twenty different 
peptidases produced by Lactococci and LABs that generate the pool of amino acids necessary 
for biosynthesis and cell growth: included are endopeptidases (that cleave at internal peptide 
bonds) and exopeptidases (that cleave at terminal peptide bonds). The latter group consists 
entirely of aminopeptidases (hydrolyse the peptide bond located between the amino terminal 
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amino acid residue and the penultimate residue), and carboxypeptidases (acting at the peptide 
carboxy end). To fully use peptides accumulated by the Opp system, LAB requires the 
combined action of endopeptidases, aminopeptidases, dipeptidases and tripeptidases. 
Anyway, some peptidases may have specificity with regard to the amino acids and their 
position within a given peptide bond: aminopeptidaseP (PepP) from L. lactis subsp. lactis 
hydrolyzes peptides containing proline at the penultimate residues. 
However, the specific casein substrates and hydrolysis products of the different PrtP enzymes 
can vary considerably. For example, some proteinases hydrolyze αS1-, β-, and k-CN, whereas 
others have preference for β-CN and relatively little activity for αS1- and k-CN [8].  
In milk fermentation processes, in addition to its vital role for bacterial growth in milk, certain 
PrtP can release bioactive health-beneficial peptides during milk fermentation [9]. 
Along the way, LAB‟s culture may also produce other small organic molecules, including 
acetaldehyde, diacetyl, acetic acid, and ethanol. Although these latter compounds are 
produced in relatively low concentrations, they may still give important contributions to the 
overall flavour profile of the finished product. The culture may also produce other compounds 
which contribute to the viscosity, body, and mouth feel of the product.  
 
 
1.3 Milk clotting enzymes 
 
Rennet is a natural complex of enzymes produced in any mammalian stomach to digest the 
mother's milk. Rennet contains many enzymes, that are able to clot milk, causing it to separate 
into solids (curds) and liquid (whey). The active enzyme in rennet is called chymosin or 
rennin but there are also other important enzymes in it, e.g., pepsin or lipase. Chymosin and 
pepsin exhert a proteolytic activity on proteins while lipase acts on lipids. Limited to our 
interest, we are concerned about the first two. 
The chymosin exerts its proteolytic activity on casein: the cleavage sites are well known in 
literature[10].  
Experiments in solution showed the presence of seven cleavage sites on β-CN [10], many of 
which are located near the C-terminal hydrophobic sequence; in particular, the Leu
192
 and 
Tyr
193
 may lead to the formation of a series of hydrophobic peptides with a bitter taste. 
The αS1-CN also has several cutting sites and among them the best known is Phe
23
-Phe
24
 
giving the peptide αS1-CN f1-23 with a high content of basic residues. The αS1-CN f1-23 is 
rapidly degraded by peptidases of starter microorganisms [11]. The αS2-CN is much more 
resistant to chymosin. Similarly also the para-κ-casein (κ-CN f1-105) does not appear to be 
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hydrolyzed, although still contains a number of potential cutting sites [12] probably because 
of its secondary structure unaccessible to chymosin action [13]. Another very important 
bovine rennet protease is pepsin, which has a chymosin like proteolytic specificity but a 
higher proteolytic activity compared to the chymosin one. 
However because of pepsin optimum pH is about 2, its action is severely limited by the pH of 
the medium which could be milk or cheese. 
 
 
1.4 Milk proteolysis during gastrointestinal digestion 
 
Dietary proteins and peptides are subjected to hydrolysis during the various stages namely 
ingestion, digestion and absorption. Ingested proteins are first hydrolyzed in the acid 
environment of the stomach, where low pH initiates protein hydrolysis and gastric pepsin 
cleaves proteins into peptides of various sizes. The next stage of luminal protein digestion, 
known as pancreatic digestion, comprises the small intestinal digestion by the major 
enzymatic secretions from the pancreas trypsin, chymotrypsin, elastase, and carboxi-
peptidases. The gastro-pancreatic digestion results in free amino acids and 3 to 6 amino acid 
peptides, which could have biological activity. Subsequent brush-border peptidases at the 
surface of the epithelial cells digest peptides into dipeptides and tripeptides and free amino 
acids while some peptides remain intact. 
The intestinal brush-border metabolism is due to the action of aminopeptidases, 
carboxypeptidases and also enterokinases and dipeptidases. For example, dipeptidyl 
carboxypeptidase preferentially cleaves di-peptides from the C-terminus of oligopeptides with 
Pro, Phe or Leu in the ultimate position. Dipeptidyl aminopeptidase IV releases di-peptides 
from the N-terminus of oligopeptides with Pro or Ala in the second position. Hence, the di-
peptides released by these enzymes are generally of the X-Pro type while tri-peptides 
containing C-terminal Pro-Pro are reported to be resistant to Pro-specific peptidases. Anyway, 
Pro- and hydroxyl Pro-containing peptides are generally resistant to degradation by digestive 
enzymes. However, certain peptides are resistant to the action of proteolytic enzymes and 
remain intact in the intestinal tract. For example, in a recent work of Picariello et al., 2009 on 
peptides surviving the simulated gastrointestinal digestion of caseins and whey proteins, the 
β-Lg f125-135 showed an exceptional stability to gastro-pancreatic and brush-border 
membrane proteolysis [14].  
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Different transport systems for the absorption of peptides have been described: oligopeptides 
seem to be transported by endocytosis, although it has been reported that more than 90% of 
the transported peptides are hydrolyzed in the absorptive cells; oligopeptides could be 
passively transported via paracellular pathways, which is known to be the main mechanism 
for transport of intact peptides; oligopeptides could be transported by transcytosis (vescicle-
mediated transcellular transport); di-peptides and tri-peptides are actively transported via 
PepT1, a specific transport system that exists in the brush-border membrane [15]. Much 
research has been carried about the transport of bioactive peptides on CaCo2 cells: opioid 
peptides [16], ACE inhibitors [17] and anti-hypertensive peptides [18] have been shown to 
cross the epithelial cell monolayer. 
These studies found that the method of transport is not only dependent on the size of the 
peptide but also on charge, molecular weight, hydrogen bonding and hydrophobicity. 
Whichever mechanism was used, a variety of peptides would reach the portal circulation, 
showing different physiological functions. Therefore, following digestion, bioactive peptides 
can either produce local effects in the gastrointestinal tract or be absorbed through the 
intestine to enter intact into the blood circulation and exert systemic effects. 
 
 
1.5 Proteolysis in cheese 
 
Although it was long argued that milk fat was the primary constituent responsible for cheese 
flavour, it is now generally accepted that, for most cheeses it is the protein fraction that is the 
most important overall contribution. So cheese made under controlled conditions in which 
proteolysis does not occur because of absence of starter and non-starter LAB, develops 
neither the flavour nor the texture of normal cheeses: these cheeses do not produce cell wall 
proteinase and casein degradation occurs to a very limited extent. Moreover, it should be 
noted that residual chymosin and milk proteinases (mainly plasmin) may also contribute to 
the peptide pool, especially during the early stages of cheese ripening. However, the starter 
and non-starter LABs are responsible for most of the subsequent casein hydrolysis. During the 
ripening process, because of the starter bacteria lyse (due to salt, low water activity, lack of 
fermentable substrates, and other factors), the entire array of intracellular enzymes is released 
into the curd matrix. Thus, the various peptidases important for peptide degradation are free to 
hydrolyze available substrates. Likewise, enzymes that act directly on amino acids, 
triglycerides, and other substrates are also released. 
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The evolution of milk casein proteolysis varies greatly among different cheese varieties 
because of different technological productions involved, which may be cooking temperature, 
pH during whey drainage, time of ripening, 
moisture conditions, residual coagulant activity, possible development of an 
highly proteolytic microflora: these differences make the pattern 
proteolysis essentially unique and characteristic for each type of cheese.  
Without going into details of thecnological parameters, we can identify the proteolysis steps 
involved during the milk transformation on cheeses [19].  
The αS1-CN Phe
23
-Phe
24
 is the first peptide bond to be early hydrolyzed by chymosin action. 
The high temperatures involved during curd cooking as in Swiss-cheeses, rapidly inactivate 
chymosin, so the plasmin, which is more resistant to high temperature, is the first proteolitic 
enzyme in this kind of cheeses. The αS1-CN f1-23 and the αS1-CN f24-199 peptides, 
themselves become a substrate for the action of other proteolytic enzymes. A more prolonged 
cheese aging corresponds to an enrichment of peptides and amino acids while little seasoned 
cheeses have a low rate of nitrogen soluble at pH 4,6; on the other end, the proteolysis degree 
in fresh cheeses like mozzarella is very small compared to those aged. In mould-ripened 
cheeses, the P. Roqueforti induced proteolysis, degrades these fragments along with β-CN. 
Consequently at the end of the ripening process the caseins are completely hydrolyzed [20]. 
In Swiss-cheese types, the β-CN is degraded faster than αS1-CN: 
the increasing levels of γ-casein, indicating that, as previously reported, the proteolytic 
activity of plasmin is particularly strong in this kind of cheeses. 
A trend common to the Swiss-cheeses can also be seen in particularly fresh cheese such as 
mozzarella, whose cooking temperatures results in a partial chimosin inactivation [21].  
However, the mozzarella is not a ripened cheese, so its index of proteolysis is very low;  
on the contrary, cheeses like Parmigiano-Reggiano, also cooked at high temperatures, are 
widely hydrolyzed by plasmin and LAB proteases because of the long periods of ripening 
(from the 12 months) [22]. 
 
 
2. Milk biologically active peptides 
 
In recent years, food proteins have gained increasing value due to the rapidly expanding 
knowledge about physiologically active peptides. Although bioactive peptides from different 
animal or plant origins as soybean have been described, those derived from milk have been in 
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the last two decades the most studied. Milk proteins provide a rich source of peptides which 
are latent until released and activated, e.g. during gastrointestinal digestion or food processing 
[23]. Once liberated, these peptides are potential modulators of many regulatory processes in 
living systems as shown in Figure 1 and may act even as regulatory compounds with 
hormone-like activity [24].  
 
Fig 1. Physiological functions of milk derived bioactive peptides. 
 
The primary and secondary structures of major bovine milk proteins are well characterized 
and the potential bioactivities of peptides released from these proteins are currently a subject 
of intensive research worldwide. In table 1, a list of milk bioactive peptide sequences in the 
primary structure of bovine αs1-, αs2-, β- and k-CN are reported (Tab 1). Most of the known 
bioactive peptides are composed of short amino acid sequences: oligopeptides present several 
advantages in comparison to large-sized molecules in view of a possible therapeutic use 
because they can more easily pass through the digestive tract and reach the blood circulation 
to be transported to their target organs.  
It must be underlined that even though bioactive peptides have been isolated in vivo in 
individuals following ingestion of caseins (CNs) or of milk-containing foods [25,26], their 
pharmacodynamic and pharmacokinetic parameters, as well as their bioavailability, remain to 
be established.     
Currently the enzymatic hydrolysis of the whole protein represents the most important way to 
produce bioactive peptides. Even if many of the known bioactive peptides have been 
produced using gastrointestinal enzymes as pepsin and trypsin, others enzymes from bacterial  
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Bovine 
casein 
Peptide Amino acid sequence Bioactivity 
αs1-CN 23-24 FF Anthipertensive 
 23-27 FFVAP Anthipertensive 
 102-109 KKYKVPQ Anthipertensive 
 144-149 YFYPEL Antioxidant 
 142-147 LAYFYP Anthipertensive 
 157-164 DAYPSGAW Anthipertensive 
 194-199 TTMPLW Anthipertensive-
Immunomodulating 
 90-95 RYLGYL Agonistic opioid 
 90-96 RYLGYLE Agonistic opioid 
 91-96 YLGYLE Agonistic opioid 
 1-23 RPKHPIKHQGLPQEVLNENLLRF Immunomodulating- 
Antimicrobial 
 43-58 DIGSESTEDQAMEDIK Caseinphosphopeptides 
 43-55 GSESTEDQAME Caseinphosphopeptides 
 59-79 QMEAESISSSEEIVPNSVEQK Caseinphosphopeptides 
 66-74 SSSEEIVPN Caseinphosphopeptides 
 106-119 VPQLEIVPNSAEER Caseinphosphopeptides 
αs2-CN 174-179 FALPQY Anthipertensive 
 174-181 FALPQYLK Anthipertensive 
 189-197 AMKPWIQPK Anthipertensive 
 189-193 AMKPW Anthipertensive 
 190-197 MKPWIQPK Anthipertensive 
 198-202 TKVIP Anthipertensive 
 1-32 KNTMEHVSSSEESIISQETYKQEKNMAINPSK Immunomodulating 
 164-179 LKKISQRYQKFALPQY Antimicrobial 
 165-203 KKISQRYQKFALPQYLKTVYQHQKAMKPWIQPKTKVIPY Antimicrobial 
 183-207 VYQHQKAMKPWIQPKTKVIPYVRYL Antimicrobial 
 2-21 NTMEHVSSSEESIISQETYK Caseinphosphopeptides 
 46-70 NANEEEYSIGSSSEESAEVATEEVK Caseinphosphopeptides 
 55-75 GSSSEESAEVATEEVKITVDD Caseinphosphopeptides 
 126-136 EQLSTSEENSK Caseinphosphopeptides 
 138-149 TVDMESTEVFTK Caseinphosphopeptides 
β-CN 1-18 RELEELNVPGEIVESLSS Cytomodulatory 
 105-117 KHKEMPFPKYPVE Cytomodulatory 
 98-105 VKEAMAPK Antioxidant 
 74-76 IPP Anthipertensive 
 84-86 VPP Anthipertensive 
 108-113 EMPFPK Anthipertensive 
 177-183 AVPYPQR Anthipertensive 
 193-198 YQEPVL Anthipertensive 
 193-202 YQEPVLGPVRGPFPI Anthipertensive 
 194-204 GPVRGPFPIIV Anthipertensive 
 114-121 YPVEPFTE Anthipertensive 
 1-28 RELEELNVPGEIVESLSSSEESITRINK Immunomodulating 
 63-68 PGPIPN Immunomodulating 
 191-193 LLY Immunomodulating 
 193-209 LLYQEPVLGPVRGPFPIIV Immunomodulating/ 
Antimicrobial 
 1-25 RELEELNVPGEIVESLSSSEESITR Caseinphosphopeptides 
 1-28 RELEELNVPGEIVESLSSSEESITRINK Caseinphosphopeptides 
 2-28 ELEELNVPGEIVESLSSSEESITRINK Caseinphosphopeptides 
 60-63 YPFP Agonistic opioid 
 60-64 YPFPG Agonistic opioid 
 60-65 YPFPGP Agonistic opioid 
 60-66 YPFPGPI Agonistic opioid 
 60-70 YPFPGPIPNSL Agonistic opioid 
 114-121 YPVEPFTE Agonistic opioid 
κ-CN 108-110 IPP Anthipertensive 
 35-41 YPSYGLN Antigonistic opioid 
 58-61 YPYY Antigonistic opioid 
 25-34 YIPIQYVLSR Antigonistic opioid 
 158-164 EINTVQV Antigonistic opioid 
Table 1. Biological active sequences in the primary structure of bovine αs1-, αs2-, β- and κ-CN. 
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and fungal sources, have been also utilised. Moreover digestive enzymes and other different 
enzyme combination of proteinases, including alcalase, chymotrypsin, pancreatin, pepsin, 
thermolysin and fungal sources, have been used to release bioactive peptides from intact 
proteins. Beside the conventional proteolytic enzymes for the production of peptides from 
protein sources, recombinant DNA techniques have also been experimented for the 
production of specific peptides or their precursors in microrganisms. Kim et al., demonstrated 
that the trypsin digest of a recombinant human αs1-CN expressed in Escherichia coli contains 
several ACE-inhibitor peptides compared to that arose from the same non recombinant 
protein [27]. 
There is now a considerable amount of scientific data to demonstrate that a wide range of 
milk peptides can regulate specific physiological functions in experimental animals and 
humans. These functions relate to general health conditions or a reduced risk of certain 
chronic diseases. It must be underlined that even if the possible beneficial effects of bioactive 
peptides have attracted increasing interest in recent years, on the other hand, there are also 
reports suggesting that some food-derived peptides might adversely affect human health. 
Among these, β-casomorphin-7 (BCM7) [28], a peptide sequence present in the milk protein 
β-CN, has been suggested to contribute to an increased risk for certain non-communicable 
diseases, such as autism, cardiovascular diseases and type I diabetes. Some literature reports 
have proposed possible mechanistic explanations for such associations. Recognising the 
alleged negative effect of BCM7 on human health, EFSA deemed it necessary to perform a 
comprehensive review of the published scientific literature in order to assess the relationship 
of this peptide and related peptides with non-communicable diseases. The EFSA reviewed all 
available scientific literature and concluded that a cause-effect relationship between the oral 
intake of BCM7 or related peptides and aetiology or course of any suggested non-
communicable diseases cannot be established. Consequently, a formal EFSA risk assessment 
of food-derived peptides was not recommended [29].  
Examples of milk peptides which have exerted physiological effects in animal model or 
human intervention studies are given in the following. 
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2.1 Effect on cardiovascular system 
 
2.1.1 Antihypertensive peptides 
Blood pressure regulation (and hypertension, when it cannot be ensured) is partially 
dependent on the rennin-angiotensin system; renin acts on angiotensinogen, releasing 
angiotensin I that is further converted into the active peptide hormone angiotensin II, a 
vasoconstrictor, by the angiotensin-converting enzyme (ACE, peptidyldipeptide hydrolase, 
EC 3.4.15.1). A great number of ACE-inhibitory peptides have been isolated from the 
enzymatic digest of various milk proteins and they are, at present, the most studied group of 
bioactive peptides. Milk antihypertensive caseins peptides, also known as casokinins, are 
mainly produced from αs1- and β-CN while only few studies concerning αs2-CN -which 
accounts ca. 10% (w/w) of the bovine casein system, owing to its poor solubility and difficult 
purification. 
Moreover, to exert an antihypertensive effect after oral ingestion, active peptides must be 
absorbed in an intact form from the intestine and further be resistant to degradation by plasma 
peptidases in order to reach the target sites. In fact, it has been demonstrated using 
monolayer-cultured human intestinal CaCo2 cells that the ACE-inhibitory tripeptide Val-Pro-
Pro can be transported intact through the cell layer via paracellular and transcellular routes, 
although a significant amount of the peptide is hydrolysed to amino acids by intracellular 
peptidases even if it is also known that Pro-containing peptides are generally resistant to 
degradation by digestive enzymes [30].  
Several bioactive peptides with ACE-inhibitory activity have also been found in cheeses even 
if their appearance is deeply influenced by proteolysis, but only to a certain degree. For 
example, an s1-CN derived antihypertensive peptide isolated from Parmesan cheese by 6 
months of ripening could not be found after 15 months [31]. Accordingly, the 
antihypertensive activity found in long-ripened Gouda cheese was half that found in its 
medium-aged counterpart [32]. Partially consistent with these findings are those reported by 
[33], when studying the ACE-inhibitory peptides in Manchego cheese manufactured with 
various starter cultures; the anti-hypertensive activity decreased within the first 4 months, was 
maximum by 8 months of ripening and decreased again towards 12 months. The protein 
fragments responsible for such activity were mainly low-molecular-weight peptides; a 
specific interest arose regarding β-CN f199–204 and αs1-CN f102–109. Peptides isolated from 
the Italian cheeses Italico and Gorgonzola, were also found inhibitory of ACE activity [34]. 
Following isolation from Gouda cheese, Saito et al., [35] analysed the structure of the 
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antihypertensive features of a few peptides, and concluded that the strongest depressive effect 
on the systolic blood pressure and the highest ACE-inhibitory capacity are associated to 
peptides found in 8-month-old cheese.  
 
2.1.2 Antithrombotic peptides 
 
Peptide sequences which inhibit the aggregation of blood platelets and the binding of the 
human fibrinogen γ–chain to platelet surface fibrinogen receptors have been classified as 
casoplatelins. Casoplatelins, which are k-CN derived peptides (f106–116, f106–112 and 
f113–116), are inhibitors of both the aggregation of ADP-activated platelets and the binding 
of human fibrinogen γ-chain to a specific receptor region on the platelet surface [36]. The 
mechanisms involved in the clotting of milk, defined as the interaction of k-CN with 
coagulating enzyme, and in the clotting of blood, defined as the interaction of fibrinogen with 
thrombin, have been proved to be similar in nature [37]. In addition, structural homologies 
between the undecapeptide f106-116 from cow‟s k-CN, on the one hand, and the C-terminal 
dodecapeptide f400-411 of human fibrinogen γ-chain, on the other, have been duly reported 
[38]. Indeed, three amino-acid residues (Ile
108
, Lys
112
 and Asp
115
) of the aforementioned 
undecapeptide of k-CN are in a homologous position when compared with the human 
fibrinogen γ-chain. Furthermore, the k-CN fragment f103-111 can prevent blood clotting 
through inhibition of platelet aggregation, but is not able to affect fibrinogen binding to ADP-
treated platelets. More recently, it was reported that k-caseinoglycopeptides from several 
animal species are a source of antithrombotic peptides. The sequence of  amino acids in f106–
171 of sheep‟s k-CN, known as k-caseinoglycopeptide, was shown to decrease thrombin- and 
collagen induced platelet aggregation in a dose-dependent manner [39]. The potential 
physiological effects of these antithrombotic peptides have not been established. Anyway 
after breast feeding or ingestion of cow‟s milk-based formulae, antithrombotic peptides 
derived from human and bovine k-caseinoglycopeptides, respectively have been detected in 
the plasma of 5-day-old new borns children [40].  
 
2.1.3 Antioxidant peptides 
 
Peptides generated from the hydrolysis of milk proteins are reported to have radical 
scavenging activity toward superoxide anion, hydroxyl radical and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) radical [41]. The antioxidant peptides exert in vitro antioxidant 
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activity on the reduction of cellular enzymes affecting both cellular catalase activity and 
glutathione (GSH) content in Jurkat cells [42] and simultaneously GSH reduction and GSH- 
reductase content increasing in CaCo2 cells [43]. The metal ion chelating actions of milk 
peptides and inhibition of lipid peroxidation have also been reported in different model 
systems. For example, the tryptic peptide β-CN f1-25 may protect polyunsaturated fatty acids 
(PUFA)-rich phospholipid liposomes against long-term iron induced oxidation, mainly due to 
iron chelation [44]. Taking into account caseinphosphopeptide (CPP) chelating ability, a 
compared antioxidant activity of CPP and casein hydrolysates in a cell membrane model 
system have been assayed: iron-induced lipid oxidation was inhibited by both casein 
hydrolysates and CPPs, with casein hydrolysates being less effective than CPPs [45]. 
The antioxidant activity of peptides has been attributed to certain amino acid sequences: high 
levels of His and same hydrophobic amino acid were related to antioxidant potency [46]. So 
peptides with Pro-His-His sequence showed the greatest antioxidant activity even if in same 
cases a possible interaction with non-peptide compounds will enhance the bioactivity. 
Furthermore, there is evidence that the antioxidant effect of individual amino acids is greater 
when they are incorporated in peptides, suggesting that peptide bond or structural 
conformation has an influence of this bioactivity [47]. 
The antioxidant activity of milk peptides will be more fully detailed in chapter two of this 
PhD thesis. 
 
 
2.2 Effect on the nervous system 
 
2.2.1 Opioid peptides 
 
Located in the nervous endocrine and in the immune system, as well as in the intestinal tract 
of mammals, opioid receptors (of the μ-, δ- and κ-type) interact with endogenous or 
exogenous ligands. The former, called „„typical‟‟ opioid peptides, e.g. enkephalin, endorphin 
and dynorphin, all share the typical N-terminal sequence Tyr-Gly-Gly-Phe. The latter, or 
„„atypical‟‟ opioid peptides, have agonistic (exorphins, or formons-„„food hormones‟‟) or 
antagonistic (casoxins) activities, and are characterized by distinct N-terminal sequences. The 
common structure of endogenous and exogenous opioid peptides (except α-casein opioids) is 
the presence of a Tyr residue at the N-terminal, followed by another aromatic residue as Phe 
or Tyr in the third or fourth position. Several authors have compiled information regarding 
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opioid receptor ligands derived from milk caseins. The major and the first opioid peptides 
discovered have been produced from β-CN and are the so-called β-casomorphins [28], which 
are fragments of β-CN between the 60th and the 70th residues, mainly f60–63, f60–64, f60–
65, f60–66 and f60–70 [48]; these peptides were characterized as μ-type ligands [49]. More 
recently, Perpetuo et al., [50] reported that the β-CN tryptic hydrolysis produced the γ-CN, 
Tyr-Pro-Val-Glu-Pro-Phe-Thr-Glu, possessing in vitro opiate-like activity. Orally 
administered opioid peptides may modulate absorption processes in the gut and influence the 
gastrointestinal function in two ways: first, by affecting smooth muscles, which reduces the 
transit time, and second, by affecting the intestinal transport of electrolytes, which explains 
their anti-secretory properties. The actual physiological effects of milk-derived opioid 
peptides remain, however, to be confirmed. The β-casomorphins or their precursors have been 
detected in the duodenal chyme of minipigs, in the plasma of newborn calves and in the 
human small intestine upon oral administration of casein or milk [51]. Anyway, opioid casein 
fragments have not been detected in the plasma of adult mammals and, therefore, it is 
suggested that only the neonatal intestine is permeable to casomorphins. Interestingly, the αs1-
CN derived peptide f91–100 has been demonstrated to possess anxiolytic-like stress-relieving 
properties in animal model and human studies [52]: this peptide has been employed 
commercially as an ingredient, e.g. for confectionery and soft drinks. 
 
 
2.3. Effect on the immune system 
 
2.3.1 Immunomodulating peptides 
 
Breast feeding facilitates transmission of passive immunity towards a number of 
multifunctional factors, which have a direct effect on the neonate‟s resistance to bacterial and 
viral infections; caseins are included among these factors. In fact, during enzymatic digestion 
of human and bovine milk caseins, peptides with immunomodulating capacities are released 
enhancing immune cell functions, measured as lymphocyte proliferation, antibody synthesis 
and cytokine regulation [53]. Jolles et al., [54] were the first to report that extracts of trypsin-
hydrolysed human milk possess immunostimulating activity. Several other peptides were later 
isolated from bovine β-CN and from bovine αs1-CN [55]. All these peptides stimulate 
phagocytic activity of murine and human macrophages in vitro, and exert a protective effect 
against Klebsiella pneumoniae infection in mice in vivo [56]. Moreover the C-terminal 
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sequence of bovine β-CN f193–209, containing β-casokinin-10 increased significantly the 
proliferation of peripheral blood lymphocytes in vivo in rats [57]. Of special interest are 
peptides released during milk fermentation with lactic acid bacteria, as these peptides have 
been found to modulate the proliferation of human lymphocytes, to down-regulate the 
production of certain cytokines and to stimulate the phagocytic activities of macrophages 
[58]. 
 
 
2.3.2 Citomodulatory peptides 
 
Cytochemical studies have provided increasing evidence that milk derived bioactive peptides 
modulate the viability (e.g., proliferation, differentiation, and apoptosis) of different human 
cell cultures [59]. These citomodulatory effects has been demonstrated especially in 
malignant cells whereas normal cells seem to be less susceptible. An apoptotic and anti-
proliferative activity in HL-60 cells have been shown for lyophilized extract of Gouda cheese 
[60] and for bovine skimmed milk digested with Saccharomyces cerevisiae [61] while a 
yoghurt fraction obtained by membrane dialysis demonstrated an anti-proliferative effect on 
intestinal CaCo-2 and IEC-6 cells [62]. Generally, the current literature on the effects of 
hydrolysed casein on cell proliferation of various cell lines shows conflicting results. 
Although there is much scientific evidence showing the anti-proliferative effects of milk 
peptides, cell growth-stimulating peptides have also been reported [63]. 
 
 
2.3.3 Antimicrobial peptides 
 
The in vitro inhibition of pathogenic bacteria strains occurs in the presence of same specific 
peptide sequence from αs1-, αs2- and β-CN. The fragment of αs1-CN f1–23, also known as 
isracidin, has demonstrated antibiotic-type activity in vivo versus S. aureus and Candida 
albicans and it can protect sheep and cows against mastitis [64]. The immunomodulatory 
peptide derived from bovine β-CN f193–209, was shown to enhance the antimicrobial activity 
of mouse macrophages [65]. A fragment from αs2-CN, f165–203, known as casocidin-I, can 
inhibit growth of Escherichia coli and S. carnosus [66]. Two other peptides were meanwhile 
isolated from a peptic hydrolysate of αs2-CN, namely f183–207 and f164–179; the former 
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exhibited higher antimicrobial activity than the latter, although both possessed comparable 
hemolytic effects [67]. 
 
 
2.4. Effect on gastrointestinal system 
 
2.4.1 Glyco-caseinmacropeptide (gCMP) 
 
During the enzymatic cheesemaking process, rennet or chymosin hydrolyses the peptide bond 
between residues 105 and 106 of k-CN, and the resulting molecule, known as glyco-
caseinmacropeptide (gCMP) is eluted in the whey. gCMP contains residues 106–169 of k-CN 
and lacks aromatic amino acids and is rich in branched chain ones. Its C-terminal portion is 
more hydrophilic, as it contains the oligosaccharides that are O-linked to Thr and Ser. Sweet 
whey, containing not only whey proteins but also the threonine-rich gCMP, is commonly used 
for the manufacture of milk infant formulae with the aim to avoid a well-known disease in 
infants fed with whey protein predominant formulae as hyperthreoninemia. Rigo et al., [68] 
tested an experimental formula based on acid whey without gCMP, against a formula based 
on whey with gCMP upon Thr metabolism; acid whey formulae are accordingly 
recommended for feeding preterm infants. So as Fanaro and Vigi emphasized, the removal of 
gGMP from whey is recommended towards the development of infant formulae closer to 
human milk [69]. The large gGMP molecule cannot be absorbed as such, so it has to be 
broken down into smaller peptides before an effect on blood components arises. Moreover a 
number of beneficial effects displayed by gCMP upon the nutrition system can be claimed as 
the control of several liver diseases [70] and a satiety effect when administered to starving 
animals which is similar to that exhibited following cholecystokinin injection [71]. Besides 
the various bioactivities displayed by gCMP (or smaller peptides derived therefrom), it is also 
known to allow absorption of calcium, iron or zinc [72].  
 
 
2.4.2 Caseinphosphopeptides  
 
The term phosphopeptide means a casein-derived phosphorylated peptide which enhances 
vitamin D-independent bone calcification in rachitic infants. In addition to their presence in 
whole milk, caseinphosphopeptides (CPPs) have also been claimed to be released by 
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proteolytic enzymes of lactic acid bacteria during ripening of such cooked curd cheeses as 
Grana Padano [73] and Comte´ [74]. The phosphate residues, corresponding to ca. 30% of the 
phosphorus content in milk, are present as monoesters of Ser and occur mainly in clusters; 
most CPPs share a common feature, i.e. they are constituted by a sequence of three 
phosphoseryl residues, followed by two glutamic acid residues, SerP-SerP-SerP-Glu-Glu [75]. 
Furthermore, the negatively charged side chains of the phosphate groups represent the binding 
sites for minerals; CPPs have been shown to bind to macroelements as Ca, Mg and Fe as well 
as oligoelements as Zn, Ba, Cr, Ni, Co and Se. Milk and dairy products provide Ca
2+
, which 
can form soluble complexes with CPPs, thus avoiding Ca phosphate precipitation, and 
enhancing intestinal absorption of Ca in the body [76]. Chabance et al., [77] have proven the 
occurrence of CPPs in the stomach and duodenum following milk ingestion. CPPs have also 
been found after in vitro and/or in vivo digestion of αs1-, αs2- or β-CN [78] and certain CPPs 
were for the first time detected in ileostomy fluid by Meisel et al., [79], which confirms the 
ability of such peptides to survive gastrointestinal passage to the human distal ileum. 
Recently, the structural features and the physiological potential of CPPs have been 
demonstrated by several in vitro studies [80,81].  
 
 
3. Analysis of food proteins and peptides by mass spectrometry-based techniques 
 
The characterization of milk-derived peptides with classical analytical methodologies is 
severally challenged by the complexity of the milk protein fraction and by the wide dynamic 
range of relative peptide abundance in both dairy products and by-products. Milk, in fact, is 
produced from living organisms which entirely reflect the complexity of the biological system 
from which they derived with the expression of protein and peptides mixtures arising from 
post-translational processing (phosphorylation, glycosylation), alternative splicing, genetic 
polymorphism. Moreover, the technological processes used for dairy production further 
contribute to enhance the heterogeneity of the protein system by inducing proteolysis. Even if 
the natural biological turnover is arrested, milk proteins may be particularly subjected to 
further change during the food storage and maturation: for instance, proteolytic phenomena 
modify the protein content in cheese, yoghurt and fermented foods. Recently, mass 
spectrometry (MS) has emerged as a leading technique because of its ability to handle the 
complexities associated with the proteins and peptides arising from induced or native 
proteolytic phenomena for protemic and peptidomic analysis, respectively. MS provides 
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specificity, speed and reliability of the analytical response even if the need of an increasingly 
comprehensive proteomic and peptidomic analysis has requested the development of 
progressively more advanced technologies that extend the horizon of MS capabilities. 
Anyway, protein identification using MS is usually carried out both in the form of whole-
protein analysis and analysis of enzymatically or chemical produced peptides: these two 
approaches have been designated as “top-down proteomics” and “bottom-up proteomics”, 
respectively. These separation strategies involve multiple steps as reverse phase, size-
exclusion, isoelectring focusing, ion-exchange, etc at the protein and/or peptide level, 
conducted on-line or off-line MS techniques, and have been recently dealt [82,83]. 
Briefly, in the “bottom-up” approach, proteins in complex mixtures can be separated before to 
enzymatic (or chemical) digestion followed by direct peptide mass fingerprinting-based 
acquisition or further peptide separation on-line coupled to tandem MS. Alternatively, the 
protein mixture can be directly digested into a collection of peptides (“shotgun” approach), 
which are then separated by multidimensional chromatography on-line coupled to tandem MS 
analysis. Although this latter is relatively simple, it results in greatly increased complexity of 
the generated peptide mixture, requiring highly sensitive and efficient separation. Information 
is also lost upon the conversion of intact proteins into a mixture of peptides, which can lead to 
incorrect identifications. Not all peptides resulting from the digestion of a protein can be 
observed or correctly identified with MS analysis, especially those with diverse or unexpected 
modifications. Furthermore the limited dynamic range of mass spectrometric analysis only 
allows for the peptides present at high relative abundance to be preferentially sampled, while 
information regarding the proteins represented as low abundance peptides in the complex 
mixture is commonly not obtained. In the “top-down” approach, instead, proteins in complex 
mixture are fractionated and separated into pure single proteins or less complex protein 
mixtures, followed by off-line static infusion of the sample into the mass spectrometer for 
intact protein fragmentation. The application of MS techniques for the qualitative and/or 
quantitative analysis of the complex protein and peptides mixtures contained in the most food 
products is playing a decisive role in the understanding of their nature, structure, functional 
properties, impact on human health and in the definition of the structure/relationship of food 
proteins and peptides.  
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4.  Mass spectrometric techniques for proteomics and peptidomics 
 
The use of MS for proteomics is not the application of a single technique for all purposes but 
rather a collection of methodologies. For any MS experiment, consideration should be given 
to the type of instrumentation, fragmentation method and strategy analysis best suited for a 
particular individual sample. 
Fundamentally, MS measures the mass-to-charge ratio (m/z) of gas-phase ions. Mass 
spectrometers consist of: a) ion source that converts analyte molecules into gas-phase ions; b) 
mass analyzer that separates ionized analytes based on m/z ratio; c) detector that records the 
number of ions at each m/z value. The development of electrospray ionization (ESI) and 
matrix-assisted laser desorption/ionization (MALDI), actually known as the two soft 
ionization techniques capable of ionizing peptides or proteins, revolutionized bio molecules 
analysis by MS. The accuracy of ESI-MS measuring proteins/peptides molecular weight is 
complemented by the capability of MALDI-MS to analyze proteins with a mass grater than 
100.000 Da  or polypeptides in a complex mixture [84]. 
The mass analyzer is central to MS technology and four types of mass analyzers have found 
largely application in proteomics and peptidomics: quadrupole (Q), ion trap (quadrupole ion 
trap, QIT; linear ion trap, LIT or LTQ), time-of-flight (TOF) mass analyzer, and Fourier-
transform ion cyclotron resonance (FTICR). All these vary in their physical principles of ion 
separation and analytical performances. “Hybrid” instruments have been designed to combine 
the capabilities of different mass analyzers and include the Q-q-Q, Q-q-LIT, Q-TOF, TOF-
TOF, LTQ-FTICR and LTQ-Orbitrap system (this latter is a new type of hybrid referable to 
the LTQ-Fourier transformation).  
Anyway, the analysis of the thousands of millions of MS/MS spectra generated in proteomic 
studies can be a daunting task, which requires sophisticated algorithms. Over the last decade, 
many search engines/algorithms have been developed for handling such complex datasets, 
among which the most popular ones include MASCOT, SEQUEST, OMSSA, X!Tandem and 
many others. Databases for searching post translational modifications by MS data include 
UNIMOD, Deltamass, FindMod and those that use MS/MS data for its characterization 
include SEQUEST, Modificomb and MODi. Although the emergence of automated database 
searching significantly increases the throughput of data analysis, it should be used with 
caution due to imperfect searching algorithms and possible errors existing in various 
databases. Validation of peptide and protein identification results have therefore become a 
necessary step.  
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5. Strategies for the characterization of milk bioactive peptides 
 
Recent analytical research on bioactive peptides in food has followed three main directions 
aimed at developing sensitive and specific methods for (i) tracing the pathway of formation of 
bioactive peptides from the parent proteins; (ii) identifying the biological properties; (iii) 
validation of the “positive” properties discovered in natural peptides by design of synthetic 
peptide analogues. These studies are aimed to explain the structure-activity relationship of 
peptides, essential information for the design of novel therapeutics or functional foods 
ingredients. Moreover, with the aim to identify the patterns of peptide formation and the 
bioactivity of the peptides present in the sample, the newest analytical approaches combine 
MS with cell biology, immunology, biochemistry and synthetic chemistry [85]. In the specific 
case of milk-derived protein/peptides, identification of bioactive components can be achieved 
through towards the following steps: 
1. Extraction and purification of peptides present in a food sample (milk, yogurt, cheese) 
using high-resolution separation techniques or selective methods for enrichment of some class 
of components (i.e. phosphopeptides).  
2. protein structural characterization by MS analysis complemented with the peptides 
produced “in vitro” or “in vivo” ones; this peptidomic approach combines a high-resolution 
separation technique (2-D gel electrophoresis, nanoHPLC) with MS or other micro-analytical 
techniques for single protein identification, characterization of post-translational 
modifications and database cataloguing. 
3. In silico analysis for prediction of possible bioactive sequences encrypted in the protein 
sequence. 
4. Synthesis of pure peptides, or of peptide analogues.  
5. Confirmation of bioactivity through appropriate biological or cellular assays.  
These 5 points aimed to the assessment of the structure-bioactivity relationship.  
 
 
6. The intestinal mucosa as a model to study food-organism interaction 
 
The intestine fully differentiated tissues are characterized by an arresting of cells in the 
quiescent state with an enterocyte turnover within 48-72 h [86]. As the intestine sits at the 
interface between the organism and its luminal environment, it represents a critical defense 
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barrier against luminal toxic agents [87]. Thus, in addition to being exposed to luminal 
nutrients, the intestinal mucosa is constantly injured by reactive oxygen species (ROS) 
endogenously and exogenously generated [88]. Imbalance between the production of ROS 
and antioxidant defences, plays an important role in the initiation of the oxidative stress [89] 
and the imposition of a severe oxidant stress typically results in cytotoxicity. The oxidative 
stress can induce phase transition in regular cell cycle from a quiescent state to a proliferative, 
apoptotic, or necrotic one.  When concentrations of oxidants are very high, the cellular 
response may activate different pathways and cell death can occur either by necrosis or 
apoptosis, prevalently [90]. Additionally, unless the concentrations of oxidants are cytotoxic, 
necrotic cell death is not necessarily an obligatory endpoint of oxidative stress [91]. 
Adenocarcinoma cells are remarkably resistant to injury by radiation, immunological, and 
chemotherapeutic agents [92]. As a consequence, these tumor cells are very difficult to treat 
and proliferate rapidly, even under conditions that may be adverse for normal cells. This is 
partially due to the endogenous overexpression of heat shock protein (Hsp) family. Hsps are 
believed to bind and protect critical cellular proteins, preventing their denaturation by adverse 
factors or conditions. Although Hsp expression can be induced by a variety of stressful 
stimuli, certain neoplasm, including human intestinal T84, HT-29 and CaCo2 cell lines, 
express constitutively high levels of Hsps even under non-stress conditions [92]. The anti-
apoptotic action of Hsp is due to their stimulation of Akt activity [93]. Moreover cancer cells 
are characterized by an increase in their intracellular concentration of biomolecules such as 
ceramides [94]. The intracellular levels of these sphingolipids are elevated in tumour cells 
after irradiation or therapy with anticancer drugs, such as doxorubicin [95], implicating 
endogenous ceramides as important mediators of cancer therapy [96]. It has also been shown 
that exogenous ceramides induce cell death in a variety of human cancer cell types [97]. 
Interestingly, cancer cells seem to be more susceptible to the toxic effect of exogenous 
ceramides than normal cells [98,99,100], rendering exogenous ceramides promising novel 
drugs for chemotherapy. The sphingolipid ceramides can be formed by sphingomyelin 
breakdown or through de novo synthesis. They are intimately involved in normal and 
cancerous cells death, growth, differentiation and senescence. This latter is a physiological 
process that leads to irreversible growth arrest, accompanied by characteristic phenotype 
changes (such as induction of senescence associated β-galactosidase activity, SA-β-gal). 
Besides to „„replicative senescence‟‟ resulting from shortening of telomeres at the ends of the 
chromosomes [101], an „„accelerated senescence‟‟ pathway not involving telomeres 
shortening, but other factors as DNA damage has been described [102]. Growth arrest in both 
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replicative and accelerated senescence induces cell cycle arrest. Food constituents which are 
known to prevent the development of colorectal cancer have been shown to enhance apoptosis 
following DNA damage and this may reflect an important mechanism of cancer prevention 
[103]. These constituents include butyrate [104,105], flavonoids [106] and glucosinate 
breakdown products from brassicas [107]. Several bioactive peptides derived from milk 
proteins are potential modulators of various regulatory processes in the body and thus may 
exert beneficial physiological effects such as antioxidant activity [108]. The antioxidant 
activity of milk protein hydrolysates has been interestingly described [109-112] and also 
individual peptides released after hydrolysis from αs-casein have been shown to possess free 
radical scavenging activities inhibiting enzymatic and non-enzymatic lipid peroxidation [113].  
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CHAPTER I 
 
1. INTRODUCTION 
 
 
1.1 Buffalo milk and Mozzarella di Bufala Campana Protected Denomination of Origin 
(PDO) cheese 
 
It is well known that buffalo milk contains twice the amounts of fat than cow: in cattle, milk 
contains between 3 to 5 %, depending on feeding and breed, while in buffalo milk the average 
fat content is usually 7 to 8% but may be as high as 13% in some breeds. Buffalo milk fat has 
a higher melting point compared to the cow milk fat, due to its higher proportion of saturated 
fatty acids (77:23, saturated:unsaturated) while phospholipids and cholesterol are lower in 
buffalo milk. Moreover, the content of protein, lactose and ash is somewhat higher in buffalo 
milk than in cow milk. Buffalo milk lacks or contains only traces of β-carotene (a precursor of 
vitamin A): this makes milk look very white, as opposed to cattle milk which has a slight 
yellow shade. In buffalo milk, vitamin A is present instead of its precursor. Physiology of 
animal, stage of lactation, season, feed, breed, time and milking sequence are some of the 
factors affecting the fat content of buffalo milk. Of the main buffalo species, the Italian one 
(Bubalus bubalis) has been widely studied in relation to the exclusive use of its milk for the 
manufacture of high-quality dairy products, among which Mozzarella cheese with Protected 
Designation of Origin (PDO) mark is the most famous in the world. In 2006, this cheese and 
other similar products have been associated to a global market of 500 million and 2-3 billion 
dollars, respectively [1].  
The highest quality buffalo mozzarella bears the "Mozzarella di Bufala Campana" trademark. 
In 1993, it was granted Denominazione di Origine Controllata (DOC) status, in 1996 the 
trademark received registry number 1107/96 and in 2008 European Union granted Mozzarella 
di Bufala Campana Protected Geographical Status and PDO indicator.  
It implies that any cheese-making process must comply with the rules established by the 
National Standard for cheese production, including above all:  
- milk must be produced in circumstantiates areas within Southern Italy regions 
(Campania, Lazio, Molise and Apulia) and the approximate area within which the 
regulations permit it to be transformed into PDO cheese; 
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- the cheese must contain exclusively water buffalo milk from “Italian Mediterranean 
breed”; 
- whole buffalo milk must be fresh, and addition of frozen or quick-frozen buffalo milk 
is not allowed; 
- no milk standardization is allowed while pasteurization is optional; 
- culturing is made by adding starter resulting from spontaneously acidified whey of the 
previuos day “sieroinnesto” within the cheese plant. 
The “Mozzarella di Bufala Campana” is a kind of bland, slightly acidic cheese, with no aged 
cheese flavour. However, it has an unusual ability to stretch, retain fat, melt evenly, and 
provide a chewy mouth feel. Even if the buffalo milk transformation is provided by PDO 
indicators, the previously cited properties are not necessarily automatic and are influenced by 
coagulants, starter cultures, seasonality, manufacturing conditions, post-manufacturing 
handling and storage. Moreover “Mozzarella di Bufala Campana” is characterized by a 
complex sensory profile depending mainly on the heterogeneity of either milk microflora 
and/or of natural whey cultures “sieroinnesto” which influence the peculiar characteristics of 
each cheese produced in different areas, so that it is not possible to define the “typical” 
sensory profile of PDO Mozzarella cheese as related to technological parameters, season, 
geographical origin and chemical composition of milk [2].  
Due to variable composition of milk and starter, yield and quality of Mozzarella cheese are 
highly variable. Moreover, the manufacturing parameters and any process step affect the 
composition and the functional properties of Mozzarella cheese. The texture, for example, is 
influenced by coagulants concerning parameters as enzyme activity, starter culture 
composition and lactic acid bacteria survival.  
The primary function of the coagulant is to transform milk in a curd that is successively 
stretched into cheese. Anyway, small amounts of residual enzymes in the curd will be carried 
out in the cheese and are responsible for proteolysis occurring in the final product altering 
cheese texture during refrigerated storage brine. For this reason, it is very important to reduce 
enzyme levels in the curd. The retention of chymosin is affected by curd pH, so cutting the 
curd at higher pH reduces chymosin level retention and the casein proteolysis in the curd [3].   
Because of texture influence on shredding, melting properties and water release during 
Mozzarella cooking, it is really important to reduce the coagulant activity in the curd and to 
produce inactivation of chymosin/pepsin attaining temperatures sufficiently high during 
cooking and stretching. Anyway, taking into account that the enzymes involved are more 
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sensible to denaturation at higher pH, the monitoring of the whey pH is important to reduce 
the level of enzymes entrapped in the curd.  
Moreover, the uncontrolled composition of the starter cultures “sieroinnesto” used in buffalo 
Mozzarella cheese production, may influence curd and cheese rheological parameters. So, to 
the natural starter bacteria composition has been standardized by  incubation at predetermined 
temperature. For these reasons, some fermenting vats with controlled temperature or 
temperature gradient are actually being used.  
 
 
1.2 Whey classification and its conversion in ingredients for food manufacture  
 
Whey is produced during manufacture of different types of cheese and casein and four major 
types of whey may be therefore identified: 
1. sweet cheese whey from the manufacture of cheese coagulated by rennet at pH 6.0 to 
6.4; 
2. acid cheese whey from the manufacture of cheese coagulated at pH 4.5 as a result of 
lactic acid bacteria; 
3. acid casein whey from the manufacture of acid casein (pH 4.5); 
4. rennet casein whey from the manufacture of rennet casein (pH 6.6); 
In view of the similarities between different types of whey, a simpler classification 
differentiates acid wheys (acid cheese whey or acid casein whey), from the sweet whey (sweet 
cheese whey or rennet casein whey). 
Whey from different sources shows some variations in composition but the most important 
type can be taken to contain about 6.5% solids of which about 4.8% is lactose, 0.6% protein, 
0.6% minerals, 0.15% lactic acid, 0.25% non-proteinaceous nitrogen compounds and 0.1% fat 
(after fat separation). Whey therefore contains about 50% of the total solids in the whole milk. 
Whey has always posed a considerable disposal problem to cheese factories and large 
quantities of whey are still either sold for stock feeding, discharged to effluent plants or used 
as fertilizers. However the past 15 years have seen a change in the philosophy of whey 
utilization with recognition that whey could be considered as a potentially valuable source of 
protein and lactose which may be used as ingredients in food manufacture. The conversion of 
whey into lactose and whey products has increased substantially and a number of new 
technologies have been applied commercially to convert whey into saleable products. The 
most important of these are described below [4]. 
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- Alcohol fermentation: Even if the production of alcohol from whey is a well-established 
fermentation process, it is only in the last 20 years that whey alcohol production has become 
commercially viable. As a carbohydrate source for alcohol production, whey has two major 
disadvantages because lactose is fermented only by few yeasts and the low concentration of 
lactose in whey gives rise to low ethanol concentrations and high distillation costs. Anyway, 
the identification of some yeasts strains as Kluyveromyces fragilis with a high efficience in 
lactose fermentation and the development of less energy distillation, have enabled the 
commercial production of whey alcohol. Before fermentation, whey has to be first 
ultrafiltrated or submitted to a heat treated with the aim to its deproteinization. 
Whey alcohol is of high quality and can either be used in the manufacture of high grade 
potable spirits as gin, vodka, or as an industrial product. 
- Demineralization: The demineratization which is carried out either by ion exchange 
treatment or by electrodialysys, increases the range of opportunities for whey use as a food 
ingredient since it will be spray dried. In fact the main use of demineralizated whey powder is 
in the manufacture of infant foods, where it is used together with skimmed milk powder to 
give the same ratios of casein/whey protein/lactose/minerals as they are found in human milk. 
- Lactose hydrolysis: Hydrolysed whey syrups are manufactured by hydrolysing the lactose 
in whey or deproteinized whey, followed by evaporation to a solid concentration of 60-75%. 
Approximately 80% of the lactose is hydrolysed in order to avoid lactose crystallization in the 
resulting syrup. Lactose may be hydrolysed by hot acid or by the enzyme β-galactosidase 
which is preferred and may be used in a batch process or in immobilized form.  Hydrolysed 
whey products may be made either from whole whey or deproteinized whey obtained as a 
permeate after an ultrafiltration step. The lactose hydrolysed whey is usually evaporated to 
70-75% solids and contains about 10% proteins, while lactose hydrolysed from a 
deproteinized whey is evaporated to only 60-65% solids and may be used as an alternative to 
glucose syrup. 
- Lactose manufacture: One of the oldest methods of whey reutilization is the manufacture 
of lactose. Whey is first evaporated to a solid concentration of 60 to 65% and then transferred 
to a crystallization tank where lactose seed crystals are added to promote crystallization. The 
lactose crystals are recovered by centrifugation, washed to remove proteins and salts, and 
dried. The liquid by-product remaining after centrifugation is known as liquor mother and 
contains about 20% proteins in dry matter. It is sold either for animal feed or as an ingredient 
in pet foods, but its high mineral content precludes use in human foods. The described lactose 
manufacture is suitable for food use but for pharmaceutical ones it is not necessary to purify 
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the washed crystals further. With this aim, the crystals are redissolved in hot water and boiled 
with calcium phosphate and charcoal; this causes the protein to precipitate while coloured 
compounds are adsorbed by charcoal. The solution is filtered hot and the lactose is 
crystallized and recovered as described above. 
- Methane production: Whey, or deproteinized whey, can be fermented anaerobically to 
convert the organic matter to methane. The methane produced is equivalent in energy terms to 
about 0.5 Kg fuel oil for each Kg solid whey converted and the gas can be used to fuel the 
factory boilers. 
- Whey protein production: Whey proteins are superior to most other food proteins in terms 
of nutritional value and possess a number of physical properties which make them very useful 
as food ingredients. Commercially, whey proteins are usually manufactured by ultrafiltration 
and are available as spray dried powders containing between 25 and 75% proteins. In food 
products, whey proteins perform in a similar manner to egg proteins; they are highly soluble, 
even at acid pH and they foam and form gels on heating. Whey protein powders are therefore 
used in the manufacture of bakery and meat products, where their gelation properties are 
particularly useful. Whey proteins are also extracted from whey using ion exchange 
chromatography techniques. These products may contain up to 90% proteins and are mainly 
used in nutritional and dietetic products.  
The availability of whey in Italy, the spraying of serum today affects latest 10%. According to 
official data, 60% is used in the liquid state in cattle feed, a little more 8% is used in the 
production of ricotta, the remaining portion is used in the manufacture of other dairy products 
(lactose, protein serum) and a portion of all secondary initiated a process of partial 
concentration not neglecting the possibility that a good part ends its life cycle dispersed into 
the environment. The data cited leave out the important impact of the reuse of the whey in the 
livestock sector with many problems related to the health of animals. In this regard, in a study 
commissioned by the European community to a group of scientific experts on the health and 
welfare (AHAW), it has emerged that animal milk byproducts that have been adequately 
treated to avoid the risk of transmission of infectious diseases, including epizootic aptha 
(FMD) and paratuberculosis (MAP) can be used on farms [5]. 
Only a small amount of serum is used as growing medium for the preparation of sierinnesto 
used as leaven in the production of natural buffalo Mozzarella cheese (PDO), as provided by 
Article 3 of the letter c DPCM 10/05/1993. 
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1.3 The whey produced during the processing of buffalo milk in Mozzarella 
 
The production of Mozzarella di Bufala Campana PDO cheese has recorded a strong increase 
in Regione Campania in the last years due to the rise in request by market, so a large amount 
of whey has to be disposed off yearly, as about 80% milk volume remains as whey after 
transformation. 
The protein component of buffalo whey contributes to the total nitrogen for 0.67% and 
consists of a fairly heterogeneous protein mixture represented by albumin (approximately 
75%), globulins (about 15%) and peptones (about 10%). 
There are also water-soluble vitamins and the characteristic yellow colour of whey is due to 
the presence of a fair amount of riboflavin or vitamin B2. Whey contains a not nitrogen 
fraction protein (NPN) which is the 0.27% of total nitrogen, as well as a small fraction of 
casein fragments, generated by proteolytic enzymes present in milk or added after treatment 
technology, respectively as plasmin and chymosin on caseins. These fragments given their 
small size are not incorporated in the caseous curd. 
The composition of whey derived from dairy milk processing, depends on the type of clotting 
occurred and, the substantial qualitative and quantitative differences emerge relatively the 
NPN composition and nature of the fragments of casein oligopeptides produces. Regarding 
buffalo whey, all along the technological process of mozzarella production three types of 
whey are produced: 
- Sweet whey immediately produced after or simultaneously to milk clotting; the NPN is 
formed of chymosin hydrolysis primary fragments: mainly the -CN Phe
105
-Met
106
 (this is 
due to secondary  type structure that characterizes  the amino acid 99-111 and is well suited 
to the formation of activated complex with chymosin), the s1-CN Phe
23
-Phe
24
 and the -CN 
Lys
28
-Lys
29
 hydrolysis induced by plasmin. 
- Acid whey (in this PhD thesis called waste whey). Obtained after maturation of the curd in 
the sweet whey, the NPN is formed by primary fragments induced by hydrolysis of the lactic 
microflora used as starter. In particular, the proteolytic activity of lactic acid bacteria (LAB), 
hydrolyzes the primary fragments producing several peptide fragments thereby increasing the 
complexity of the peptide fraction. 
- Scotta. It‟s a liquid acid-sugar deprived almost entirely of the thermally coagulated whey 
protein fraction, which is instead incorporated into the “ricotta”. The Ricotta is only produced 
from sweet whey, as waste whey presents a pH below 5, which represents the pH 
corresponding to the pI of whey proteins that would be destabilized. Only recently Ricotta has 
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been included in the register of protected designations of origin and protected geographical 
indications as Ricotta di Bufala Campana (PDO) by the Commission Regulation (EU) No 
624/2010.  
In sweet whey and waste whey the most abundant protein component is represented by whey 
proteins whose solubility is a function of heat treatment involved in the technological process 
of making cheese while in the scotta they are almost completely absent. 
In particular, there is a quantitative reverse on the two main whey proteins α-La and β-Lg: in 
sweet and waste whey the β-Lg is the most abundant of α-La while in scotta, the α-La which 
is more heat resistant, focuses on a relative basis compared to β-Lg. 
In our regional reality, where most of the production of Ricotta is from cheese whey 
processing, only sweet whey is used, since waste whey presents a pH below 5, which 
represents the pH corresponding to the pI of whey proteins that would be destabilized. 
It‟s worth repeating that, traditionally, the sweet and acid whey distinction is made by 
technology of production of cheese whey: sweet whey is obtained from a cheese made with 
rennet in its various types of liquid, powder or solid, while acid whey, when coagulation is 
conducted or with bacterial cultures or acidifying chemicals. 
However, even after separation of the valuable whey proteins for the Ricotta production, the 
whey remaining is still a highly polluting liquid and has high chemical oxygen demand. 
Therefore, whey has to be considered as a by-product in milk processing and, according to the 
Italian legislation (D.L. 22/97), it is a “special waste” and its disposal engraves highly on 
costs. The treatment of dairy wastewater which conforms to environmental regulations is a 
crucial problem due to its high biological oxygen demand (BOD). The main cause of the 
BOD in dairy wastewater is due to residual whey which consists mainly of lactose.  
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2. AIM OF THE SECTION 
The present PhD thesis will contribute to determine the structural features responsible of 
bioactivity and the structure-function relationship of buffalo milk bioactive peptides by  
integration of the new and complementary peptidomic analytical tecniques above illustrated. 
For this reason, a combined approach is given by the characterization of the evolution of the 
proteolysis pattern generated on buffalo milk proteins in vivo by action of endogenous 
proteases, or by action of technological process during milk transformation in mozzarella 
cheese, with the study of antioxidant properties and citomodulatory effects exerted on an in 
vitro cell culture model as the human colorectal adenocarcinoma cells (CaCo2). CaCo2 cells 
undergo a process of spontaneous differentiation during the 21-day culture, leading to the 
formation of a monolayer of cells expressing several morphological and functional 
characteristics of the mature enterocyte. The CaCo2 cell cultures have been commonly used 
with in vitro assays to assess and understand intestinal nutrients and drug transport at the 
cellular level. In this work we used the CaCo2 model system because it is closer to what could 
be the target of action of the peptide mixtures we studied if these preparations will be used in 
the formulation of functional food. 
These information are aimed to push the peptidomics investigation beyond the many studies 
carried out on selected peptides produced in vitro from bovine milk proteins, mainly by 
purified proteases or microbial cell-wall proteinases. Moreover no study has been carried out 
on peptides in buffalo milk. Peptides naturally occurring in milk or in cheese whey have not 
been exhaustively characterized, and their potential bioactive properties have not been studied 
so far.  
The need for the characterization of the peptide fraction in buffalo milk arises from the fact 
that the production of Mozzarella di Bufala Campana Protected Denomination of Origin 
(PDO) cheese has recorded a strong increase in Regione Campania in the last years due to the 
rise in request by market. On the other hand, during the production of Mozzarella, it is 
expected that a large number of peptides can be released in the whey, for the combined 
proteolytic effect on milk caseins endogenous enzymes (plasmin, cathepsin D), rennet 
enzymes (chymosin, pepsin) and lactic acid bacteria exo- and endo-peptidases. The mild 
manufacturing conditions employed in production of Mozzarella di Bufala cheese could 
effectively preserve the bioactive molecules in whey, particularly in sweet whey and waste 
whey. Even in fresh milk the presence of peptide size larger or smaller generated by an early 
action of endogenous proteases on casein is likely; many of these polypeptides are also 
precursors of many peptide entities in whey. Milk, of course, must be considered a food of 
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high commercial value, when compared to the whey left from processing; the characterization 
of peptides from milk casein origin, however, is highly informative allowing to extrapolate 
the hydrolytic action of endogenous proteases than to the later action of lactic acid bacteria 
and the contribution of technological processing in determining the final peptide composition. 
 
The analytical research has followed three main consequential directions aimed to (i) tracing 
the pathway of formation of bioactive peptides, (ii)  identifying their biological properties on 
CaCo2 cell line cycle modulation and (iii) ascertaing the positive properties discovered in 
natural peptides by synthetic structural analogues toward the biological assays reiteration. 
In particular, we characterized the soluble peptide extracts from river buffalo sweet whey 
(BSW), waste whey (BWW) and “scotta” (BS), tracing the breakdown pathway generating 
potential bioactive peptides,  starting from raw river buffalo milk  (BM). The peptide extracts 
were characterized with mass spectrometric techniques, such as matrix assisted laser 
desorption ionization-time of flight (MALDI-TOF) and electrospray ionization (ESI) mass 
spectrometry, this latter either off-line or on-line with reverse phase high performance liquid 
chromatography (RP-HPLC). In addition, we investigated the antioxidant and cytomodulatory 
effects of the peptide extracts from BS, BSW, BWW and BS on hydrogen peroxide induced 
oxidative damage in CaCo2 cell lines [6]. 
With the aim to explain the molecular mechanism involved in the cytomodulatory  and 
antioxidant response of CaCo2 cells, the more active peptide extracts BWW was further 
purified by a chromatographic step obtaining 5 peptide subfraction (f1-f5). BWW peptide 
sub-fractions were characterized by complementary mass spectrometric techniques and we 
studied the effects of BWW sub-fractions on: A) mitochondrial oxidative stress and 
expression of heat shock proteins (Hsp 70 and Hsp 90); B) cell cycle and differentiation; C) 
production of ceramides and senescence. These effects were investigated on CaCo2 cell line 
in which oxidative damage was induced with hydrogen-peroxide (H-CaCo2), to simulate the 
response of intestinal cells which are constantly exposed to luminal oxidants during food 
digestion.  
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3. MATERIALS AND METHODS 
 
For the determination of peptides produced during buffalo milk manufacturing and for the 
analysis of their bioactivity, a combined use of extraction, purification, mass spectrometric 
techniques and biological assay was used. 
 
 
3.1 Materials 
 
River buffalo raw milk and whey samples from manufacturing of Mozzarella di Bufala 
Campana  PDO cheese were provided by three local dairy farm of the Salerno area (Southern 
Italy). To prevent undesired peptide hydrolysis, immediately after collection samples were 
added with 1mM phenyl-methyl-sulfonyl fluoride (PMSF, Sigma, St. Louis, MO) and stored 
at -20°C until used. 
All chemicals and reagents were of analytical grade or better from Sigma. HPLC-grade 
acetonitrile (AcN), methanol (MetOH) and trifluoroacetic acid (TFA) were purchased from 
Carlo Erba (Milano, Italy). The 218TP54 reversed-phase column C18 (5 μm, 250 mm x 4.6 
mm) was purchased by Vydac (Hesperia, CA). Dulbecco‟s Modified Eagle‟s Medium 
(DMEM), PBS (Phosphate Buffer Saline, composed of 0.1M phosphate buffered saline 
containing NaCl 0.138M, KCl 0.0027M, pH 7.4), Minimum Essential Medium (MEM) 
nonessential amino acids, streptomycin, penicillin, L-glutamine, FBS (Fetal Bovine Serum), 
and Nonidet P40 were obtained from Gibco-BRL (Grand Island, NY). Tissue culture 
plasticware was furnished from Becton Dickinson (Lincoln Park, NJ, USA). Hydrogen 
peroxide (H2O2) 1M solution was prepared
 
immediately before use. Hydroethydine (HE) was 
purchased from Invitrogen Srl (Milan, Italy).  
 
 
3.2 Extraction of peptides from buffalo milk and whey samples 
 
BM, BSW, BWW and BS samples were collected at the proper stage of the technological 
process of Mozzarella manufacturing. The cream was separated from milk or whey by 
centrifugation at 4500 g at 4°C for 30 min (Haereus Biofuge, Kendro, Germany). In order to 
harden the cream, the tubes were kept at -20°C for 10 min and finally the cream was scraped 
off. 
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Skimmed whey samples (25 ml) were ultra-filtered on Centriprep
 
cartridges having a 3KDa 
cut-off membrane (Millipore, Bedford, MA). The permeates, lyophilized and solubilised in 6 
ml 0.1% (v/v) aqueous TFA, were purified from saline contaminants and lactose with a Sep-
pak C18 cartridge (Waters, Milford, MA), previously equilibrated in 0.1% TFA and eluted 
with 70/30/0.1 AcN/water/TFA (v/v/v). The peptide extracts, were dried using a Savant 
concentrator (Speed-Vac, Milan, Italy) and stored at -20°C either for structural analysis or for 
biological assays. Fresh milk was processed as above after skimming and isoelectric 
precipitation of casein as previously reported [7]. The analytical approach for proteomic and 
bio-functional characterization of the peptides extract from BM, BSW, BWW and BS is 
reported in Fig 1. 
 
 
Fig 1. Analytical approach for proteomic and bio-functional characterization. 
 
 
3.3 Matrix-assisted laser desorption ionisation mass spectrometry (MALDI-TOF-MS) 
analysis 
 
MALDI-TOF-MS experiments were carried out on a Voyager DE-PRO mass spectrometer 
(PerSeptive Biosystems, Framingham, MA) equipped with a N2 laser (337 nm, 3 ns pulse 
width) operating both in linear or in reflector positive ion mode, using the Delayed Extraction 
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technology. Accelerating voltage was 20 kV and tipically 250 laser pulses were acquired for 
each mass spectrum. In the analysis of sphingolipids laser power was maintained at the lowest 
possible values in order to prevent in source fragmentation. The peptide or the lipid mixture, 
were loaded on the stainless steel together with 1 μl of matrix 2,5- dihydroxybenzoic acid -
DHB, 10 mg/ml MetOH/0.1% (v/v) TFA- for lipid analysis and α-ciano-4-hydroxycinnamic 
acid –CHCA, 10 mg in 1 ml AcN 50% (v/v)/ 0.1% (v/v) TFA- for peptides. The external mass 
calibration was performed with low mass peptide standards (PerSeptive Biosystem). To check 
repeatability spectra were acquired in triplicate at least. Post-Source Decay (PSD) fragment 
ion spectra were obtained after isolation of the appropriate peptide precursor using timed ion 
selection. Fragment ions were refocused onto the final detector by stepping the voltage 
applied to the reflector and the individual segments were combined using the software 
developed by PerSeptive BioSystems furnished with the instrument. Signals detected in the 
mass spectra were associated with the corresponding peptides on the basis of the expected 
molecular weight deduced from the sequence of the casein fractions [8] by using a suitable 
computer program (GPMAW 5.1, Lighthouse data, Odense, Denmark). 
 
 
3.4 Liquid chromatography Electrospray Mass Spectrometry (LC/ESI-MS) analysis of 
BWW peptide extract 
 
The BWW peptide extract was fractionated by HPLC using an HP 1100 modular system 
(Agilent Technology, Palo Alto). Sample was loaded onto a 218TP52, 5 µm reversed-phase 
C18, 250 x 2.1 mm column (Vydac, Hesperia, CA). Solvent A was water containing 0.1% 
TFA (v/v) and solvent B was AcN containing 0.1% TFA (v/v). A linear gradient from 5 to 
70% solvent B was applied over 90 min, after 5 min of isocratic elution at 5% solvent B, at a 
constant flow rate of 0.2 ml/min. UV detection was carried out at 220 nm. The effluents were 
directly injected, through a 100 µm i.d. fused silica capillary into the electrospray source of a 
Platform single quadrupole mass spectrometer (Waters, Manchester, UK). The ESI mass 
spectra were scanned  in the positive ion mode, from 1600 to 400 m/z at a scan cycle of 4.9 
s/scan and 0.1 s inter-scan delay. The source temperature was 180°C and the capillary and 
orifice voltages were 3.6 kV and 40 V, respectively. Mass scale calibration was performed 
using the multiple charged ions from a separate injection of horse heart myoglobin. Mass 
spectra were elaborated using the software MassLynx 2.0, furnished with the spectrometer.  
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Tandem MS (MS-MS) data were obtained by using a Q-STAR PULSAR (Applied 
Biosystems, Foster City, CA) equipped with nanospray interface (Protana, Odense, 
Denmark). Dried samples were resuspended in 0.1% TFA, desalted by using ZipTip C18 
microcolumns (Millipore, Bedford, MA), and sprayed from gold-coated “medium-length” 
borosilicate capillaries (Protana). The capillary voltage used was 800 V. Double-charged ion 
isotopic clusters were selected by using the quadrupole mass filter and then induced to 
fragment by collision. The collision energy was 20 to 40 eV, depending on the size of the 
peptide. The collision- induced dissociation was processed by using Analyst 5 software 
(Applied Biosystem). The deconvoluted MS-MS spectrum was manually interpreted with the 
help of Analyst 5 software.  
 
 
3.5 Large scale fractionation by RP-HPLC of peptide extract from BWW 
 
To assay inhibition properties of simplified peptide sets, BWW peptide extract was 
fractionated using an HP 1100 modular HPLC apparatus (Agilent, Palo Alto CA, USA). The 
sample was loaded onto a 218TP54, 5μm reversed-phase column C18, 250 mm x 4.6 mm 
column (Vydac, Hesperia, CA). Solvent A was water containing 0.1% TFA (v/v) and solvent 
B was AcN containing 0.1% TFA (v/v). A linear gradient from 5 to 70% solvent B was 
applied over 60 min with a flow rate of 1 ml/min, after 5 min at isocratic elution (5% solvent 
B). UV detection was carried out at 220 and 280 nm using a multi-wave length detector. For 
each run, 100 μl of a 23,5 mg/ml solution of peptide extracts from BWW were injected; 
eluted peptide fractions were manually collected at 10 min time intervals, obtaining on the 
whole five different peptide sub-fractions, labelled in chronological order f1-f5. Due to 
limited sensitivity of CaCo-2 cell growth inhibition assay, sub-fractions collected at the same 
retention times from three HPLC runs were joined together and used for biological assays.  In 
Fig 2, the analytical approach for f3 proteomic and bio-functional characterization is reported.  
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Fig 2. Analytical approach for f3 proteomic and bio-functional characterization. 
 
 
3.6 nano- ESI MS and nano- ESI MS/MS analysis 
 
Before nano-electrospray mass spectrometry (nano- ESI MS) analysis, each peptide sub-
fractions was purified from residual salts by loading onto ZipTipC18 Reversed Phase pre-
packed micro-columns (Millipore Bedford MA, USA), previously equilibrated with 0.1% 
TFA, washing with 0.1% TFA and eluting by aqueous 50% AcN (v/v) containing 0.1% TFA 
(v/v). Flow direct injection nano-ESI MS and nano-ESI MS/MS experiments of peptide sub-
fractions, manually collected from BWW RP-HPLC, were carried out using an hybrid 
quadruple-orthogonal acceleration time of flight  Q-star Pulsar (PESciex, Toronto, Ontario, 
Canada) equipped with a nanospray source (Protana Inc., Odense, Denmark), operating in 
positive ion mode. The samples were diluted, doubling the volume, in a solution 2:1 (v/v) 
H2O + 5% acetic acid/AcN and introduced in the source trough borosilicate needles, gold 
coated (Protana Inc., Odense, Denmark). Needle voltage was 800 V and orifice voltage was 
set at 40 V to minimize fragmentation; air at the pressure of 10 psi was used as “curtain gas”. 
In nano-ESI MS/MS experiments, N2 was used as collision gas; Q0 and Q2 quadrupole 
voltages were respectively 58.0 V and 9.9 V.  
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3.7 Extraction of sphingolipids from growth media of preconfluent cells with and 
without f3 treatment  
 
Spingolipids were extracted form cell culture media of preconfluent cell by adding an equal 
volume of a mixture of chloroform/methanol 80:20. After vortexing and centrifuging for 5 
minutes at 4000 rpm (Minifuge centrifuge, Heraeus, Osterode, Germany), the upper phase 
was transferred to a new vial for MALDI-TOF-MS analysis. 
 
 
3.8 Cell culture and cell proliferation assay 
 
CaCo2 cells (American Type Culture Collection, Rockville, MD) were grown at 37°C in h-
glucose MEM containing: 1% (v/v) MEM non-essential amino acids and supplemented with 
10% (v/v) decomplemented FBS (Flow, McLean, VA), 100 U/ml penicillin, 100 μg/ml 
streptomycin, 1% L-glutamine and 1% sodium pyruvate. The cells (17-21 passages) were 
grown in a humidified atmosphere of 95% air/5% CO2 at 37°C and were plated in 12 multi-
well plates at different densities. After incubation for 4 h in DMEM with 10% FBS, the cells 
were washed with 1% PBS to remove unattached dead cells.  
The starved cells (DMEM without serum) were pre-treated for 30 min with 50 M H2O2 (H-
CaCo2) and then incubated with the peptide extracts. To this aim, the dry peptide extracts 
from BM, BSW, BWW and BS were weighed, dissolved in DMEM without serum and added 
to the H-CaCo2 cells at the final concentrations of 0,1 or 1 mg/ml.  
1.0 x 10
5
 H-CaCo2 cells treated with the peptides extracts were seeded in 12 multi-well plates 
and incubated at 37˚C. After 12 h the cells were counted with a hemocytometric counter and 
cell proliferation was determined through CyQuant Cell Proliferation Assay Kit (Invitrogen, 
Milan, Italy) with dye fluorescence measurement at 480 and 520 nm emission maximum. 
For the BWW sub-fractions biological assay, the pre-confluent H-CaCo2 (21 passage) were 
incubated with 0.08 mg/ml of BWW and RP-HPLC purified sub-fractions (f1,f2,f3,f4,f5) for 
24 h at 37˚C. All experiments were performed on triplicate cultures. After 24h the cell 
number and the cell proliferation was determined as already described. Cell proliferation was 
expressed in percentage of proliferation compared with the control.  
The control sample was constituted by H-CaCo2 cells not added of peptide extract (untreated 
cells). Cell proliferation was expressed as percentage of proliferation compared with the 
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control sample, which was therefore assumed as 100%.  All experiments were performed on 
triplicate cultures and data are the mean ± SD of three experiments. 
 
 
3.9 Flow cytometry analysis of H-CaCo2 
 
H-CaCo2 cells were seeded in 6 multi-well plates at the density of  25 x 10
5
 cells/plate. After 
12 h incubation with 0.08 mg/ml of peptide extracts from BM and BWW in DMEM without 
serum at 37°C, and 24 h of incubation with 0.08 mg/ml of f3 sub-fraction, the cells were 
washed in PBS, pelleted in centrifuged and directly stained in a propidium iodide (PI) 
solution (50 mg PI in 0.1% sodium citrate, 0.1% Nonidet P40, pH 7.4) for 30 minutes at 4°C 
in the dark. Flow cytometric analysis was performed using a FACScan flow cytometer 
(Becton Dickinson, San Jose, CA, USA). To evaluate cell cycle PI fluorescence was collected 
as FL2 (linear scale) by the ModFIT software (Becton Dickinson). For the evaluation of 
intracellular DNA content, at least 20,000 events for each point were analyzed in at least three 
different experiments giving a s.d. lower than 5%.  
The  mitochondrial superoxide anion production  was analysed by hydroethidine (HE) 
staining. The cells were incubated for 1 h at the end of treatment with 20 ng/ml HE stock 
solution. At the time of processing, cells were scraped,  washed twice with PBS and the pellet 
was added to 1 ml PBS. The hydroethidine-superoxide anion (HE-O) accumulation was 
determined using the CellQuest software (FACScan, Becton Dickinson) furnished with the 
cytometer. For each sample, 2 x 10
4
 events were acquired. Analysis was carried out by 
triplicate determination on at least three separate experiments. 
 
 
3.10 Alkaline phosphatase activity 
 
Alkaline phosphatase (ALP) activity was used as a marker of colonic differentiation degree. 
The H-CaCo2 cells were washed and lysed with 0.25% sodium deoxycholate essentially as 
described by Herz et al (1981) [9]. ALP activity was determined using the Sigma Diagnostics 
ALP reagent (No. 245). Total cellular protein content of samples was determined by the 
Bradford microassay using the Coomassie Protein Assay Reagent Kit (Pierce). ALP activity 
was calculated as units of activity for mg of protein. 
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3.11 Western blot  assay 
 
The effect of f3 sub-fraction on expression of Hsp 70, Hsp 90, Akt (also named protein kinase 
B) and Cyclin A was determined by Western blot. H-CaCo2  treated and untreated  (control) 
were lysed using an ice cold lysis buffer (50 mM Tris, 150 mM NaCl, 10 mM EDTA, 1% 
Triton) supplemented with a mixture of protease inhibitors containing antipain, bestatin, 
chymostatin, leupeptin, pepstatin, phosphoramidon, pefabloc, EDTA, and aprotinin 
(Boehringer, Mannheim, Germany). Equivalent protein samples were resolved on 8-12% 
sodium dodecyl sulphate (SDS)-polyacrylamide gels and transferred to nitrocellulose 
membranes (Bio-Rad, Germany). For immunodetection, membranes were incubated 
overnight with specific antibodies at the concentrations recommended by the Manufacturer. 
All antibodies were diluted in Tris buffered saline/Tween 20-1% milk powder. This step was 
followed by incubation with the corresponding horseradish peroxidase conjugated secondary 
antibody (antimouse-IgG 1:2000, anti-rabbit-IgG 1:6000; Biosource, Germany). Protein 
bands were detected by enhanced chemiluminescence (ECL-kit, Amersham, Germany). Total 
Akt expression was monitored by Western blot analysis with an antibody recognizing Akt 
independently from its phosphorylation state. For the measure of the activity, Akt was 
immunoprecipitated with a specific anti-Akt antibody and its activity was measured in an in 
vitro kinase assay using GSK-3a as substrate. Immunoprecipitated Akt kinase was used to 
phosphorylate glycogen synthase kinase-3a (GSK-3a). GSK-3a phosphorylation was 
measured by Western blot analysis with a specific anti-phospho-GSK-3a/b antibody. 
Reactions were carried out according to the instructions of the Akt kinase assay kit from New 
England Biolabs. 
 
 
3.12 β-Galactosidase assay 
 
Senescence was assessed by β-galactosidase staining. Cells were washed with PBS and fixed 
with 2% formaldehyde and 0.2% glutaraldehyde at room temperature for 5 min. After two 
washes with PBS, the cells were incubated at 37°C for 4 hours in a humidified chamber with 
freshly prepared SA-β-Gal staining solution (1 mg/ml X-Gal in dimethylformamide, 40 mM 
citric acid and phosphate buffer, pH 6.0, 5 mM potassium ferrocyanide, 150 mM sodium 
chloride, and 2 mM magnesium chloride). After one day, cells were washed twice with PBS 
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at room temperature for 10 min, and staining was visualized and captured using an optical 
microscope (Carl Zeiss, Inc., USA). 
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4. RESULTS AND DISCUSSION 
 
4.1 Characterization of peptides in Buffalo Milk and in cheese whey produced during 
Mozzarella PDO technological process 
 
4.1.1 The peptides of river buffalo raw milk 
The peptide extracts from raw BM were analysed in mixture by MALDI-TOF-MS (Fig 3). 
The mass spectrum clearly showed the presence of two families of casein fragments, those 
deriving from the N-terminal end of αs1-CN and those from the C-terminal end of β-CN. The 
simultaneous occurrence of peptides progressively shortened in the same mixture suggested 
the possible identity of the signals in the spectrum, as it was possible to reconstruct entire 
sequences on the basis of the differences in molecular masses corresponding to amino acids 
(Fig 3, inset). For unambiguous assignment of peptide identity, MALDI-TOF-MS PSD 
analysis and ESI-MS/MS tandem mass spectrometry analysis were carried out.  
 
 
Fig 3. MALDI-TOF mass spectrum of the low molecular mass peptide fraction (MW‹3KDa) extracted from river 
buffalo raw milk (BM). In the insets the peptides derived from the main fragments β-CN f193-209 and αs1-CN f1-
23 are schematized. 
 
The peptide αs1-CN f1-23 arose from primary cleavage at the level of the Phe
23
-Phe
24
 bond, a 
well known chymosin proteolytic cleavage site [10]. As chymosin is only added at the 
beginning of the cheese-making process and is not present in raw milk, the peptide bond 
Phe
23
-Phe
24
 was probably hydrolyzed by the milk endogenous enzyme cathepsin D [11]. 
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Furthermore, Oomen [12] showed that also the proteolytic action of L. delbrueckii spp. 
bulgaricus on αs1-CN produced peptide 1-23 in cow milk. This finding, combined with a 
possible carboxypeptidase-like enzyme activity producing the shorter peptides αs1-CN f1-22 
and f1-21, suggested that αs1-CN N-terminal fragments could be generated by action of 
extracellular PI- and PIII- proteinases of lactic acid bacteria similarly to what occurs in bovine 
αs1-CN [13].  
The bovine peptide αs1-CN f1-23 presents an antimicrobial activity towards Staphylococcus 
aureus and Candida albicans [14]. However, the sequence of cow αs1-CN f1-23 differs from 
its buffalo homologue in two amino acid substitutions: His
4
Pro and Glu
14
Gly [15]. 
Therefore a possible antimicrobial activity for buffalo milk-derived peptide should be 
confirmed experimentally.   
Similarly, for the C-terminal portion of cow β-CN, the finding of the precursor peptide β-CN 
f193-209, followed by the shorter peptides f193-208 and f193-207, supported the hypothesis 
of a carboxypeptidase-like activity in BM. Furthermore, β-CN f193-209 is non specifically 
produced by isolated proteolytic enzymes (unpublished data) indicating that the entire Leu
192
-
Leu-Tyr
194
 sequence is particularly susceptible to hydrolysis possibly because it is located in 
an exposed protein region.   
A multifunctional activity has already been described for the 193-209 region of bovine β-CN, 
which contains the bioactive sequence -casokinin-10. Since the C-terminal sequence of β-
CN is conserved between river buffalo and cow species, precursors of peptides with 
immunostimulatory and ACE- inhibitory activities [16] are therefore possibly present also in 
BM.  
 
 
4.1.2 The peptides of Mozzarella PDO sweet whey 
 
k-CN is the main substrate of chymosin in cheesemaking, but natural calf rennet contains 
traces of other proteases, such as pepsin or gastricsin (pepsin C) [17]; furthermore, the 
microflora of “starter” cultures significantly contributes to proteolysis.  
Accordingly, the MALDI-TOF-MS peptide pattern of BSW (Fig 4A) was more complex than 
that observed for BM peptide extract. Several peptides produced from the C-terminal portion 
of β-CN, from k-CN (in particular from the k-casein macropeptide, CMP f106-169) and from 
αs1-CN were identified in BSW peptide extract (Table 1).  
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The precursor peptide αs1-CN f1-23 previously detected in BM disappeared completely in 
BSW, although its increase was expected  because of  the known  susceptibility of the Phe
23
-
Phe
24
 bond to chymosin action [18]. This finding  could be justified by the secondary 
proteolysis on the early casein fragment f1-23 which sequentially produced αs1-CN f1-22, f1-
21, f1-19;  the identification of αs1-CN f24-37 confirmed the cleavage at sites Phe
23
-Phe
24
 and 
Val
37
-Asn
38
, this latter by action of chymosin [13].  
The fragments derived from -CN C-terminal region were still present in the MALDI-TOF 
spectrum of BSW peptide extract, although at a lower relative intensity. The precursor peptide 
f193-209 found in milk was also present in BSW. Identification of β-CN f193-206, f193-207, 
f193-208 and f195-206, f195-207, f195-208, f195-209 supported the occurrence of secondary 
proteolysis by action of aminopeptidase and carboxypeptidase removing amino acids 
sequentially from both the ends of primary peptides. 
The peptide β-CN f161-177 was produced by hydrolysis at the level of the residues Gln160-
Ser
161, as already known for bovine β-CN [19]. Similarly β-CN f57-68 and f58-68 were 
produced, supporting the hypothesis that, since -CN is resistant to chymosin action [20] its 
proteolysis can be ascribed to bacterial hydrolytic enzymes.  
Para-k-CN (the N-terminal peptide 1-105 of k-CN generated by chymosin action on casein 
during milk curding) was scarcely sensitive to proteolysis, whereas several CMP fragments 
were detected, (Table 1), confirming the CMP sensitivity to proteolysis [21]. As expected by 
the specificity of chymosin action, significant amount of intact k-CN CMP either glycosylated 
or non glycosylated (data not shown) were also found. CMP-derived peptides could have a 
beneficial role in modulating the gut microflora, as the casein macropeptide is known to 
promote the growth of bifidobacteria mainly because of its carbohydrate content (mainly 
sialic acid) [22].  
Furthermore, CMP and CMP-derived peptides (casoplatelins) may have important biological 
value as in bovine they exhibited antithrombotic activity [23].  
Only the peptides f185-206 (MH
+
=2723.8) and f185-207 (MH
+
= 2836,1), both with the N-
terminal Gln converted to pyroglutamic acid (p-Glu) were identified from αs2-CN (see Table 
1). 
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Fig 4. MALDI-TOF mass spectra of the low molecular mass peptide fractions (MW‹3KDa) extracted from whey 
at the different stages of Mozzarella di Bufala Campana production: (A) sweet whey (BSW); (B) waste whey 
(BWW); (C) “scotta” (BS). Assignment of the main mass signals are given in Table 1. 
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4.1.3 The peptides of Mozzarella PDO waste whey 
 
As evidenced by MALDI-TOF-MS analysis (Fig 4B), the BWW peptide pattern was very 
complex because of secondary protease and peptidase action during curd maturation under 
whey. A multiplicity of peptides from β-, k- and αs1-casein were identified. In the MALDI-
TOF spectrum, the most prominent signals arose from the C-terminus of β-CN, probably also 
because of their high ionization efficiency in MALDI. For this reason, the BWW peptide 
mixture was also characterized by HPLC/ESI-MS (Fig 5). 
A number of peptides derived from -CN, not present in the BSW peptide extract, were 
identified in peptide extracted from BWW (Table 1). A drastic progress in the proteolysis of 
the primary peptide αs1-CN f1-23 was also observed. Several fragments of this peptide were 
likely produced by the lactic acid bacteria cell-wall envelope enzymes [22].  
Furthermore, k-CN fragments either from CMP (f116-127, already identified in BSW) or 
from para-k-CN, such as f25-40 and f25-45, occurred in BWW. Peptides from para-k-CN, 
together with the primary peptide f66-79 were identified only in BWW. Infact , the region 66-
79 of para-k-CN was particularly exposed to proteolytic attack, as several fragments derived 
from it. It has to be underlined that para-k-CN following the increase of bacterial proteolytic 
activity and the pH lowering during curd maturation, becomes sensitive to proteolysis. In 
bovine, this was already reported by Visser et al., [21] who noted that peptides from para k-
CN are generated by action of lactic acid bacteria belonging to Lactococcus lactis ssp. 
cremoris AM1.  
 
Fig 5. HPLC/ESI-MS chromatogram of the BWW peptide extract. The total ion current (TIC) chromatogram is 
shown. Co-elution of several peptides in each chromatographic peaks (inset) emphasizes the great complexity of 
the peptide fraction. 
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Table 1. Identification by mass spectrometry analysis of casein peptides extracted from BSW, BWW and BS 
produced at the different stages of Mozzarella di Bufala Campana production.  
Expected mass is the mass calculated on the basis of the known casein amino acid sequences.  
*For signals simultaneously occurring in different spectra, only one of the measured molecular masses is 
reported; slight fluctuations on the first decimal place for a signal in different spectra are due to the daily 
calibration.  
§ 
 • indicates the presence of peptide. 
 
 
4.1.4 The peptides from “scotta” 
 
“Scotta” is the residual whey resulting from the thermal coagulation of whey proteins during 
the production of “ricotta” starting from sweet whey. Fig 4C shows the MALDI-TOF 
spectrum of peptide extracted from BS and the peptides identified are reported  in the Table 1. 
The signals MH
+
=2723.8 and MH
+
=2145.5 assigned to s2-CN f185-206 and αs1-CN f180-
199 respectively, were found unchanged from BSW to BS, most likely because of proteolytic 
enzyme inactivation due to thermal treatment applied in the production of “ricotta”. The 
finding that the BSW peptide pattern is quite similar to BS, allowed us to conclude that most 
of the peptides of BSW are not included in “ricotta” whey protein network and that the 
peptide content of whey is scarcely affected by mild thermal treatment. 
 
 
4.2 Functional effects of peptides extracted from BM, BSW, BWW and BS on CaCo2 
cells 
 
Recent studies, carried out on several human cancer cell lines, have shown that milk-derived 
peptides may act on the regulation of cell growth, differentiation and apoptosis [24-27]. 
Based on these considerations, we decided to evaluate the protective effects of peptides 
derived from Mozzarella whey samples against H2O2-induced DNA damage in CaCo2 cell 
lines. Starved cells were exposed to 50 M H2O2 for 30 min (H-CaCo2) and then treated for 
24 h  with 0.1 and 1 mg/ml of peptide extracted from BM, BSW, BWW and BS. Interestingly, 
we observed that only exposure of H-CaCo2 cells to BWW 1 mg/ml resulted in a 43% 
reduction in cell proliferation (Fig 6) and decreased mithocondrial superoxide H-CaCo2 anion 
production analyzed by FACS. The adduct mean fluorescence intensity decreased from 6.2% 
for the control (H-CaCo2 cells) to 3.7% with BWW peptide extract fraction (Fig 7). To 
further investigate the effect of peptide extracted from BWW on cell proliferation, the 
distribution in each phase of the cell cycle was determined by flow cytometric analysis of 
DNA content.  
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Fig 6.  H-CaCo2 cell proliferation assay. Starved cells were pre-treated for 30 min with H2O2 (50 μM) and then 
incubated with 0.1 and 1 mg/ml of peptides extracted from BM, BSW, BWW and BS at 37 °C for 12 h. The 
control sample was constituted by H-CaCo2 cells untreated with the peptide extracts. Cell proliferation 
measured in treated samples was expressed as percent increase (proliferative effect) or decrease 
(antiproliferative effect) compared with that of the control sample, assumed as 100%. All experiments were 
performed on triplicate cultures and data are the mean ± SD of three experiments. 
 
 
 
 
 
 
Fig 7. Flow cytometry  analysis of oxidative stress in H-CaCo2 after incubation with peptide extracted from 
buffalo milk (BM), sweet whey (BSW), waste whey (BWW) and  “scotta” (BS). The control represented H-
CaCo2 cells untreated with peptide extract. All experiments were performed on triplicate cultures and data are 
the mean ± SD of three experiments. 
 
As reported in Fig 8, a significant reduction (p< 0.05) of cells in S phase and an accumulation 
in the G1 phase were observed in H-CaCo2 cells treated with 0.08 mg/ml BWW for 24 h. 
Concomitantly a sub-G1 peak in H-CaCo2 cells (data not shown) was detected. These results 
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suggest that, at the experimental concentration, BWW peptide extract is able to inhibit cell 
proliferation, interfere with cell cycle and exert a possible pro-apoptotic activity in H-CaCo2 
cancer cells. 
 
 
Fig 8. BM and BWW effects on G1 and S phase of H-CaCo2 cell cycle. All experiments were performed on 
triplicate cultures and data are the mean ± SD of three experiments. 
 
 
It is worth noting that the difference in the biological activity between the peptide extracted 
from BWW and the other three samples, finds a correspondence in the different peptide 
composition defined by the structural study (compare the MALDI spectra in Fig 3 and Fig 4). 
This means that the components responsible for the biochemical effects are specifically 
produced in the transition from BSW to BWW during curd maturation. 
 
 
4.3 Mass spectrometry characterization and proliferation effect of BWW sub-fractions 
on H-CaCo2 cell lines  
 
As evidenced by RP-HPLC analysis (Fig 9A), BWW produced during “Mozzarella di Bufala 
Campana PDO” manufacturing is a very complex mixture of peptides which derived from 
hydrolysis of caseins by endogenous proteases (e.g. plasmin), proteolytic enzymes of rennet 
and endo-/exo-peptidases from lactic acid bacteria. Peptide sub-fractions were obtained by 
RP-HPLC purification of BWW by collecting eluates at 10 min time intervals. 
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Fig 9. (A) RP-HPLC fractionation of the 3 kDa-permeate obtained from BWW. Each peptide fraction was 
collected at 10 min time intervals and termed with f followed by a number. (B) H-CaCo2 cell proliferation assay. 
The H-CaCo2 were treated for 24h with different RP-HPLC sub-fractions (f1-f5) of BWW. Cell proliferation was 
expressed as percent compared with the control. Each experimental value is the mean of three different 
determinations. 
 
Five peptide sub-fractions (f1, f2, f3, f4 and f5) were tested for 24h in H-CaCo2 cell line to 
assay proliferation effects (Fig 9B). BWW reduced H-CaCo2 proliferation of about 30% 
compared with the control sample represented by H-CaCo2 cells untreated with peptide 
extract. f1, f2, f4 and f5 had no statistically significant effect on cellular proliferation 
compared to control cells, while only f3 showed a marked antiproliferative effect (67% 
growth reduction), with respect to the unfractionated BWW (p value > 0,0001). To further 
investigate its composition and biological effects, f3 was characterized by MALDI-TOF MS 
(Fig 10). The peptides mainly derived from κ-cn, g-CMP (glyco-caseinmacropeptide) and β-
cn while only three peptides were from αs1- and  αs2-CN (Table 2).  Peptides identity was 
confirmed by nanoESI-MSMS as shown in Fig 11 where the fragmentation spectrum 
nanoESI-MSMS of double charge ion with m/z=766.9 and molecular weight 1531.8 Da 
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corresponding to the sequence k-CN f 155-169 is shown. A limited number of peptides 
remained unidentified. The mass spectrometry analysis allowed us to identify the single 
peptide components and to hypothesize the presence of active sequences and of their 
precursors (Table 2) as for the β-CN f57-68 and β-CN f60-68 which are precursors of the 
agonist opioid β-casomorphin 7 and β-casomorphin 5 [16].  Very little information is available 
on the release of BCMs during digestion of β-casein from buffalo milk, so the presence of these 
peptides is a very interesting information and according to our knowledge it fully complies 
with the data provided by Petrilli et al., [28]: buffalo β-CN simulating gastro-pancreatic 
digestion using pepsin, trypsin, chymotrypsin, elastase, carboxypeptidase A, 
carboxypeptidase B and leucine amino peptidase, does not release BCM7, but only a pro-
BCM7 with amino acid sequence corresponding to residues 59-68 of buffalo β-casein. This 
information leads us to observe that even with the involvement of different enzymatic entities, 
the gastro-pancreatic process and the proteolysis occurring in BWW, involves peptide similar 
entities.  
Recently, it has been reported that casomorphin-agonist peptides derived from the limited 
proteolysis of caseins, interacting with both opioid [29,30] and somatostatin receptors [31], 
acted in decreasing cell proliferation. In particular, Hatzglou et al. [28] have proved that in 
T47D human breast cancer cells in vitro, α- and β-casomorphins inhibit cell proliferation in a 
dose-dependent manner, by interaction with δ- and κ-opioid receptors. Opioid and 
somatostatin receptors are present in the cells of nervous, endocrine and immune system as 
well as in the intestinal tract of mammals [32], including CaCo2 cells. Therefore, the 
proliferation decrease we observed in colon cells could be mediated by a direct interaction 
between opioid precursors contained in BWW peptide extract and the specific opioid and 
somatostatin receptors [33,34] expressed on CaCo2 cells. 
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Fig 10. MALDI-TOF mass spectrum of f3 sub-fraction eluted at 20<tr<30 about. In the insets the peptides 
derived from the main fragments β-CN f188-209 and κ-CN f106-133 are schematized. 
 
 
Fig 11. Nano-electrospray ionization tandem mass spectrometry (nanoESI-MSMS) fragmentation of the double 
charge ion with m/z = 766.9 and molecular weight 1531.8 Da corresponding to the sequence of k-cn f(155-169) 
identified in f3 subfraction. 
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Table 2. Identification by mass spectrometry analysis of casein peptides eluted in f3 sub-fraction after RP-HPLC 
analysis of the 3-kDa permeate of BWW. Expected mass is the mass calculated on the basis of the known casein 
amino acid sequences.  
*For signals simultaneously occurring in different spectra, only one of the measured molecular masses is 
reported; slight fluctuations on the first decimal place for a signal in different spectra are due to the daily 
calibration.  
§ The carbohydrate part of peptides from g-CMP occurs in the same glycosilated chain composed of only few 
sugars as N-acetyl Galactosamine (GalNAc), Galactose (Gal) and Neuraminic Acid (NeuAc). 
 
 
4.4 The antioxidant effect of f3 reduced Hsp 70 and 90 expression and Akt activity  
 
The antioxidant effect of f3 on H-CaCo2 cell line was investigated through analysis of the 
intracellular redox status of H-CaCo2 cells treated with f3 by evaluating mitochondrial 
superoxide anion production (Fig 12).  
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Fig 12. Flow cytometry measure of oxidative stress on H-CaCo2 without (-) and with(+)  f3 treatment. The 
intensities of the bands were expressed as percentage respect to the control. For each sample, 2 x 10
4
 events 
were acquired. In the inset was reported fluorescence spectra of bands associated with O-HE analysis,  with 
“negative control” was indicated the H-CaCo2 without HE, the “positive control” was H-CaCo2 with HE and “ 
+ f3”  the H-CaCo2 treated with f3. 
 
 
Hydroetidine was used to measure mitochondrial superoxide anion production of vital cells. 
The adduct mean fluorescence intensity decreased from 6.2% in the control to 2.5% in the 
cells treated with f3. This indicated a corresponding decrease in the superoxide anion 
production. 
This finding led us to investigate if the decrease of superoxide anion production might 
influence the expression level of Hsp70 and 90, which are significantly elevated in many 
cancers, and in the case of some tumor types this is linked with poor prognosis and a muted 
response to chemotherapy. In the specific case of CaCo2 adenocarcinoma cell line, it has been 
previously reported that high Hsp levels are expressed constitutively even under non stress 
conditions [35]. This expression has been associated with enhanced survival to conditions 
such as oxidant- and thermal- induced stress. In Fig 13 the expression levels of Hsp 70 and 
Hsp 90 are reported. Fig 13A reports the western blot analysis of Hsp 70 and Hsp 90 in H-
CaCo2 cells treated with 0.08 mg/ml of f3 for 24h. Treatment with f3 decreased Hsp 70 and 
Hsp 90 expression of 36% and 10% respectively (Fig 13B). 
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Fig 13. Western blot analysis of H-CaCo2 without (-) and with (+) f3 treatment. (A) The bands associated with  
expression of Hsp70, Hsp90, house-keeping γ-tubulin, Akt and Phospho-GSK-3a/b(Ser21/9) after 24h of 
treatment with f3 are visualized. The expression of the house-keeping protein γ-tubulin, was used as loading 
control. (B) The expression levels of the above proteins are reported as percentage respect to the level of the 
protein in untreated cells, used as control. Bars show the mean values ± SD. Each experimental value reported  
is the mean of three different determinations.  
 
Hsps have a profound impact on the activities of several prosurvival signaling cascades, 
including those mediated by Akt, a downstream effector of the PI3-K pathway, a ubiquitous 
lipid kinase involved in receptor signal transduction by tyrosine kinase receptors [36]. There 
is increasing evidence that the activation of PI3-K/Akt is associated with colorectal 
carcinoma, and can convert differentiated human gastric or colon mucosa to a less 
differentiated and more malignant phenotype [37-39].  
Akt is overexpressed in several cancers, including those of the colon, pancreas, ovary, and 
breast [40]. Moreover, Akt phosphorylation in human colon carcinomas is correlated with cell 
proliferation and inhibition of apoptosis, as well as different clinico-pathological parameters 
such as invasive grade, vessel infiltration, lymph node metastasis, and tumor stage [41,42].  
For this reason, we compared the expression and activity of Akt in H-CaCo2 treated with f3 
and control cells (Fig 13A). The treatment with f3 induced no effect on Akt expression 
whereas the level of p-GSK-3 was decreased of 37% with respect to the control cells (Fig 
13B).  
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4.5 Effect of f3 on lipid synthesis and secretion 
 
We examined whether the Hsp decrease by f3 treatment in  preconfluent H-CaCo2  was 
correlated  with production of ceramides. It is well known that several inductors of cell death, 
including TNFα [43], anthracyclines [44], or irradiation [45] involve ceramide signalling.  
Administration of exogenous ceramide also causes cell death in various cancer cell lines [46]. 
It is noteworthy that many cancer cells have a specific „sphingolipid–phenotype‟, including 
lower endogenous ceramide levels [47] and a higher sensitivity to the effects of exogenous 
ceramides [48]. 
So it is well accepted that ceramides function as a second messenger in cells: the increase in 
their intracellular concentration in response to extracellular signals induces cell arrest and 
inhibition of growth in cancer cells [49-51].  
In Fig 14 the MALDI-TOF mass spectra of the chloroform extracts from the cell growth 
medium without (Fig 14A) and with (Fig 14B) f3 incubation are reported. A series of 
sphyngolipid components in the mass range 700-1200 Da was observed in the cells treated 
with f3, whereas a single component at m/z 1031 Da was found in the control sample. 
Identified sphyngolipid classes in the sample treated with f3 include ceramides EOH, EOS, 
AH and cerebrosides EOS, all molecules involved in the process of cell differentiation [43]. 
To denominate families of sphingolipids, we followed the nomenclature of Motta et al., who 
designated the three types of fatty acids in sphingolipids as non-hydroxy acids, α-hydroxy 
acids and ω-hydroxy acids esters linked to linoleate as N, A and EO, respectively [52].  
The three types of sphingoid bases, sphingosine, phytosphingosine and 6-hydroxysphingosine 
found in ceramides and cerebrosides were indicated as S, P and H. For example, a ceramide 
consisting of a ω-hydroxyacid ester-linked to a molecule of phytosphingosine would be 
designated as CER EOP, according to Motta et al., [52].  
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Fig 14. MALDI- TOF mass spectra of chloroform extracts from the growth serum  of  pre-confluent cells without 
(A) and with (B) f3 incubation. A series of sphyngolipid components in the mass range 700- 1200 Da was 
observed in the cells treated with f3. CER, ceramides; CERBR, cerebrosides. 
 
 
 
4.6  Effect of f3 on  H-CaCo2 cells: quiescence, differentiation and senescence  
 
In order to elucidate if the ceramide productions was involved in the regulation of the cell 
cycle, we analyzed  by FACS the percentage of G1/G0, G2/M, and S-phase cells. In Fig 15A 
the percentage of G1, G2, and S-phase untreated and treated cells with f3 after 24h is 
reported.  The treatment resulted in accumulation of cells in the G1/G0 phases (66%), while 
concomitantly the S-phase populations decreased (25%). These results suggested
 
that f3 arrest 
the cell cycle in G1 phase as further confirmed by a 5-fold decrease of cyclin A expression as 
shown in Fig 15B [53].  
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These results are associated  with increased expression of  alkaline phosphatase  activity (Fig 
15B), a marker of enterocytic differentiation correlated to post-confluent phase. Moreover, 
cell cycle arrest is accompanied by an increased senescence-associated (beta)-galactosidase 
(1.5-fold), compared to control (Fig 15C) [54].  
 
Fig 15. (A): G1, G2 and S phases cell cycle and cyclin A expression and (B) Alkaline phosphatase activity of H-
CaCo2 treated with f3. To evaluate cell cycle, PI fluorescence was collected as FL2 (linear scale). In the inset 
Western blot analysis with Anti-cyclin A antibody is reported. (B) Alkaline phosphatase activity/mg proteins is 
showed. ALP activity were measured in homogenates of H-CaCo2 cells  (without and with f3 treatment) and 
expressed as activity per cell proteins. (C) senescence-associated (beta)-galactosidase activity. Bars show mean 
values ± SD; each experimental value reported  is the mean of three different determinations. 
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5. CONCLUSIONS 
 
Many of the peptides originated from the degradation of milk proteins have been 
characterized as biologically active. In this context, the criterion generally used to assess the 
quality of food proteins, based solely on the nutritional properties of the protein, should be 
revised on the protein ability to release peptides with biological activity, during food 
processing. The great complexity and the wide dynamic range of relative peptide abundance 
in these products severely challenge the capabilities of existing analytical methodologies. A 
major step forward has been achieved by combining the biochemical and biological approach 
with the tools of proteomics technologies like addressed in this PhD project.  
With regard to the results obtained in this study, we can conclude that: 
 
 although raw BM has an intrinsic peptide pattern produced by milk endogenous 
proteases, the proteolysis of buffalo milk proteins, occurring during the production of 
Mozzarella di Bufala Campana PDO cheese, further increases the complexity and 
heterogeneity of each peptide extract. The structural characterization allowed us to 
conclude that milk proteolysis is the result of a complex series of events due to the 
combined action of either native or endogenous milk proteases, milk clotting enzymes, 
starter culture, and contaminating microflora. Compared to BM, BSW and BS, only 
the low-molecular mass peptides in BWW was highly heterogeneous, with a large 
number of different oligopeptides.  
 the differences in the biological activity among the peptide extracted from BM, BSW, 
BWW and BS, find a correspondence in the different peptide composition defined by 
the structural study. Only BWW peptide extract is able to inhibit cell proliferation, 
interfere with cell cycle and exert a possible pro-apoptotic activity in H-CaCo2 cancer 
cells.  The absence of this effect in the peptide extract from original milk (BM) 
suggests that the production of specific bioactive compounds occurs specifically 
during the production process of Mozzarella cheese. Previous studies [38,39] have 
suggested protective activity of peptides originating either from the bacterial cell-wall 
or by hydrolysis products of the lactic acid bacteria. 
 the f3 peptide fraction obtained through BWW chromatographic purification not only  
preserves the same antioxidant and anti-proliferative action on H-CaCo2 cells, but also 
decreases mitochondrial superoxide anion production and reduces Hsp70 and Hsp90 
expression in survival H-CaCo2. The lowered Hsp expression induced by f3 treatment 
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made these cells significantly more sensitive to the injurious effects of the antioxidant 
agents. CaCo2 cells, infact constitutively express high levels of Hsps even under non 
stress conditions which is at the basis of their high resistance to chemical,  
immunological and chemotherapeutic agents. Moreover, the f3 treatment induces 
increased secretion of ceramides which resulted in cell cycle arrest, differentiation, 
and in subsequent „accelerated senescence” cell death in H-CaCo2. It is known that 
the intestine undergoes a continuous remodelling process in which ceramides play an 
important role as messenger molecules.  
 
This finding might envisage future applications of the active peptide fractions for the 
development of nutraceuticals for prevention of gut disfunctions, for healthing recovery in 
cases of acute injuries such as damage occurring in celiac disease or other intestinal 
pathologies and to increase the efficacy of drugs for treatment of gastrointestinal cancer. An 
intriguing finding was that peptides characterized in f3 are spontaneously produced during the 
cheese-making process of buffalo Mozzarella cheese, and released by action of the lactic acid 
bacteria into the waste whey, a natural source with low or null cost, available in large 
amounts, from which peptides could be easily purified once the appropriate industrial method 
has been set up. This information could also drive research in the utilization of industrial by-
products for the development of dietary supplements for functional foods and of novel drugs 
for pharmaceutical industry. 
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CHAPTER II 
 
1. INTRODUCTION 
 
1.1 Donkey milk 
 
Donkeys provide a kind of milk with nutritional and therapeutic properties known since the 
time of Herodotus (V century B.C). Taking into account that modern food trends are turning 
towards alternative products which are more responsive to new market demands, donkey milk 
represents a novel possibility for food technology science for its promising opportunities. 
Although donkeys are less important for milk production than cows, buffaloes, sheep and 
goats, they have been traditionally important dairy animals in Asia, Africa and Eastern 
Europe. Donkey milk resembles human milk in many ways and is claimed to have special 
therapeutic properties: it is becoming increasingly important in Europe because it is 
recommended as a substitute for cow's milk protein allergy (CMPA) which affects about 3% 
of children in the first three years of life [1]. 
Hypoallergenic alternatives to breast milk have been proposed through the years and include 
soy formulas and extensively hydrolysed milks. The extensive hydrolysed formulas, which 
are industrial milk-based products treated with proteolytic enzymes, have been recommended 
as the first choice for the dietoteraphy of CMPA patients [2]. However, administration of 
these foods, does not completely solve the problem in children with CMPA especially for the 
presence of possible residual epitopes. Moreover, the unpleasant bitter taste and the poor 
palatability of the breast milk substitutes can be a significant problem not only for those 
children suffering from CMPA.  
For these reasons, in the last few years, milk from non-bovine mammals (goat, donkey, mare, 
camel) has been extensively studied to identify the best natural substitute for human milk [3-
5]: it seems that milk produced by mono-gastric animal species, such as donkey and mare, is 
the most suitable. 
Donkey milk was found to be a valid alternative to both IgE-mediated and non-IgE mediated 
CMPA, with favourable effects on palatability in an increasing number of clinical trials [6,7], 
although the mechanism of this tolerance, likely related to the protein composition, has not 
been fully clarified yet.  
Moreover, a recent clinical study confirmed that feeding with donkey milk is a safe and valid 
treatment for the most complicated cases of multiple food intolerance, too [6]. In addition to 
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its use for infants, some researchers have reported that donkey milk has an effect on the 
osteogenesis process, as well as in arteriosclerosis therapy, for the rehabilitation of patients 
with coronary heart disease or premature senescence, and in hypocholesterolemic diets [8]. 
Overall, donkey milk is considered to be highly digestible, rich in essential nutrients and to 
posses an optimum whey protein/casein ratio, making it suitable not exclusively for the 
treatment of CMPA.  
In the past, donkey breeding was diffuse in Italy. The progressive mechanization of the 
agricultural activity, the depopulation of rural districts and the consequent reduction of 
working, has been causing a gradual decrease of donkeys and mules population since the end 
of the Second World War, with a strong acceleration during 1970s. The fifth Italian 
Agricultural census (ISTAT, 2006) reports a donkey population of 19325 heads in the year 
2000. Nowadays, the donkey breeds officially standardized in Italy are: Amiata, Asinara, 
Martina Franca, Ragusano and Sardo. However, many other breeds are spread on the national 
territory, for example Grigio Siciliano, Pantelleria and Romagnolo. Since 1996, the local 
Breeders‟ Association of Forlì-Cesena-Rimini area has been promoting the recovery of 
donkey breeds and it has started a project in order to recognize the breed in the National Stud 
Book. The Central Technical Committee of Italian Breeders‟ Association admitted donkey 
breeds in the Register in 2005 [9].  
Nowadays, in Italy, the consumption of donkey milk is gradually increasing thanks to the 
interest of consumers searching for a natural product, not only to replace human or bovine 
milk when needed. In the last few years, the number of farms breeding donkeys has notably 
risen and in 2006 the Italian Breeders Association (AIA) introduced functional controls on 
donkey milk production.  
The various research projects funded at national level in recent years have certainly helped to 
increase knowledge about donkey milk composition and at the same time have placed the 
emphasis on its nutritional value. Notwithstanding this renewed growing interest, donkey‟s 
milk has not been completely investigated and, in particular, the data available for its protein 
components are still poor [10-13]. 
 
 
1.2 Donkey milk: composition and commercial regulations 
 
Donkey, as well as horse species, belongs to the Equus family, and this phylogenetic 
relationship emerges in the similarity of their milk composition [14]. 
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Mare milk (which is closely related to donkey milk) has been studied extensively, while little 
is known about donkey milk. The composition of donkey milk differs considerably from that 
of the milk of the principal dairying species such as cow, buffalo, goat and sheep, while it is 
quite similar to that of horse and human ones, as shown in table 1. Overall, in comparison to 
bovine milk, donkey milk contains less fat fewer proteins and inorganic salts, a relevant 
percentage of essential amino acids, but more lactose with a concentration close to the one 
found in human milk: donkey milk has been regarded as the best breast milk substitute thanks 
to its intrinsic composition. 
Furthermore, donkey milk also contains a high amount of lysozyme, which is practically 
absent in the milk produced by cows, sheep and goats: this enzyme possesses bactericidal 
properties as it hydrolyzes the polysaccharides of bacterial cell walls and inhibits bacteria 
development [15]. 
 
Species 
Total 
solids 
Protein 
Casein
/Whey 
ratio 
Fat Lactose Ash 
Gross 
energy 
Donkey
a
 
(Equus asinus africanus) 
88.4 17.2 1.3:1 3.8 68.8 3.9 1582 
Horse
a 
(Equus caballus) 
102.0 21.4 1.1:1 12.1 63.7 4.2 1883
b
 
Man
a
  
(Homo sapiens) 
124.0 9.0 0.4:1 38.0 70.0 2.0 2763
b
 
Cow
c
 
(Bos taurus) 
127.0 34.0 4.7:1 37.0 48.0 7.0 2763
d
 
Buffalo
a
 
(Bubalus bubalis) 
172.0 46.5 4.6:1 81.4 48.5 8.0 4644
b
 
Sheep
c
 
(Ovis aries) 
181.0 55.9 3.1:1 68.2 48.8 10.0 4309
d
 
Goat
a
 
(Capra hircus) 
122.0 35.0 3.5:1 38.0 41.0 8.0 2719
b
 
a= values are express as g kg-1 milk 
b= values are express as kJ kg-1 milk 
c= values are express as g L-1 milk 
d= values are express as kJ L-1 milk 
 
Table1. Gross composition of the milk of selected species [16]. 
 
According to the Italian law, donkey milk can only be sold directly from the farm as raw milk 
(Regio Decreto 1929 n_ 994, paragraph 15, 43). 
The EC Regulation n. 853/2004 allows the sale of donkey milk being these animals included 
in the “other milk species”. According to this EC Regulation, donkey milk should have a total 
bacterial plate count of less than <1,500,000/ml at 30°C. Anyway, if donkey milk is assigned 
to infants or elderly human beings, it‟s absolutely necessary that, besides the nutritional re-
quirements, the sanitary aspects are also evaluated. Conte has already discussed the European 
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indications as inadequate for the control of milk quality in donkeys, demonstrating that in 
presence of some milk bacteria (S. aureus, S. intermedius, S. dysgalactiae) there is no 
evidence, in donkeys, of clinical signs and/or increased somatic cell count (SCC) [17].  
 
 
1.3 Donkey milk protein composition 
 
Even if the content of mature donkey milk protein is lower than that of bovine milk, there is a 
strong resemblance within the principal classes of proteins as casein and whey proteins. 
Caseins are the principal class of proteins in cow‟s milk (about 80% of total milk proteins), 
while donkey milk contains fewer caseins with a casein/whey protein ratio of 1.3:1 compared 
to 4.7:1 for cow‟s milk. So, due to the high content of whey proteins which is slightly less 
than the amount of caseins, donkey milk does not permit the production of cheese. Anyway, 
the information on the distribution and composition of each part of the class of donkey casein 
and whey proteins is extremely limited and even susceptible to novel discoveries, perhaps the 
identification of new components that were originally thought to be non existent in donkey 
milk, as for example for s2-CN (see results). 
Notwithstanding the renewed growing interest, donkeys‟ milk has not been completely 
investigated and, in particular, the data available for its protein components are still poor 
[10,13]. 
For these reasons, in our study, we assumed as reference the mare milk protein, where no data 
in literature can be found for the donkey counterpart. The available knowledge on donkey 
milk protein structures mainly concerns the primary structure and genetic polymorphism of 
whey proteins, as -lactalbumin ( -La) [18,19], -lactoglobulin ( -Lg) I and II, [10, 20-21] 
lysozyme [18, 22] and SA (serum albumin) [UniProtKB/Swiss-Prot Q5XLE4].  
Regarding donkey casein composition, the occurrence of -CN and s1-CN has been reported, 
by means of IEF and MS-analysis through fitting of their tryptic hydrolysates with the known 
mare counterparts [23] and the entire -CN and s1-CN sequence has been determined [24, 
25]. 
A more recent study [26] was based on N-terminal sequencing and peptide mass 
fingerprinting of 33 spots excised from 2-DE of donkey milk using horse protein as reference.  
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1.4 Caseins 
 
Casein micelles are primarily a source of amino acids, calcium, phosphate and bioactive 
peptides for neonates [27]. 
The casein fraction of most milk types consists of four gene products: s1-, s2-, β- and k-CN, 
of which the first three are calcium-sensitive. All caseins display a distinct lack of secondary 
structure, which led Holt and Sawyer [28] to classify them as rheomorphic proteins.  
The following sections present the state of art of individual caseins separately by referring to 
those of mare for the above reasons, focusing the attention on the donkey ones when literature 
data are available.  
 
 
1.4.1 s1-CN 
 
Mare s1-CN amino acid sequence has been derived from its cDNA (GenBanck Acc. No 
AAK83668) sequence by Lenasi et al.,  [29].  
The protein consists of 205 amino acids and (without post-translational modifications) it 
presents a molecular weight of 24614.4 Da. Two smaller isoforms of s1-CN have been 
identified in equine milk, which are probably due to alternative splicing processes during 
transcription leading to casual exons skipping events involving exon 7 and 14 result from the 
skipping of exons [13]. 
Equine s1-CN contains six potential phosphorylation sites [29], five of which are in very 
close proximity (Ser
75
, Ser
77
, Ser
79
, Ser
80
, Ser
81
) forming a phosphorylation centre.  
The phosphorylation modification levels of the native isoforms of equine s1-CN induce an 
hight heterogeneity: Matéos et al., [30] identified 36 different isoforms with several 
phosphate groups ranging from two to six or eight (depending on whether exon 7 was 
skipped), which present a complex pattern on 1D and 2D electrophoresis. 
Recently, Cunsolo et al., [25] identified in the dephosphorylated casein fraction of an 
individual milk sample collected in Eastern Sicily from a donkey belonging to Ragusano 
breed at middle lactation stage, four s1-CN isoforms with experimentally measured Mr of 
23658, 23786, 24278 and 24406 Da with two minor components with experimentally Mr of 
25142 and 25272 Da. The variant B (197 amino acids; Mr 23786 Da) and variant B1 (196 
amino acids; Mr 23 658 Da) differ for the presence of a glutamine residue at position 83 in the 
full-length component and present the amino acid substitutions Gln
8
 →His and His115 →Tyr 
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with respect to the mare‟s αs1-CN. The other two components also named variant A (202 
amino acids; Mr 24406 Da) and variant A1 (201 amino acids; Mr 24278 Da), which also 
differ in the presence of a glutamine residue at position 88 in the full-length component, show 
the insertion of the pentapeptide HTPRE between Leu
33
 and the Glu
34
, which accounts for the 
increase of 620 Da in their molecular masses. The two αs1-CNs variant A and A1 bearing the 
pentapeptide HTPRE present a less acidic nature (theoretical pIs of 6.12) with respect to the 
variants B and B1 (theoretical pIs of 6.01).  
Taking into account the exon modular structure of mare‟s αs1-CN, it is reasonable to assume 
that the pentapeptide HTPRE between Leu
33
 and the Glu
34
 is encoded by the exon 5,which is 
instead constitutively spliced in mare‟s αs1-CNs, where it should express the sequence 
SIPREVRK [29].  
On the other hand, the existence of the two isoforms lacking a glutamine residue is probably 
related to a cryptic splice site occurring at the first codon (CAG) of exon 11 (encoding this 
glutamine residue) as already reported for ewe, [31] goat, [32] cow and water buffalo [33] αs1-
CNs. 
The other two minor components at 25142 Da and 25272 Da might correspond to two 
additional αs1-CN isoforms, according to the results on the characterization of αs1-CN in 
mare‟s milk [30]. 
The existence of different αs1-CN variants also clearly indicates that the donkey αs1-CN 
polymorphism is typical of equidae milk and reflects the complex exon/intron structure of αs1-
CN. 
 
 
1.4.2 s2-CN 
 
Similar to human milk in which the s2-CN have never been identified, mare‟s milk may not 
express s2-CN: the complete amino acid sequence of equine s2-CN is unknown. 
Ochirkhuyag [34] published the sequence of s2-CN N-terminal 15 amino acid residues (Lys-
His-Lys-Met-Glu-His-Phe-Ala-Pro-???-Tyr-???-Gln-Val-Leu) and only some of which were 
later confirmed by Miranda [13].  
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1.4.3 -CN 
 
The amino acid sequence of equine β-CN, derived from the cDNA, is reported by Lenasi et 
al., [29] and revised by Girardet et al., [35], by the insertion of eight amino acids (Glu
27
 to 
Lys
34
). 
The theoretical molecular mass of this 226 amino acid polypeptide is 25511.4 Da. Two 
smaller variants of equine β-CN, which probably result from casual exon-skipping during 
transcription, were reported by Miranda et al., [13]. 
The 28 N-terminal amino acid residues contain seven potential phosphorylation sites (Ser
9
, 
Ser
15
, Ser
18
, Ser
23
, Ser
24
, Ser
25
, Ser
28
) and multi-phosphorylated isoforms of equine β-CN, 
containing three to seven phosphoserine residues, have been reported, with isoelectric points 
varying from pH 4.74 to 5.30 [30].  
Equine β-CN (Swiss-Prot Accession No. Q9GKK3) also presents several isoforms that 
contains potentially more phosphate groups than the bovine and human counterparts, i.e. up to 
7P and only recently, the location of the phosphorylated residues on the primary structure has 
been recently determined [36].  
In particular, it seems that the in vivo phosphorylation follows a sequential way and is not 
randomly performed: the isoform 4 P was found to be phosphorylated on residues Ser
9
, Ser
23
, 
Ser
24
, and Ser
25
 and the subsequent phosphate groups on Ser
18
, Thr
12
 and Ser
10
, led to the 
formation of the isoforms 5P-7P, respectively. 
The primary structure of a low-Mr β-CN variant which seems to be specific of the equine 
species, has been characterized by Miclo et al., [37], and is available in Swiss-Prot databank 
with the accession number Q9GKK3.  
The low-Mr β-CN is apparently absent from the milk of other mammals including ruminants 
and low-Mr β-CN was isolated from Haflinger mare‟s milk. This short protein (94 amino acid 
residues and Mr 10591.6 ±2 Da) is an internally truncated form of the full-length equine β-CN 
(226 residues). 
In particular, in the short β-CN, a large deletion (residues 50-181) is due to a cryptic splice 
site usage occurring within exon 7 during the course of primary transcripts processing. Seven 
phosphorylation forms were identified with one to seven phosphate groups with pIs ranging 
between 4.67 and 4.01. The major isoforms carry five and six phosphate groups. 
In equine sodium caseinate, the Lys
55
-Ile
56 
bond of equine β-CN is readily hydrolysed by 
bovine plasmin whereas no cleavage of a corresponding bond, Lys
48
-Ile
49
, in bovine β-CN, 
occurs [38]. 
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Similarly in bovine β-CN, Lys28-Lys29 is readily cleaved by plasmin but the equivalent, Lys37-
Leu
38
, in equine β-CN, is insensitive [39]. Other plasmin cleavage sites in equine β-CN are 
Lys
111
-Arg
112
, Arg
112
-Lys
113
 and Lys
113
-Val
114
 [39]. Equine β-CN is readily hydrolysed by 
chymosin at Leu
198
-Tyr
199
 [40]. 
Concerning donkey milk β-CN, Cunsolo et al., 2009 identified in the dephosphorilated casein 
fraction of a milk sample collected from an individual donkey belonging to the Ragusana 
breed of Eastern Sicily, two coeluting proteins with Mr values of 25529 and 24606 Da, 
identified as donkey β-CN [24].  
The new donkey β-CN shows a mass difference of 923 Da due to the presence of the domain 
E
27
SITHINK
34
 in the full length component (Mr 25529 Da) as occurred in the mare‟s β-CN.  
In view of these analogies between donkey and mare β-CN, the full length (226 aa) was 
termed variant A, whereas the shorter one (218 aa) was termed variant A
Δ5
. The two donkey 
β-CNs present nine amino acid substitutions with respect to the mare‟s β-CN used as 
reference: L-S
37
, R-H
52
, S-N
81
, P-V
84
, L-V
91
, R-Q
203
, P-L/I
206
, L-F
210
 and A-P
219
 (amino acid 
positions are referred to the full-length variant A). These substitutions account for the increase 
of 18 Da in the Mr of the donkey‟s β-CN in comparison with the mare‟s counterparts. About 
the phosphorylated β-CN pattern, the variant A consists of three isoforms carrying from 5 to 7 
phosphate groups, whereas no data were obtained about the phosphorylation level of the short 
β-CN. 
 
 
1.4.4 κ-CN 
 
The presence of κ-CN in equine milk was an issue of debate for several years, with several 
authors reporting its absence [34] even if other studies [41] not only showed its presence, 
albeit at a low concentration, but also proposed its primary structure.  
The equine κ-CN contains 165 amino acid residues and is available in Swiss-Prot databank 
with the accession number P82187. Before post translational modifications equine κ-CN 
molecular weight is 18847.7 Da. Although no direct information is available on κ-CN 
glycosylation, lectin binding studies indicate that equine κ-CN is glycosylated , probably at 
residues Thr
123
, Thr
127
, Thr
131
,Thr
149
, Thr
153
 [29].  
Like mare milk, donkey one could have a κ-CN content so low to make it difficult to identify: 
donkey κ-CN has not been structural characterized.  
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1.5 Non-protein-nitrogen NPN of mares milk 
 
It is widely recognized that the NPN fraction of milk consists primarily of urea, peptides, 
amino acids and ammonia. NPN constitutes 10-15% of the total nitrogen in mature equine 
milk which is intermediate between the values for human milk and ruminant milk, 25 % and 
5%, respectively.  
Anyway, the NPN of equine milk as well as that of donkey milk, has not been studied in 
detail [42,43]. 
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2. AIM OF THE SECTION 
 
Taking into account that the donkey milk soluble peptides in non nitrogen fraction have never 
been characterized and their potential antioxidant bioactivity has never been investigated, the 
aim of this section is to study the low molecular weight peptides (Mr‹3KDa) by a peptidomic 
approach. Moreover, we have investigated the antioxidant effect of donkey milk peptides 
(DMPs) on linolenic acid in oxidative stress conditions induced by hydrogen-peroxide 
(H2O2). This study has been carried out on donkey milk samples provided by the broader 
SELMOL project.  
Since the structural characterization of NPN peptides can not be conduced unless reported to 
the primary sequence of the protein from which they are generated, a proteomics 
characterization on the casein component has also been carried out.  
In particular, the donkey caseome has been characterized coupling one-dimensional (PAGE, 
UTLIEF) and 2-DE (PAGE  UTLIEF) profiles, stained with either Coomassie Brilliant 
Blue (CBB) and specific polyclonal antibodies, with structural MS analysis. 
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3.  MATERIALS AND METHODS 
 
 
3.1 Materials     
 
All chemicals were of the highest commercially available purity and were used without 
further purification. TEMED, ammonium persulphate, glycine, urea, ammonium bicarbonate 
(AMBIC), HPLC grade H2O, formic acid (FA) and CH3CN were purchased from Carlo Erba 
(Milan, Italy). TFA, sinapinic acid (SA), α-cyano-4-hydroxycinnamic acid (CHCA), 
iodoacetamide, dithiotreitol, phenyl-methyl-sulfonyl fluoride (PMSF) and linolenic acid (LA) 
were obtained from Aldrich (St. Louis, MO, USA). Modified trypsin, sequencing grade was 
Promega (Madison, WI, USA), alkaline phosphatase (AP) was Roche (Mannheim, Germany). 
Zip-tip C18 microcolumns and Centriprep® 10-KDa cut-off membrane were Millipore 
(Bedford, MA, USA). Sep-pak C18 cartridge were Waters (Milford, MA). Acrylamide, Bis, 
Ampholine buffers were GE Healthcare Amersham Bioscience (Buckinghamshire, UK). 
Coomassie Brilliant Blue R 250 and G 250 were purchased from Bio-Rad (Richmond, CA 
94804, USA). 
All chemicals and reagents were of analytical grade or better from Sigma. HPLC-grade 
acetonitrile (AcN) was purchased from Carlo Erba (Milano, Italy). 
 
 
3.2 Donkey  milk sampling: casein and native milk peptides extraction  
 
Milk samples collected from 63 donkeys reared in Italy were analysed individually. To 
prevent undesired peptide hydrolysis, immediately after collection, samples were added with 
1-mM PMSF.  
Fresh milk was skimmed by centrifugation at 4500 g at 4 ◦C for 30 min (Haereus Biofuge, 
Kendro, Germany). To harden the cream, the tubes were kept at −20 ◦C for 10 min and finally 
the cream was scraped off.  
Each casein sample was prepared by acid precipitation from skimmed milk, followed by 
centrifugation at 2500 x g for 15 min, as described by Aschaffenburg & Drewry [44]. The 
casein sample was freeze-dried and stored at -20°C before use.  
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Only 18 on 63 milk samples were used for the extraction of native donkey milk petides 
(DMPs32-DMPs45), with an ultra-filtration step on Centriprep® cartridges with a 3-KDa cut-
off membrane. The permeates, lyophilised and solubilised in 0.1% (v/v) aqueous TFA, were 
purified from saline contaminants and lactose with a Sep-pak C18 cartridge, previously 
equilibrated in 0.1% TFA and eluted with 70/30/0.1 AcN/water/TFA (v/v/v). The peptide 
extracts were dried using a Savant concentrator (Speed-Vac,Milan, Italy) and stored at -20 ◦C 
either for structural analysis or for biological assay.  
 
3.3 Electrophoretic and immunoblotting analysis 
 
Casein samples (20 g/L) for electrophoretic analysis were dissolved in a 9 M urea solution, 
containing 2-mercaptoethanol (1 mL/L). Polyacrylamide gel electrophoresis (PAGE) at pH 
8.6 was carried out with a vertical electrophoretic apparatus (Protean II, Bio-Rad, Richmond, 
CA 94804, USA) at 200 V and 6°C for 7 h according to the procedure described by Chianese 
et al [45]. Staining was performed with Coomassie Brilliant Blue R-250. 
Ultra-Thin Layer Isoelectric Focusing (UTLIEF) on polyacrylamide gels (0.25 mm) was 
carried out as previously described [45]. Briefly, the pH gradient in the range 2.5-6.5 was 
obtained by mixing Ampholine buffers (GE Healthcare Amersham Bioscience, 
Buckinghamshire, UK), 2.5-5, 4.5-5.4 and 4-6.5 (1.6:1.4:1 by volume). The gel was stained 
with CBB G-250 as described by Krause et al., [46]. The 2-DE procedure was achieved by 
combining the first dimension PAGE gel with  
the second dimension UTLIEF gel; in particular, an unstained strip of gel  
PAGE, rinsed twice in distilled water and in 9 M urea with mercaptoethanol  
0.01% (v/v), was applied along the cathode of prefocused UTLIEF plate. 
For immunoblotting analysis, the casein fractions separated either by PAGE, UTLIEF or 2-
DE analysis were transferred by capillary diffusion from the gel onto a nitrocellulose 
membrane (0.45 m, Trans-Blot, Bio-Rad). Immunodetection was carried out according to 
the procedure already described by Chianese et al., [45] using rabbit polyclonal antibodies 
against bovine peptides s1-CN (187-199) and β-CN (195-199) and porcine - and s2-CN. 
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3.4 RP-HPLC analysis  
 
Casein samples were fractionated by RP-HPLC on a 214TP54, 5 m Vydac C4, 250 x 4.6 mm 
internal diameter column (Vydac, Hesperia, CA, USA) at a detection wavelength of 220 nm. 
Solvent A was 0.1% trifluoroacetic acid in ultra pure water (v/v) and solvent B 0.1% (v/v) 
TFA in acetonitrile. 200 L of a solution containing 1 mg (casein sample)/mL (solvent A) 
were loaded onto a C4 column, equilibrated with solvent A. The elution program involved a 
gradient from 30 to 50% solvent B in 40 min, then from 50 to 100% B in 2 min, at a flow rate 
of 1 mL/min. Each eluted casein fraction was manually collected, freeze-dried, and stored at -
20°C.  
 
 
3.5 In-gel digestion of protein spots 
 
In-gel digestion of the protein spots was carried out on selected gel pieces manually excised 
from the CBB-stained two dimensional electrophoresis gels, following the procedure reported 
by Mamone et al., [47]. Analysis of intact proteins eluted from gels was carried out according 
to Cohen & Chait [48]. 
 
 
3.6 Matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry analysis 
 
MALDI-TOF-MS experiments were carried out on a Voyager DEPRO mass spectrometer 
(PerSeptive Biosystems, Framingham, MA) equipped with delay extraction technology and 
N2 laser at 337 nm. Mass spectra were acquired both in positive linear or reflector mode and 
10 mg/mL SA and CHCA both dissolved in 50% ACN/0.1% TFA, were used as matrices for 
the analysis of proteins and peptides, respectively. MALDI-TOF analysis of intact proteins 
were obtained in linear positive ion mode over the m/z range 10000–30000 and were 
averaged from about 150 laser shots. 
Only the mixtures of tryptic peptides were subjected to a desalting/concentration step with 
Zip-Tip C18 microcolumns prior to analysis by MALDI-TOF. Spectra were obtained in 
reflectron positive ion mode over a m/z range 600-4000 and were averaged from about 150 
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laser shots. External calibration was performed by acquiring separate spectra of a mixture of 
standard peptides (Perseptive Biosystems).  
 
 
3.7 Electrospray Quadrupole-Time of Flight-Mass Spectrometry 
 
Peptides and proteins were analysed by micro LC ESI Q-TOF MS using a CapLC Waters 
high-throughput configuration
 
directly connected to a Q-TOF Ultima Mass Spectrometer 
(Waters Corporation, Manchester, UK). Samples (1 L) were loaded on 5 mm x 100 m ID 
Zorbax
TM
 300 SB C18 trap columns (Agilent Technologies), and the peptides were separated 
on 15 cm x 100 m ID Atlantis C18 capillary columns at a flow rate of approx. 1 L/min. 
Solvent A contained an aqueous 0.1% formic acid solution and solvent B contained 84% 
ACN in 0.1% FA. The gradient consisted of isocratic conditions at 5% B for 10 min, a linear 
gradient to 30% B over 40 min, a linear gradient to 100% B over 10 min, and then a linear 
gradient back to 5% B over 5 min. MS analyses were performed in positive mode using ESI. 
LC-MS was performed with the Q-TOF Ultima operating in either (continuum) MS mode or 
in MS/MS mode for data dependent acquisition (DDA) of MS/MS peptide fragmentation 
spectra. 
 
 
3.8 TBAR’s test  
 
The sensitivity of measuring Thiobarbituric Acid Reactive Substances (TBARS) has made 
this assay the method of choice for screening and monitoring lipid peroxidation, a major 
indicator of oxidative stress [49].  
The biological assay, was performed on 10 µl of each DMPs [16 µg/µl], to which 2 ml of 
tiobarbituric acid solution (0.37% v/) and TCA (15% v/v) were added and adjust to a final 
volume with HCl 0.25 N.  The sample is first boiled 30 min at 100°C, then cooled in ice and 
finally centrifuged 5 min at 8000 rpm. A spectrophotometric analysis of the supernatant was 
carried out at λ 532 nm.  
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4. RESULTS and DISCUSSION 
 
 
4.1 PAGE and immunoblotting analysis of donkey casein  
 
The donkeys casein samples were analysed individually. In Fig. 1, the two most common 
individual donkey casein samples Coomassie Brilliant Blue stained (1A) were compared to 
the cow counterparts on the basis of their relative net charge at alkaline pH by PAGE 
analysis. The results obtained after specific immunostaining with polyclonal antibodies 
against s1-, s2-, - and -CN (Fig. 1B, 1C, 1D and 1E, respectively), allowed to detect the 
four donkey casein fractions.  
 
Fig. 1. PAGE analysis at pH 8.6 of the two common donkey’s casein samples (1 and 2) compared to cow casein, 
after CBB staining (A) and identification of the four casein fractions by immunoblotting with polyclonal 
antibodies against s1 (B), s2 (C), (D) and -CN(E). 
 
By comparing the two species with each other, cow and donkey -CN exhibited a very similar 
anodic mobility, while donkey s1- and s2-CN a lower and reversed anodic mobility than its 
cow counterpart. The immunostained profiles showed: i) an overlap between s1- and s2-CN 
components; ii) proteolysis of s2- and -CN, giving rise to derived peptides having higher 
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( s2-CN derived fragments) and lower anodic mobility ( -CN derived fragments) than the 
parent protein.  
Considering the NPN peptide composition of donkey milk, consisting mainly in -CN and 
s2-CN derived peptides generated by plasmin-like specific cleavages (as reported in 4.5 
paragraph), it can be supposed that the same enzymes produced the above -CN and s2-CN 
derived insoluble peptides at pH 4.6. 
Finally, as shown in CBB stained PAGE analysis (Fig. 1A), it was very difficult to detect the 
-CN components without specific immunostaining (Fig. 1E), likely depending either on the 
low amount of this fraction in the milk or on its lower reactivity to CBB staining. These 
results showed: i) the lowest mobility of -CN towards the anode compared to the other 
donkey casein fractions; ii) a different electrophoretic mobility of the two -CN (sample 1 > 
sample 2) likely due to the occurrence of genetic polymorphism at this locus (Fig. 1E). 
 
 
4.2 UTLIEF analysis and immunoblotting of donkey casein  
 
The UTLIEF profiles of the two donkey casein samples, with the four casein fractions 
labelled in brackets after specific immunostaining, are shown in Fig. 2 (2B, 2C, 2D and 2E). 
The results underlined a more complex overlapping phenomenon, due to the similar pI of 
casein fractions components, with respect to the above PAGE analysis. In particular, donkey 
and cow -CN exhibit a very similar pI value, but a different compositional heterogeneity (8-
9 components in donkey vs 2-3 in cow), due to the different phosphorylation degree of each 
donkey -CN component and to the presence of deleted forms, as in mare counterpart [13].  
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Fig. 2. UTLIEF analysis of the two common donkey casein samples, 1 and 2, compared to cow casein as 
reference, after CBB staining (A) and identification of the four casein fractions by immunoblotting with 
polyclonal antibodies against  s1 (B), s2 (C), (D) and -CN(E). 
 
At this regard, Cunsolo et al., [24] found three phosphorylated components (5P, 6P and 7P) 
by MS analysis only in the full-length protein, while no information on the phosphorylation 
degree has been provided for the shorter -CN form lacking the -CN fragment (27-34) [24].  
Unlike PAGE, UTLIEF analysis allowed the separation of s1-CN and s2-CN focalising at 
different pI values. However, s2-CN components partially overlapped the -CN ones, and all 
these caseins fractions ( s1-CN, s2-CN, and -CN) were overlapped by -CN components 
(10-12) focalising throughout the pH gradient (Fig. 2). Concordantly with PAGE analysis 
(Fig. 1) s2-CN and -CN derived fragments focused at lower and higher pI values than their 
parent casein, respectively. 
 
 
4.3 2-DE analysis (PAGE  UTLIEF) 
 
To resolve the protein mixture components, the most commonly used 2-DE analysis consists 
in the “vertical” PAGE-SDS separation of in-gel “horizontally” focalised proteins, where the 
effectiveness of separation depends on the differences among the protein MWs. In ruminants, 
it is known, casein MW values, unlike these of whey proteins, are very close [50]. For this 
reason, the 2-DE combination applied for donkey caseome resolution was the “vertical” 
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UTLIEF analysis of the two donkey caseins in-gel PAGE at pH 8.6 separated (Fig. 3), as 
already reported for sheep and goat caseome [43,51].  
 
 
 
Fig. 3.  2-D separation (PAGE  UTLIEF) of donkey casein samples 1 and 2 showed in Figures 1-2. Staining 
with CBB and with antibodies preparation raised against s2 (A), s1 (B),  (C) and -CN (D). 
 
By means of specific immunostaining (Fig. 3A, 3B, 3C, 3D) the four zones, each containing a 
casein family ( s1-, s2-,  -  and -CN), were outlined with circles in Fig. 3.  
These results allowed to conclude: 
 in both samples the s1-CN composition consisted of two doublet bands (a, b and c, d), 
having decreasing pI values towards the anode; 
 in sample 2, the number of -CN components was doubled (six) with respect to 
sample 1 (three), likely due to occurrence of genetic polymorphism; 
 the most heterogeneous donkey casein fraction was -CN, since at least 11 
components were specifically immunostained in the 2-D map, focalising throughout 
the entire working pH range. 
 
 
4.4 LC/MS analysis of donkey caseins  
 
Comparison of the HPLC profiles of samples 1 and 2 (Fig. 4) showed that the latter was more 
heterogeneous than the former for the presence of the additional peak 4* eluted at shorter 
elution time than peak 4, common to the two samples.  
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Fig 4. UV profile (  =  220 nm) of LC chromatogram of donkey whole casein samples 1 and 2. 
 
In Table 2, the MW of eluted components, determined by means of LC/ESI/MS analysis 
either before or after PA action, was reported. These data showed the same eluted components 
in the four common peaks. In particular in peak 1 -CN  originated by hydrolysis of both full 
protein length fragments, (226 a.a.) and from its deleted form lacking peptide (27-34) [24], 
were identified. The MW values of components eluted in peak 2 (Table 2) and those of their 
derived tryptic peptides (results not shown), both fitting with the reported s1-CN sequence 
[25], allowed to conclude the presence of donkey s1-CN at different phosphorylation degrees 
(5P and 6P) as well as their counterpart deleted of a Gln residue (-128Da). In the same way in 
peak 3 donkey s1-CN, deleted of fragment s1(34-38; -621 Da) carrying 6P and 5P, was 
identified together with its deleted form lacking both Gln residue and s1 (34-38) fragment. 
These results suggested that also in donkey the compositional heterogeneity of s1-CN is 
depending on discrete phosphorylation (5P, 6P) and on the presence of non-allelic forms 
generated by RNA incorrect splicing, as in sheep and goat caseins [32-34]. 
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a Protein identification is based on 1 and 2 or more peptides. 
b nP: unknown number of phosphate groups. 
 
Table 2.  Donkey casein identification in sample 1 and 2 by LC/ESI-MS analysis. The 
additional peak 4* is only referred to sample 2. 
 
 
In peak 4, the full-length -CN and its deleted form lacking of fragment (27-34), both 
having 5, 6 and 7 P/mole, eluted. These forms have been already detected by Cunsolo et al., 
[24] only in the full-length protein. These data, in addition to pI theoretical values of the two 
-CN forms (Table 3), allowed us to identify them on the 2-DE map (Fig. 3) as the main and 
the minor components of donkey -CN, respectively. In peak 4*, a novel -CN was found 
Retention time 
(min) 
Peak Molecular mass, Da Protein identification
a
  
  native dephosphorylated  
19.2 1 16959 
17039 
17119 
18042 
18120 
18202 
18279 
  β-CN fragment (-922 Da) nPb 
β-CN fragment (-922 Da) nPb 
β-CN fragment (-922 Da) nPb 
β-CN fragment nPb 
β-CN fragment nPb 
β-CN fragment nPb 
β-CN fragment nPb 
21.6 2 24761 
24681 
 
24890 
24810 
 
 
24283 
 
 
24412 
αs1-CN 6P (-128 Da) 
αs1-CN 5P (-128  Da) 
αs1-CN      (-128  Da) 
αs1-CN 6P  
αs1-CN 5P 
αs1-CN 
22.1 3 24269 
24189 
 
24141 
24061 
 
 
23786 
 
 
23662 
αs1-CN 6P (-621  Da) 
αs1-CN 5P (-621  Da) 
αs1-CN      (-621  Da) 
αs1-CN 6P (-621  Da) (-128  Da) 
αs1-CN 5P (-621  Da) (-128  Da) 
αs1-CN      (-621  Da) (-128  Da) 
28.0 4* 25034 
25113 
25193 
 
26050 
26131 
 
 
 
24632 
 
 
25570 
β-CN* 5P (-923  Da) 
β-CN* 6P (-923  Da) 
β-CN* 7P (-923  Da) 
β-CN*      (-923  Da) 
β-CN* 6P 
β-CN* 7P 
β-CN* 
28.8 4 25013 
25099 
25178 
 
25938 
26023 
26101 
 
 
 
24619 
 
 
 
25542 
β-CN 5P (-923  Da) 
β-CN 6P (-923  Da) 
β-CN 7P (-923  Da) 
β-CN      (-923  Da) 
β-CN 5P 
β-CN 6P 
β-CN 7P 
β-CN 
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having a MW 28 mass units higher than the most common -CN present in peak 4. This 
showed the occurrence of genetic polymorphism at this casein locus. 
 
P/mole Lenght, 
a.a. 
Mr, Da Protein Theoretical 
Molecular 
Weight, Da 
pI 
7 226 26101 -CN 7P 26075 4.74 
6 226 26023 -CN 6P 25997 4.82 
5 226 25943 -CN 5P 25919 4.91 
      
7 218 25178 -CN 7P (-923 Da) 25151 4.64 
6 218 25099 -CN 6P (-923 Da) 25073 4.72 
5 218 25013 -CN 5P(-923 Da) 24995 4.80 
 
Table 3. Experimentally measured Mr of full lenght and deleted forms occurring in β-CN. The theoretical 
molecular weight and isoelectric points are calculated using the algorithm from ExPASy’s Scansite Compute 
pI/Mw program [34].    
 
Although no HPLC-eluted component was detected to confirm the presence of donkey s2-
CN, it was possible to identify this fraction by MS analysis of the excised spots 1, 2 and 3 
from 2-DE map (sample 2 in Fig. 3).  
 
 
 
 
 
 
 
 
Table 3. MALDI TOF/MS analysis relative to spot 3, 2 and 1 excised from the 2-D gel of donkey’s casein sample 
2 shown in Fig. 3 A*. A database search using the Mascot software retrieved phosphopetides from in-gel digest of 
each band with tripsin before and after AP action. 
 
As an example, in Fig. 5 the MALDI MS spectrum of the component excised from spot 1, 
before and after AP action, was reported. These procedure (results in Table 4) showed that 
donkey s2-CN occurred in spots 1, 2 and 3 with 10, 11 and 12 P/mole respectively. These  
Band Molecular Mass, Da Protein identification
a
 
  native dephosphorylated   
1 26829  
26029 
  αs2-CN 10P 
  αs2-CN 
2 26909  
26029 
  αs2-CN 11P 
  αs2-CN 
3 26989  
26029 
  αs2-CN 12P 
  αs2-CN 
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assignments were confirmed by MS analysis of tryptic digests (Table 5). The alignment of the  
tryptic peptides gave a 90% coverage corresponding to a protein 221 a.a. in length, in 
agreement with the cDNA sequence reported by Ramunno as shown in Fig. 6 [52]. 
 
 
 
 
 
Table 5. In-gel s2 –CN tryptic digest of spot 1 excised from the 2-D gel of donkey casein sample 2 shown in 
Fig. 3, by QTOF/ESIMS analysis. 
 
 
 
 
Identification Peptide sequence αs2 casein Theoretical 
mass 
Measured 
mass 
115-147  IVLTPWDQTKTGASPFIPIVNTEQLFTSEEIPK 3701.25 3702.25 
37-63+2P CSTSCEEATRNINEMESAKFPTEVYSS 3174.29 3177.17 
193-219  IVHQHQTTMDPQSHSKTNSYQIIPVLR 3159.59 3161.03 
37-63 CSTSCEEATRNINEMESAKFPTEVYSS+2P 3014.29 3015.81 
1-22+2P KHNMEHRSSSEDSVNISQEKFK+2P 2777.85 2777.89 
125-148  TGASPFIPIVNTEQLFTSEEIPKK 2647.04 2646.03 
89-109 KQLNKINQFYEKLNFLQYLQA 2644.09 2646.83 
125-148+1P TGASPFIPIVNTEQLFTSEEIPKK +1P 2727.04 2728.50 
26-46  YVVIPTSKESICSTSCEEATR 2417.71 2419.03 
26-46+ 1P YVVIPTSKESICSTSCEEATR + 1P 2497.71 2499.33 
56-72+ 6P FPTEVYSSSSSSEESAK+6P 2301.88 2301.50 
101-114  LNFLQYLQALRQPR 1760.08 1761.10 
111-124 RQPRIVLTPWDQTK 1738.03 1738.83 
8-22  SSSEDSVNISQEKFK 1684.79 1685.78 
10-23 SEDSVNISQEKFKQ 1638.46 1639.64 
209-221  TNSYQIIPVLRYF 1613.89 1613.97 
34-46+1P ESICSTSCEEATR+1P 1495.52 1496.50 
149-161 TVDMESTEVVTEK 1467.62 1468.60 
174-184 LLNKINQYYEK 1425.66 1427.77 
34-46 ESICSTSCEEATR 1415.52 1415.50 
209-219  TNSYQIIPVLR 1303.53 1304.87 
9-18+2P SSEDSVNISQ+2P 1225.06 1226.54 
112-121 QPRIVLTPWD 1224.43 1224.49 
115-124  IVLTPWDQTK 1200.41 1200.85 
9-18 SSEDSVNISQ 1065.06 1066.67 
185-192  FTLPQYFK 1043.24 1043.70 
73-80  FPTEREEK 1035.13 1036.68 
47-55  NINEMESAK 1035.15 1036.55 
1-7  KHNMEHR 951.08 951.61 
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Fig 5. MALDI TOF/MS spectrum relative to spot 1 excised from the 2-D gel of donkey casein sample 2 shown in 
Fig. 3 before (A) and after AP action (B). 
 
 
 
Fig 6. Primary structure of donkey s2-CN. Underlined, sequence determined by MS/MS, covering 90% of its 
cDNA sequence; S residues phosphorylated, in bold; S and T residues only partially phosphorylated, S and T in 
bold. 
 
 
4.5 DMPs peptidomic characterization  
 
DMPs were extract in solid phase without chemical agents. This method allowed us to extract 
efficiently low molecular weight peptides and to avoid a possible interference of the 
precipitating agent used with the TBARS-test. The DMPs mixture was individually 
characterized by MALDI-TOF MS mass spectra and the peptides identified among the 18 
DMP samples are reported in Table 6. Only in DMP 32 peptides from αs1-CN have been 
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identified: the αs1-CN peptides are produced by a primary proteolysis action of Leu
125
-Ile
126 
and Glu
150
-Pro
151 
and by a subsequent amino-peptidase action. This result allowed us to 
conclude that donkey αs1-CN has a lower susceptibility to proteolysis not involving the 
conventional N-terminal protein sequence as occurs in other species [53,54]. 
 
Measured 
mass 
MH+ * Identification Sequence 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 
1367,14 β-cn f(41-51) HEGQQQREVEH •
§   •   • • • • • • • • • • • • 
1505,07 β-cn f(42-53) HEGQQQREVEHQ •  • •               
1620,23 β-cn f(42-54) HEGQQQREVEHQD • • • • • •      •      • 
1748,34 β-cn f(41-54) KHEGQQQREVEHQD • • • •  •      •       
1779,54 β-cn f(40-53) FKHEGQQQREVEHQ •      • • •   •   • • •  
1895,59 β-cn f(40-54) FKHEGQQQREVEHQD • • • • • •     • •       
2023,81 β-cn f(40-55) FKHEGQQQREVEHQDK • • • •  •      •       
1595,81 β-cn f(176-189) VAPFPQPVVPYPQR •    •  • • • • • • • • • • • • 
1710,84 β-cn f(176-190) VAPFPQPVVPYPQRD       • • • • • • • • • • • • 
2137,03 β-cn f(176-194) VAPFPQPVVPYPQRDTPVQ   •      •    •  • •   
2207,47 β-cn f(176-195) VAPFPQPVVPYPQRDTPVQA   •     • • • • • • • • • • • 
2354,97 β-cn f(176-196) VAPFPQPVVPYPQRDTPVQAF • • • •  •   • • • • • • • • •  
2467,57 β-cn f(176-197) VAPFPQPVVPYPQRDTPVQAFL • •  •  •   • • • • • • • •  • 
2743,7 β-cn f(176-199) VAPFPQPVVPYPQRDTPVQAFLLY   •            •    
2987,95 β-cn f(176-201) VAPFPQPVVPYPQRDTPVQAFLLYQD           •   • • • • • 
3497,33 β-cn f(177-207) APFPQPVVPYPQRDTPVQAFLLYQDPQLGLT   •                
2882,44  β-cn f(200-226) QDRQLGLTGEFDPATQPIVPVHNPVIV    •               
2689.92 αs2-cn f(23-46) QEKYVVIPTSKESICSTSCEEATR • • •   •             
2805,01 αs2-cn f(23-47) QEKYVVIPTSKESICSTSCEEATRN • • • •  •          •   
2901,19 αs2-cn f(24-49) EKYVVIPTSKESICSTSCEEATRNIN • • • •  •             
3030,21 αs2-cn f(23-49) QEKYVVIPTSKESICSTSCEEATRNIN • • • •  •             
3383 αs2-cn f(21-49)+1P FKQEKYVVIPTSKESICSTSCEEATRNIN • • •   •             
2582 αs2-cn f(1-20)+3P KHNMEHRSSSEDSVNISQEK • • • •  •             
2502 αs2-cn f(1-20)+2P KHNMEHRSSSEDSVNISQEK • • • •               
2889,82 αs1-cn f(128-150) MKENSQRKPMRVVNQEQAYFYLE     •              
3045,62 αs1-cn f(127-150) RMKENSQRKPMRVVNQEQAYFYLE     •              
3158,17 αs1-cn f(126-150) IRMKENSQRKPMRVVNQEQAYFYLE     •              
3271,66 αs1-cn f(125-150) LIRMKENSQRKPMRVVNQEQAYFYLE     •              
                     
Table 6. Identification by mass spectrometry analysis of casein peptides extracted from individual DMP.  
Measured  mass is the mass measured by MALDI-TOF MS.*For signals simultaneously occurring in different 
spectra, only one of the measured molecular masses is reported; slight fluctuations on the first decimal place for 
a signal in different spectra are due to the daily calibration. 
§
 • indicates the presence of peptide. 
 
 
The αs2-CN derived peptides have been identified in DMP 28, DMP 29, DMP 30, DMP 31 
and DMP 33. The peptides identified are αs2-CN f1-20 1P, αs2-CN f1-20 2P and the primary 
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peptides αs2-CN f21-49 1P which with a simultaneously action of amino- and carboxy-
peptidases produces several other shorter peptides. 
Overall, the most abundant peptides come from β-CN in particular both from its C-terminal 
zone already known for its susceptibility to Lactococcus sp. 8  proteases type I, III and from 
the region zone including 40-55 amino acids.  
The primary fragment 40-55 is produced by a cleavage site at Lys
39
-Phe
40 
and Lys
55
-Ile
56
. The 
donkey β-CN Lys55-Ile56 has already been demonstrated as a specific plasmin cleavage sites 
[38], while no information is available for the Lys
39
-Phe
40
. 
Taking into account the sequence similarities between the amino acids involved in the two 
cleavage sites, we can deduce that also Lys
39
-Phe
40 
has been hydrolyzed by plasmin. The 
primary fragment 40-55 is further hydrolyzed by a combined action of amino- and carboxy-
peptidases producing different peptides identified in DMP 28, DMP 29, DMP 30, DMP 31, 
DMP 33 and DMP 39.  
The finding of the precursor peptide β-CN f176-199, followed by its shorter peptides at the C-
terminal side, supported the hypothesis of a carboxy-peptidase-like activity in donkey milk. 
The β-CN C-terminal identified peptides have all been produced by the Lys175-Val176 
cleavage. This cleavage site is homologous to cow β-CN Lys169-Val170 with a common 
susceptibly to plasmin action. The k-CN is not susceptible to the proteolytic action of 
endogenous milk enzymes as plasmin neither to the bacterial protease, so no peptides have 
been tried for this casein. Anyway, a limited number of peptides were unidentified because 
probably they arose from casein fragment involving genetic variants which have not been 
characterized.  
Cow‟s β-CN potentially contains a great number of bioactive peptides in its primary 
sequence. Donkey β-CN produced numerous peptides coming from the entire sequence f40-
55 and from its C-terminal sequence beginning from the precursor peptides f176-201. With 
the aim to identify potential bioactive peptides encrypted in donkey β-CN, an alignment 
between cow β-CN (UniProtKB P02666-1) and donkey β-CN (UniProtKB P86273-1) has 
been carried out (Fig 7a). 
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Fig 7. Alignment of the primary sequence of the cow’s (UniProtKB P02666-1) and (UniProtKB P86273-1) β-CN 
(Panel a). Potential bioactive sequence encrypted in donkey β-CN sequence (Panel b).  
 
 
 
 
                                                                                                                                      Chapter II 
 
97 
 
The alignment process allowed us not only to ascertain an overlapping of 56% between β-
CNs, but to identify the potential bioactive peptides encrypted in the primary sequence of 
donkey β-CN, as shown in Fig 7b.  
However, the immunomodulating peptide f191-193cow→f197-199donkey has a completely 
conserved sequence, while the multifunctional peptide with antihypertensive and antioxidant 
activity f177-183cow→f183-189donkey are not completely conserved sequences. These peptides 
showed an overlap of 85% differing by a single amino acid substitution A
177
cow→V
183
donkey. 
This substitution should not alter the biological activity because they are both hydrophobic 
amino acids and it is known that the presence of hydrophobic amino acids in the peptide 
sequence is a key structural requirement for the antioxidant activity [55]. 
 
 
4.6 Donkey milk peptides antioxidant activity 
 
The explanation of the antioxidant effect of donkey milk peptides (DMPs) on linolenic acid in 
oxidative conditions (H2O2), needs some consideration to introduce the results obtained with 
the thiobarbituric acid reactive substances (TBARS) test based on the measurement of 
malondialdehyde (MDA) formed as a consequence of linolenic acid lipid peroxidation. 
The antioxidant activity of peptides has been attributed to certain amino acid sequences as 
well as the peptide presence of peptide bonds or structural conformation arrangement. The 
presence of high levels of His and of some hydrophobic amino acids was related to peptide 
antioxidant power: the activity of His-containing peptides is thought to be connected to their 
hydrogen-donating ability, lipid peroxy-radical trapping, and/ or the metal ion chelating 
ability of the imidazole group. So, the hydrophobicity of the peptide also appears to be an 
important factor for its antioxidant activity due to increased accessibility to hydrophobic 
targets (as for example fatty acids). Furthermore, there is evidence that the antioxidant effect 
of individual amino acids is greater when they are incorporated in peptides, indicating that the 
peptide bond or structural conformation has an influence of this activity. Thus, peptide 
composition can lead to both synergistic and antagonistic effects with regard to the 
antioxidant activity of free amino acids.  
TBARS test is based on the measurement of malondialdehyde (MDA) formed as a 
consequence of linolenic acid lipid peroxidation. In the presence of hydrogen peroxide, 
thereby increasing the possibility of formation of hydro peroxides from linolenic acid, only 4 
individual DMPs (P31, PP39, P40 and P44) exert a pro-oxidant effect (Fig 8), while all the 
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other samples exert an antioxidant effect compared to the control. Currently, we have no 
information about the molecular mechanism involved in the different quantitative production 
of MDA mediated by DMP. Probably, as every antioxidant including vitamin antioxidants, 
DMP could react as a redox (reduction-oxidation) agent, protecting against free radicals in 
some circumstances, promoting free radical generation in others. In particular, DMP has an 
anti-oxidant function in vitro when molecules with a pro-oxidant action as H2O2 are 
concomitantly present.  
This information allowed us to conclude that donkey casein peptides effectively protected 
linolenic acid from oxidation in the presence of H2O2. The more interesting antioxidant effect 
is exerted by P28 and P40: both samples were effective inhibitors of TBARS development 
when lipid oxidation was promoted by H2O2. 
 
 
 
Fig 8. Antioxidant activity evaluated by TBARS test of peptides extracted from individual DMP and incubated 
with linolenic acid and the oxidant agent H2O2. 
 
The antioxidant activity found for P28 and P40, may probably be due to an isolated and/or 
combinated effect of αs2-CN caseinphosphopeptides and of β-CN C-terminal peptides. As 
shown in table 7, the determination of aliphatic index allowed us to evaluate the relative  
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Table 7. Aliphatic index and GRAVY of the sequences identified in DMPs extracts. 
* The aliphatic index of a protein is calculated according to the following formula: 
Aliphatic index = X(Ala) + a * X(Val) + b * ( X(Ile) + X(Leu) ) 
where X(Ala), X(Val), X(Ile), and X(Leu) are mole percent (100 X mole fraction) of alanine, valine, isoleucine, 
and leucine. The coefficients a and b are the relative volume of valine side chain (a = 2.9) and of Leu/Ile side 
chains (b = 3.9) to the side chain of alanine. 
§
GRAVY (Grand average of hydropathicity) values were calculated using the ProtParam tool of the ExPASy 
Proteomics Server. GRAVY value for peptides are  calculated according to Kyte and Doolittle as the sum of 
hydropathy values of all the amino acids, divided by the number of residues in the sequence [56]. 
# 
aliphatic index and GRAVY have been determined only for the peptide sequence without taking into account the 
number of phosphate groups. 
 
 
 
 
 
Peptide Sequence 
Aliphatic  
index* 
GRAVY
§
 
β-cn f(41-51) HEGQQQREVEH 26.36 -2.555 
β-cn f(42-53) HEGQQQREVEHQ 24.17 -2.633 
β-cn f(42-54) HEGQQQREVEHQD 22.31 -2.700 
β-cn f(41-54) KHEGQQQREVEHQD 20.71 -2.786 
β-cn f(40-53) FKHEGQQQREVEHQ 20.71 -2.336 
β-cn f(40-54) FKHEGQQQREVEHQD 19.33 -2.413 
β-cn f(40-55) FKHEGQQQREVEHQDK 18.12 -2.506 
β-cn f(176-189) VAPFPQPVVPYPQR 69.29 -0.257 
β-cn f(176-190) VAPFPQPVVPYPQRD 64.67 -0.473 
β-cn f(176-194) VAPFPQPVVPYPQRDTPVQ 66.32 -0.458 
β-cn f(176-195) VAPFPQPVVPYPQRDTPVQA 68.00 -0.345 
β-cn f(176-196) VAPFPQPVVPYPQRDTPVQAF 64.76 -0.195 
β-cn f(176-197) VAPFPQPVVPYPQRDTPVQAFL 79.55 -0.014 
β-cn f(176-199) VAPFPQPVVPYPQRDTPVQAFLLY 89.17 0.092 
β-cn f(176-201) VAPFPQPVVPYPQRDTPVQAFLLYQD 82.31 -0.185 
β-cn f(177-207) APFPQPVVPYPQRDTPVQAFLLYQDPQLGLT 84.84 -0.245 
β-cn f(200-226) QDRQLGLTGEFDPATQPIVPVHNPVIV 104.44 -0.104 
αs2-cn f(23-46) QEKYVVIPTSKESICSTSCEEATR 60.83 -0.575 
αs2-cn f(23-47) QEKYVVIPTSKESICSTSCEEATRN 58.40 -0.692 
αs2-cn f(24-49) EKYVVIPTSKESICSTSCEEATRNIN 71.15 -0.492 
αs2-cn f(23-49) QEKYVVIPTSKESICSTSCEEATRNIN 68.52 -0.604 
αs2-cn f(21-49)+1P FKQEKYVVIPTSKESICSTSCEEATRNIN 63.79# -0.600# 
αs2-cn f(1-20)+3P KHNMEHRSSSEDSVNISQEK 34# -1.830# 
αs2-cn f(1-20)+2P KHNMEHRSSSEDSVNISQEK 34# -1.830# 
αs1-cn f(128-150) MKENSQRKPMRVVNQEQAYFYLE 46.52 -1.270 
αs1-cn f(127-150) RMKENSQRKPMRVVNQEQAYFYLE 44.58 -1.404 
αs1-cn f(126-150) IRMKENSQRKPMRVVNQEQAYFYLE 58.40 -1.168 
αs1-cn f(125-150) LIRMKENSQRKPMRVVNQEQAYFYLE 71.15 -0.977 
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contribution of non-polar amino acids in the peptide sequence, while the GRAVY index 
provides us information about the total polarity of the peptide: negative GRAVY values are 
related to the hydrophilic attitude, while positive values to the hydrophobic ones.  
Overall, we ascertained that only the peptides produced from the entire sequence of β-CN C-
terminal are the most hydrophobic among all the peptides identified in DMPs. 
Antioxidant activity of the DMPs hydrolysates seems to be inherent to the characteristic 
amino acid sequences of peptides identified. Taking into account that these peptides are 
produced by endogenous donkey milk proteases we can assume that the protease specificity is 
responsible for milk antioxidant activity. 
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5. CONCLUSIONS 
 
In previous studies [45,51] one-dimensional electrophoresis did not provide efficient 
separation of caseins because of their partial overlapping, meanwhile vertical UTLIEF 
analysis of proteins horizontally in-gel PAGE separated after immunostaining was the most 
resolving 2-DE. This technique revealed a characteristic protein pattern for the two donkey 
casein samples consisting in: i) at least four s1-CN main components: ii) three -CN 
components, doubled in sample 2; iii) three s2-CN components and: iv) eleven -CN 
components.  
By means of LC-ESI MS analysis, the heterogeneity of s1-CN was assigned to either discrete 
phosphorylation (5, 6 and 7 P/mole) or non-allelic deleted forms generated by incorrect RNA 
splicing, as already shown in the homologous goat and sheep casein [31-33]. The full length 
-CN and its deleted form were both found equally phosphorylated with 5, 6 and 7 P/mole 
and a novel β-CN variant was found in sample 2. The molecular mass determined by ESI/MS 
before and after dephosphorylation of the variant showed a MW 28 Da higher than the most 
common β-CN and the same phosphorylation pattern.  
Donkey s2-CN contained 10, 11 and 12 P, and its structural characterization confirmed for 
the first time the correctness of the cDNA-derived sequence [52]. 
Thus, the combined methodologies applied in this study were able to disclose the 
heterogeneity of each donkey casein fraction due to post-translational phenomena, as well as 
the occurrence of polymorphism at β-CN locus.  
The proteomic information allowed us to a deeper structural characterization of donkey milk 
NPN peptides spontaneously generated by early proteolysis due to endogenous proteases. The 
peptidomic characterization demonstrate that donkey milk caseins shows an alternative 
proteolysis susceptibility when compared to proteolysis occurring on buffalo caseins (as 
demonstrated in Chapter I of this PhD thesis). Endogenous proteases in donkey milk also act 
on s2-CN known to be insensitive to the proteolytic action.  
Moreover, the NPN donkey casein peptides effectively protected linolenic acid from 
oxidation in the presence of H2O2 demonstrating for the first time the antioxidant activity of 
donkey milk peptides. This contributes to further expand the already widely recognized 
donkey milk functional properties.  
Overall, the information resulting from proteomic/peptidomic approach may be useful when 
programming breeding strategies for preservation and selection of donkey biodiversity, aimed 
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to production of donkey milk for human consumption. In fact, the variability associated with 
genetic polymorphism complemented with a major or minor complexity in the expression of 
single casein components may influence qualitative and quantitative donkey milk composition 
and, as a consequence, its allergenic properties.  
The protein fraction is largely  responsible for bovine milk allergenicity and  both donkey and 
mare milk have been widely used to replace human milk, especially for children affected by 
CMPA. Interspecies comparison between donkey and ruminants proteome revealed that 
donkey caseins resemble human, camel and porcine caseins to a higher degree than ruminants 
do. Goat milk has been all along used in CMPA patients even if recent studies have shown 
that donkey milk [6] has a major therapeutic effect compared to goat milk, although the 
mechanism of this tolerance, likely related to the protein composition, has not been fully 
clarified. If once donkey milk hypoallergenicity was thought responsible of the s2-CN 
absence, similarly to the human milk, in this work we have demonstrated the presence of the 
s2-CN in the donkey milk. This means that the donkey milk hypoallergenicity is not caused 
by the absence of s2-CN, but there are other milk proteins possibly involved. Therefore, the 
data obtained by the proposed analytical approach may open new possibilities for 
understanding the structural basis triggering milk allegenicity, as well as for designing and 
developing more efficient and safe substitutes of maternal milk. At present, compared with 
bovine milk, the characterization of donkey milk caseins is at a relatively early stage progress, 
and only limited data are related to its genetic polymorphism.  
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                      Chapter II 
 
103 
 
4. BIBLIOGRAPHY 
 
[1] Sampson, H.A. Update on food allergy. Journal of Allergy and Clinical Immunology. 2004.113, 805.  
[2] Høst, A., Koletzko, B., Dreborg, S., Muraro, A., Wahn, U., Aggett, P., Bresson, J.-L., Hernell, O., Lafeber, 
H., Michaelsen, K.F., Micheli, J.-L., Rigo, J., Weaver, L., Heymans, H., Strobel, S., Vandenplas, Y., Dietary 
products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society 
for Pediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the 
European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on 
Nutrition. Archives of Disease in Childhood.  1999. 81, 80. 
[3] Businco, L., Giampietro, P.G., Lucenti, P., Lucaroni, F., Pini, C., Di Felice, G., Iacovacci, P., Curadi, C., 
Orlandi, M. Allergenicity of mare‟s milk in children with cow‟s milk allergy. Journal of Allergy and Clinical 
Immunology. 2000. 105, 1031. 
[4] Muraro, M.A., Giampietro, P.G., Galli, E. Soy formulas and nonbovine milk. Annals of Allergy, Asthma and 
Immunology. 2002. 89 (Suppl. 6), 97. 
[5] Restani, P., Beretta, B., Fiocchi, A., Ballabio, C., Galli, C.L., Cross-reactivity between mammalian proteins. 
Annals of Allergy, Asthma and Immunology. 2002. 89 (6 Suppl.), 11. 
[6] Carroccio, A., Cavataio, F., Montalto, G., D‟Amico, D., Alabrese, L., Iacono, G. Intolerance to hydrolysed 
cow‟s milk proteins in infants: clinical characteristics and dietary treatment. Clinical and Experimental Allergy. 
2000. 30, 1597. 
[7] Monti, G., Bertino, E., Muratore, M.C., Coscia, A., Cresi, F., Silvestro, L., Fabris, C., Fortunato, D., 
Giuffrida, M.G., Conti, A. Efficacy of donkey‟s milk in treating highly problematic cow‟s milk allergic children: 
an in vivo and in vitro study. Pediatric Allergy and Immunology 2007. 18, 258. 
[8] Chiofalo, B., Salimei, E., Chiofalo, L. Ass‟s milk: Exploitation of an alimentary resource. Riv. Folium. 2001. 
1 (Suppl. 3), 235. 
[9] Beretti, V., Zanon, A., Soffiantini, C.S., Sabbioni, A. Preliminary results about morphological and 
demographic traits of Romagnolo donkey. Ann. Fac. Medic. Vet. di Parma. 2005. XXV, 131. 
[10] Cunsolo, V., Costa, A., Saletti, R., Muccilli, V., Foti, S., Detection and sequence determination of a new 
variant b-lactoglobulin II from donkey. Rapid Communication in Mass Spectrometry.  2007. 21, 1438. 
[11] Herrouin, M., Molle´, D., Fauquant, J., Ballestra, F., Maubois, J.L., Leonil, J. New genetic variants 
identified in donkey‟s milk whey proteins. Journal of Protein Chemistry. 2000. 19, 105.  
[12] Vincenzetti, S., Polidori, P., Salimei, E., Mariani, P., Allegri, S., Cammertoni, N., Quadrini, B., Vita, A. 
Purification and identification of as1- and b-caseins from asses‟ milk. Veterinary Research Communications.  
2005. 29, 211. 
[13] Miranda, G., Mahe, M.F., Leroux, C., Martin, P. Proteomic tools to characterize the protein fraction of 
Equidae milk. Proteomics 2004. 4, 2496. 
[14] Park, Y.W. in: Park, Y.W. Haenlein G.F.W. (Eds.), Minor species milk - Handbook of milk of non-bovine 
mammals, Blackwell, Oxford.  2006,  393.  
[15] Vincenzetti, S., Polidori, P., Fantuz, F., Mariani, P.L., Cammertoni, N., Vita, A., Polidori, F. Donkey‟s milk 
caseins characterization. Ital. J. Anim. Sci. 2005. 4 (2), 427.  
                                                                                                                                      Chapter II 
 
104 
 
[16] Lowe, T.U., Huppertz, T., Fox, P.F. Equine milk proteins: Chemistry, structure and nutritional significance. 
Int. Dairy J. 2010. doi:10.1016/j.idairyj. 2010.02.007. 
[17] Conte, F., Definizione dei principali criteri per il controllo del latte d‟asina. In: F. Conte (ed.) L‟asino 
all‟attenzione della comunità scientifica e del territorio. Chiriotti Editori. 2008. 57. 
[18] Conti, A., Napolitano, L., Lai, P., Pinna, W., Godovac-Zimmerman, J. Isolation of donkey whey proteins 
and N-terminal amino acid sequence of alpha- lactalbumins A and B, beta-lactoglobulins I and II and lysozyme. 
Milchwissenschaft. 1989. 44, 138. 
[19] Giuffrida, M.G., Cantisani, A., Napolitano, L., Conti, A., Godovac-Zimmermann, J. Bovine beta-
Lactoglobulin H. Isolation by Preparative Isoelectric Focusing in Immobilized pH gradient and Preliminary 
Characterization. Biol. Chem. Hoppe-Seyler. 1992. 373, 931. 
[20] Godovac-Zimmermann, J., Conti, A., James, L., Napolitano, L. Microanalysis of the Amino-Acid Sequence 
of Monomeric beta-Lactoglobulin I from Donkey (Equus asinus) milk. Biol. Chem. Hoppe- Seyler. 1988. 369, 
171. 
[21] Godovac-Zimmermann, J., Conti, A., Sheil, M., Napolitano, L. Covalent structure of the minor monomeric 
beta-lactoglobulin II component from donkey milk. Biol. Chem. Hoppe- Seyler. 1990. 371, 871. 
[22] Herrouin, M., Molle, D., Fauquant, J., Ballestra, F., Maubois, J.L., Leonil, J. New genetic variants identified 
in donkey‟s milk whey proteins. J. Protein Chem. 2000. 19, 105. 
[23] Criscione, A., Cunsolo, V., Bordonaro, S., Guastella, A.M., Saletti, R., Zuccaro, A., D‟Urso, G., Marletta, 
D. Donkeys‟ milk protein fraction investigated by electrophoretic methods and mass spectrometric analysis. Int. 
Dairy J. 2009. 19, 190. 
[24] Cunsolo,  V., Cairone, E., Saletti, R., Muccilli, V., Foti, S., Sequence and phosphorylation level 
determination of two donkey β-caseins by mass spectrometry. Rapid Comm. Mass Spect. 2009. 23,  1907. 
[25] Cunsolo, V., Cairone, E., Fontanini, D., Criscione, A., Muccilli, V., Saletti, R., Foti, S. Sequence 
determination of αs1-casein isoforms from donkey by mass spectrometric methods. J. Mass Spect. 2009. 44, 
1742. 
[26] Bertino, E., Gastaldi, D., Monti, G., Baro, C., Fortunato, D., Perono Garoffo, L., Coscia, A., Fabris, C., 
Mussap, M., Conti, A. Detailed proteomic analysis on DM: insight into its hypoallergenicity. Front. Biosci. E2 
2010. 526.  
[27] Shekar, C.P., Goel, S., Rani, S.D.S., Sarathi, D.P., Alex, J.L., Singh, S., et al. k-Casein-deficient mice fail to 
lactate. Proceedings of the National Academy of Sciences, USA. 2006. 103, 8000. 
[28] Holt, C., Sawyer, L. Caseins as rheomorphic proteins: interpretation of primary and secondary structures of 
the as1-, b- and k-caseins. Journal of the Chemical Society, Faraday Transactions. 1993. 89, 2683. 
[29] Lenasi, T., Rogelj, I., Dovc, P. Characterization of equine cDNA sequences for as1-, b- and k-casein. 
Journal of Dairy Research. 2003. 70, 29. 
[30] Matéos, A., Miclo, L., Mollé, D., Dary, A., Girardet, J.M., Gaillard, J.L. Equine as1-casein: characterization 
of alternative splicing isoforms and determination of phosphorylation levels. Journal of Dairy Science. 2009. 92, 
3604. 
[31] Ferranti, P., Malorni, A., Nitti, G., Laezza, P., Pizzano, R., Chianese, L., Addeo., F. Primary structure of 
ovine αs1-caseins: localization of phosphorylation sites and characterization of genetic variants A, C and D. 
Journal of Dairy Research. 1995. 62, 281. 
                                                                                                                                      Chapter II 
 
105 
 
[32] Ferranti, P., Addeo, F., Malorni, A., Chianese, L., Leroux, C., Martin, P. Differential splicing of pre-
messenger RNA produces multiple forms of mature caprine alpha(s1)-casein. European Journal of Biochemistry. 
1997. 249, 1. 
[33] Ferranti, P., Lilla, S., Chianese, L., Addeo, F. Alternative non allelic deletion is constitutive of ruminant 
αs1-casein. Journal Protein Chemistry. 1999. 18, 595. 
[34] Ochirkhuyag, B., Chobert, J.M., Dalgalarrondo, M.,  Haertlé, T. Characterization of mare caseins. 
Identification of as1- and as2-caseins. Lait. 2000. 80, 223. 
[35] Girardet, J,M., Miclo, L., Florent, S., Mollé, D., Gaillard, J.L. Determination of the phosphorylation level 
and deamidation susceptibility of equine b-casein. Proteomics. 2006. 6, 3707.  
[36] Matéos, A., Girardet, J.M., Mollé, D., Corbier, C., Gaillard, J.L., Miclo, L. Identification and 
phosphorylation sites of equine β-casein isoforms. Rapid Communication in Mass Spectrometry. 2010. 24, 1533. 
[37] Miclo, L., Girardet, J.M., Egito, A.S., Mollé, D., Martin, P., Gaillard, J.L. The primary structure of a low-
Mr multiphosphorylated variant of b-casein in equine milk. Proteomics. 2007. 7, 1327. 
[38] Egito, A.S., Girardet, J.M., Poirson, C., Mollé, D., Humbert, G., Miclo, L., Action of plasmin on equine b-
casein. International Dairy Journal. 2003. 13, 813. 
[39] Egito, A.S., Miclo, L., López, C., Adam, A., Girardet, J.M., Gaillard, J.L. Separation and characterization of 
mares‟ milk as1-, b-, k-caseins, g-casein-like, and proteose peptone component 5-like peptides. Journal of Dairy 
Science. 2002. 85, 697. 
[40] Egito, A.S., Girardet, J.M., Miclo, L., Mollé, D., Humbert, G.,  Gaillard, J.L. Susceptibility of equine k- and 
b-caseins to hydrolysis by chymosin. International Dairy Journal. 2001. 11, 885. 
[41] Iametti, S., Tedeschi, G., Oungre, E., & Bonomi, F. Primary structure of κ-CN isolated from mares‟ milk. 
Journal of Dairy Research. 2001. 68, 53. 
[42] Atkinson, S.A., Schnurr, C., Donovan, S.M., & Lönnerdal, B. Non-protein nitrogen components in human 
milk: biochemistry and potential roles. In S. A. Atkinson, & B. Lönnerdal (Eds.), Protein and non-protein 
nitrogen in human milk. Boca Raton, FL, USA: CRC Press. 1989. 117. 
[43] Walstra, P.,Wouters, J.T.M., Geurts, T.J. Dairy science and technology (2nd ed.). Boca Raton, FL, USA: 
CRC Press. 2006. 
[44] Aschaffenburg, R., Drewry, J. New procedure for the routine determination of the various non-casein 
proteins of milk. 15th International Dairy Congress. 1959. 3, 1631. 
[45] Chianese, L., Quarto, M., Pizzolongo, F., Calabrese, M.G., Caira, S., Mauriello, R., De Pascale, S., Addeo, 
F. Int. Dairy J. Occurence of genetic polymorphism at the αs1-casein locus in Mediterranean water buffalo milk. 
2009. 19, 181. 
[46] Krause, I., Buchberg, J., Weib, G., Pfluger, M., Klostermeyer, H. Electrophoresis. 9 1988. 609. 
[47] Mamone, G., Caira, S., Garro, G., Nicolai, M.A., Ferranti, P., Picariello, G., Malorni, A., 
Chianese, L., Addeo, F. 
Casein phosphoproteome: identification of phosphoproteins by combined mass spectrometry and two-
dimensional gel electrophoresis.  
Electrophoresis. 2003. 24, 2824. 
[48] Cohen, S.L., Chait, B.T. Anal. Biochem. Mass spectrometry of whole proteins eluted from sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis gels. 1997. 247, 257. 
                                                                                                                                      Chapter II 
 
106 
 
[49] Potargowicz, E., Rysz, J., Szerszenowicz, E., Olszewski, R., Nowak, D. Determination of selected 
biomarkers can be used in monitoring oxidative stress in the course of chronic failure. Pol Merkur Lekarski. 
2005. 18,105,358. 
[50] McSweeney, H.E. in: Fox, P.F., McSweeney, P.L.H. (Eds.), Advanced Dairy Chemistry. 
1. Proteins, Kluwer Academic/Plenum publishers, USA, 2003, p. 139. 
[51] Bevilacqua C., Ferranti, P., Garro, G., Veltri, C., Lagonigro, R., Leroux, C., Pietrolà, E., 
Addeo, F., Pilla, F., Chianese, L., Martin, P. Interallelic recombination is probably responsible for the occurrence 
of a new alphas1-casein variant found in goat species. Eur. J. Biochem. 2002. 269, 1293. 
[52] L. Ramunno, Direct Submission in EMBL/GenBank/DDBJ Databases, December 2008. 
[53] Larsen, L.B., Benfeldt, C., Rasmussen, L.K., Petersen, T.E. Bovine milk procathepsin D and cathepsin D: 
Coagulation and milk protein degradation. J. Dairy Res. 1996, 63, 119.  
[54] P´ellisier, J.P., Mercier, J.C., Ribadeau Dumas, B. ´Etude de la protéolyse des casein αs1 et β par la présure. 
Spécificité d‟action. Peptides amers libérés. Ann. Biol. Anim. Biochim. Biophys. 1974. 14, 343. 
[55] Rival, S.G., Fornaroli, S., Boeriu, C.G., & Wichers, H.J. Caseins and casein hydrolysates. 1. Lipoxygenase 
inhibitory properties. Journal of Agricultural and Food Chemistry. 2001. 49, 287. 
[56] Kyte, J. and Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. 
Biol. 1982. 157, 105. 
 
 
 
 
 
 
                                                                                                                                      
Concluding remarks 
 
107 
 
CONCLUDING REMARKS 
 
The analytical strategy developed in this PhD project, allowed us to evaluate the presence, 
production and bioactivity of peptides in milk and its derived products in two model cases as 
buffalo milk transformation in Mozzarella di Bufala Campana PDO (Chapter I) and donkey 
milk (Chapter II).  
The two model cases studied have been investigated by the application of proteomic and 
peptidomic procedures. Taking into account that the use of mass spectrometry for proteomics 
and peptidomics is not the application of a single technique for all purposes,  in this PhD 
thesis a collection of methodologies, each with strength suited to particular inquires, have 
been applied with the aim to obtain different information on protein/peptide nature, structure, 
functional properties, impact on human cell cultures and in the definition of their 
structure/relationship. Moreover, the integration of proteomic and biochemical methodologies 
allowed to identify bioactive peptides and to provide molecular basis to elucidate structure-
function relationships. 
The information acquired allowed us to conclude that milk is a complex biological system 
with the expression of proteins mixture arising from post-translational process, genetic 
polymorphism, alternative splicing. The technological process used for dairy production, 
further enhance the heterogeneity of the protein system by inducing proteolysis which give 
the formation of peptides mixtures more complex and with a more interesting biological 
activity on cell cycle modulation than that generated by milk endogenous proteases in milk. 
Moreover, the information acquired in the two model cases studied may drive production, 
utilization and design of bioactive compounds on the basis of their nutritional and economic 
significance and allowed us to hypothesize that the  general criteria used to asses food protein 
quality, based on proteins nutritional properties, should be revised according to the protein 
ability to release peptides with biological activity.
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